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BSR base specifying residue 
CRISPR clustered regulary interspaced short palindromic repeats 
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Zusammenfassung 
TALEs (Transcription Activator Like Effectors) sind Proteine, die von bakteriellen 
Pflanzenpathogenen der Gattung Xanthomonas über ein Typ III Sekretionssystem in 
Pflanzenzellen injiziert werden. In den Pflanzenzellen aktivieren TALEs Wirtsgene 
deren Expression das Wachstum oder die Verbreitung des Bakteriums begünstigen. 
Die TALE DNA-Bindedomäne ist aus 10-30 nahezu identischen, 33-35 Aminosäure-
langen Modulen (‚Repeats’) aufgebaut. Jeder Repeat bindet ein Nukleotid, wobei 
Aminosäure 13 die Basenspezifität definiert. Die bekannten Basen-
paarungspräferenzen der verschiedenen Aminosäuren in Repeat Position 13 - der 
sogenannte TALE Code – ermöglicht es TALE Proteine mit gewünschter DNA-
Bindungsspezifität zu generieren oder die DNA Zielsequenzen von TALEs 
vorherzusagen. 
In der hier vorliegenden Arbeit und den dazugehörigen Fachartikeln werden zwei 
neue Klassen TALE-ähnlicher Proteine charakterisiert. Zum einen die Bats 
(Burkholderia TALE-likes), des Bakteriums Burkholderia rhizoxinica. Zum anderen 
die MOrTLs (marine organism TALE–likes), die in einer marinen 
Metagenomdatenbank identifiziert wurden. Es konnte gezeigt werden, dass die DNA 
Zielsequenzen der hier beschrieben TALE-ähnlichen Proteine mit dem TALE-Code 
vorhergesagt werden können. Detailstudien zeigten jedoch, dass die Repeats eines 
Vertreters der MOrTLs geringere Basenspezifitäten aufweisen als die der typischen 
TALEs. Zusätzlich unterscheiden sich MOrTLs und Bats durch ihre Affinität und 
höheren Proteinstabilität von TALEs. Durch funktionale Analysen von 
Proteinchimären konnte gezeigt werden, dass Repeats von TALEs und den TALE-
ähnlichen Bat und MOrTL Proteinen untereinander kompatibel sind. Da Repeats von 
Bat und MOrTL Proteinen mit TALE Repeats funktional kompatibel sind, liefern diese 
neuen Proteinklassen auch wertvolles Rohmaterial für die Konstruktion von 
Chimären mit neuen Eigenschaften. 
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Summary 
Members of the plant pathogenic bacterial genus Xanthomonas inject TALEs 
(Transcription Activator Like Effector) by a type III secretion system into host plant 
cells. Inside the plant cells TALEs bind and activate host genes thereby promoting 
bacterial disease. The DNA binding domain of TALEs is modular and consists of 
imperfect 33-35 long tandem-arranged amino acid repeats. Each repeat binds to a 
single nucleotide with position 13, determining base specificity. The base specificity 
of distinct residues in position 13 is known as the TALE code. This TALE code 
provides the possibility to create custom TALEs with desired DNA target specificity or 
to predict DNA targets of native TALEs.  
This work characterizes two new members of the TALEs, called TALE-likes: (1) Bats, 
which derive from the bacterium Burkholderia rhizoxinica and (2) MOrTLs, whose 
DNA sequences were found in a marine metagenomics database.  We demonstrate 
that DNA binding preferences of these two classes of TALE-likes can be predicted 
with the TALE-code. Yet, some of the repeats have a lower base specificity than 
TALEs. Additionally the TALE-likes have a different affinity to DNA and higher protein 
stability compared to TALEs. Analysis of protein chimeras showed that repeats of 
TALEs and TALE-like proteins are compatible and can be used to create protein 
chimeras. The TALE-likes have different DNA affinities and protein stabilities as 
compared to the TALEs. They can be adapted to create new proteins and protein 
chimeras with new useful properties. 
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Introduction 
TALEs are effector proteins of plant pathogenic Xantomonads 
Members of the bacterial genus Xanthomonas infect a wide range of plants, including 
important crops such as pepper, tomato, rice and soybeans (Leyns et al., 1984). The 
gram-negative bacteria inject transcription activator like effectors (TALEs) into plant 
cells via the Type III secretion system (Rossier et al. 1999; Kay et al., 2007). TALEs 
are transported to the plant nucleus and transcriptionally activate the promoters of 
susceptibility genes (S-genes) to promote disease (Figure 1) (Bogdanove et al., 
2010).  
 
Figure 1: Model of the molecular function of TALEs. (A) After the infection of the plant by 
Xanthomonas campestris pv. vesicatoria (Xcv), TALEs are translocated by the Type III secretion 
system (B) into the plant cell (C). TALEs are transported into the nucleus (D), where they induce 
expression of specific target genes (E). Figure not to scale. 
Many S-genes encode sugar transporters or transcription factors, which can facilitate 
bacterial growth (Chu et al. 2006; Zhou et al., 2015; Hu et al., 2014; Sugio et al., 
2007). In resistant plants, plant immunity can be triggered by the detection of TALEs. 
There are at least four mechanisms for counteracting the pathogenic effect of TALEs:  
(1) Direct detection of the TALE protein by the plant disease resistance proteins 
harbouring nucleotide binding site–leucine rich repeat (NBS-LRR) domain structures 
(2) Mutation of a general transcription factor that interacts with the TALE 
(3) Mutation of the binding site of the TALE in the promotor of the S-gene
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(4) Activation of an executer gene by the TALE, whose promoter contains the TALE 
binding sequence (Gu et al., 2005; Römer et al., 2007; Ballvora et al., 2001; 
Schornack et al., 2004; Moscou & Bogdanove, 2009; Schornack et al., 2004). 
TALEs are modular DNA binding transcription factors  
The TALE protein is composed of 3 major structures: (1) The N-terminus, harbouring 
type III secretion signals and the N-terminal region (NTR) (Yang et al., 2000), the (2) 
central repeat region (CTR) that mediates DNA binding and consists of almost 
identical protein repeats (Bonas et al., 1989) and (3) the C-terminus, with nuclear 
localisation signals (NLS) (Yang et al., 2005b; Y. Yang & Gabriel, 1995b) and an 
acidic activation domain (AAD) (Yang et al., 2000; Zhu et al., 1998) (Figure 2).  
 
Figure 2: Model of the functional domains of a TALE. The TALE consists of the following domains 
(from N- to C-terminus): I) type III secretion signals (T3SS, red line). II) Four N-terminal cryptic repeats 
(green ovals, -3 to 0). III) central repeat region (CTR) with seventeen repeats (display of a typical 
repeat shown below, at position 12 and 13. The XX is a placeholder for amino acids called repeat 
variable diresidue (RVD), which varies throughout the central repeats). IV) Additional two cryptic 
repeats at the C-terminus (compare text). V) Nuclear localisation signals (NLS, yellow ovals). VI) A 
transcriptional activation domain (AD, red triangle). Model not to scale. 
Experimental and computational data (Boch et al., 2009; Moscou & Bogdanove, 
2009) supported by subsequent structural analysis (Deng et al., 2012; Mak et al., 
2012) demonstrated that the TALE’s nearly identical repeats in the CTR mediate 
sequence specific contact to the DNA. Each repeat recognizes a single base of the 
DNA. The TALE wraps around the DNA as a positive super helix, supported by its 
repeats. The repeats themselves are forming two alpha helices interrupted by a loop 
structure (Deng et al., 2012; Mak et al., 2012).  
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Figure 3: TALE structure. (A) and (B) Structure of the TALE PthXo1 DNA binding region in complex 
with its DNA target site. From Mak et al. 2009. Reprinted with permission from AAAS. (C) All TALE 
repeats have almost the same structure. Each repeat has a short (a) an and long (b) alpha helix 
connected by a loop where the two amino acids (position 12 and 13) of the RVD are located. From 
Deng et al. 2009. Reprinted with permission from AAAS. 
The majority of the binding energy is derived from the TALEs’ non-base specific 
interaction between the positively charged residues 16 and 17 of the repeats with the 
negatively charged DNA phosphate backbone (Deng et al., 2012). The TALE repeat 
array forms a single electropositive stripe around the DNA (Figure 3). While every 
repeat consists of almost identical amino acid sequences, the amino acids at position 
12 and 13 of each repeat are variable. Hence, they are referred to as repeat variable 
residues (RVDs). The amino acid at position 12 is oriented away from the DNA and 
connects to the amino acid at position 8 in the first helix of the repeat. The hydrogen 
of the 12th amino acid makes a direct hydrogen bond to the carbonyl oxygen of the 
amino acid at the position 8 (Deng et al., 2012). This bond constrains the RVD-loop 
and stabilizes it. Earlier, it was believed, that the RVD defines the base specificity, 
but later on it was discovered that the amino acid at position 13 is responsible for it; 
in most cases by direct contact with the DNA (Mak et al., 2012). This amino acid is 
therefore called base specifying residue (BSR) (de Lange et al., 2014a). The base 
preference of the most common RVDs HD, NG, NN and NI is C, T, G and A 
respectively (Boch et al., 2009; Moscou & Bogdanove, 2009). The interactions 
between the protein and DNA are mediated by hydrogen bounds (e.g. NN to G), 
nonpolar interactions (e.g. NG to T) or van der Waals forces (e.g. HD to C) (Deng et 
al., 2012; Mak et al., 2012). The base specificity is often achieved by negative 
discrimination, due to a physical and electrostatic clash between the “non-perfect-
match”-bases. For example the N* RVD (* depicts a missing 13th amino acid) allows 
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only pyrimidin bases, because there is a steric hindrance for purines (Cong et al., 
2012).  
Transcription factors typically activate only a limited number of genes, which is due to 
target specificity of their DNA binding domains. DNA specificity is defined by the 
affinity to the optimal sequence, compared to the affinities of all other possible 
sequences (off-targets). The base specificity of TALEs is generally very high, but not 
absolute. For instance, the interaction of amino acids I and D at position 13 of the 
repeat is highly specific to the bases adenine and cytosine respectively (Boch et al., 
2009). On the other hand, a strong interaction can also be observed between an N at 
position 13th and bases guanine and adenine (Boch et al., 2009; Miller et al., 2015). 
Even though in most cases the BSR is in direct contact with the DNA, its binding is 
still influenced by the 12th amino acid of the repeat (Miller et al., 2015; Rogers et al., 
2015). In case of H or N at this position, an overall higher protein activity could be 
observed (Miller et al., 2015). Furthermore, the second specifically bound DNA base 
of the TALE is in the most cases an adenine, whether it is supported by its BSR or 
not (Boch et al., 2009; Miller et al., 2015; Rogers et al., 2015). Other factors that can 
influence the specificity of TALEs are protein length (Meckler et al., 2013) and the 
identity of the adjacent RVDs. For instance it could be shown, that depending on the 
context, the RVD NN binds preferably to an adenine or guanine (Miller et al., 2015).  
Parts of the N-terminus consist of so called non-canonical or cryptic repeats (NTR), 
with lower homologies to the canonical repeats of the CTR (Gao et al., 2012; Szurek 
et al., 2002). The -3 to 0 repeats have the same overall structure as the canonical 
repeats, but seem to interact with DNA in a functionally distinct way as compared to 
the canonical repeats. The cryptic repeat -1 connects with a thymine base of the 
DNA (position 0 of the binding motif) by interaction with the tryptophan at position 
232 of TALE protein (Mak et al., 2012). Therefore most natural targets start with a 
thymine base (Boch et al., 2009; Moscou & Bogdanove, 2009). The other cryptic 
repeats do not show a base specificity. Instead of the BSR they contain a loop region 
spanning amino acids 11-15 (Mak et al., 2012). The NTR is important for the initial 
non-sequence-specific binding of the TALE to the DNA (Cuculis et al., 2015). This 
initial binding is almost independent of the DNA sequence (Gao et al., 2012) and 
facilitates sliding along the DNA. After this “nucleation event”, the CTR recognizes 
the DNA in a sequence specific fashion (Cuculis et al., 2015). Additional cryptic 
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repeats (+1, +2) are found at the C-terminus. It is known, that the +1 repeats exhibit 
base specificity (Boch et al. 2009).  
Natural occurrences of TALEs and TALE-like proteins 
Proteins with homology to TALEs (TALE-likes) are not restricted to the genus 
Xanthomonas but are also present in the bacterial plant pathogen Ralstonia 
solanacearum (de Lange et al., 2013; Hopkins et al., 1992) and Burkholderia 
rhizoxinica, a bacterial endosymbiont of a plant pathogenic fungus (Lackner et al., 
2011a; Schornack et al., 2013). Similar to TALEs, the TALE-likes of Ralstonia 
(RipTALs) are transported into the nucleus and have an activation domain at the C-
terminus to potentially activate genes in the host plant (de Lange et al., 2013). The 
function of the TALE-likes of Burkholderia (Bats) is unknown. While Xanthomonas 
TALE repeats differ mainly in their RVDs, RipTALs and Bats show amino acid 
sequence variation also in non-RVD residues of their repeats. TALE-likes use the 
same RVD code as TALEs, but the frequency of different RVDs varies. RipTAL 
repeats are functionally compatible with TALEs and interchangeable (de Lange et al., 
2013; Li et al., 2013). Unlike TALEs, RipTALs have a preference for G at position 0 of 
the binding site (de Lange et al., 2013). In contrast to TALEs, the RVDs of RipTALs 
are quite similar. While RipTALs and TALEs are transcriptional activators, the 
function of Bats remains cryptic. The challenging model system (pathogenic fungal 
symbiont) has made the characterization of the proteins in their natural context 
difficult (Lackner et al., 2011b; Lackner et al., 2009; Silipo et al., 2012). The protein 
characterization of the Bats is part of this work.  
The dawn of new genome engineering tools 
During the last few years, the geneticist’s toolbox consisting of DNA sequencing, 
restriction enzymes and PCR, got more powerful through the inclusion of 
programmable DNA binding proteins (PDPs). Some of them can be used to cut DNA 
and therefore act as a genome editing tool. With additional fusion proteins they can 
also mark loci, introduce epigenetic changes, activate or repress genes or exchange 
genomic regions (reviewed in de Lange et al. 2014a). To delete or modify a single 
gene and not to affect others is one of the major obstacles in modern biotechnology. 
It is therefore beneficial to have more than one technology of PDPs available as they 
exhibit different positive and negative characteristics depending on the application.  
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In the following chapters, three of the most used PDP systems are described: Zinc 
finger proteins, the CRISPR/Cas9 system and the TAL effectors.  
Zinc finger proteins 
Method of the year 2011 was the Zinc-finger Nuclease (ZFN) ("Method of the Year 
2011," Nature Methods, 2012). It consists of a specific Zinc-finger (ZF) DNA binding 
protein and a nuclease. The composite protein is able to cut DNA in vivo and in vitro. 
Generally ZF proteins used for genome engineering belong to the Cys2-His2 group 
of ZFs which carry the motif X2-Cys-X2,4-Cys-X12-His-X3,4,5-His in their protein 
sequence (Kim et al., 1996; Papworth et al., 2006). The zinc ion in the ZF is 
coordinated between an alpha-helix and an antiparallel beta-sheet by the two 
histidine and two cysteine residues. A ZF binding protein consists of several single 
zinc finger domains which are organized in tandem (Gommans et al., 2005). For 
sufficient binding at least two fingers are required. For biotechnological applications 
typically three or more fingers are used in tandem to bind a 9 to 12 DNA base pair 
long motif (Pabo et al., 2001). Each of these fingers binds to 3 bases of the major 
groove of the DNA (Fairall et al., 1993; Pavletich & Pabo, 1991). The specificity is 
defined by the alpha-helix (“recognition helix”, especially the amino acids at position -
1, 2, 3 and 6) of each finger that connects to the 3 or more DNA bases and produces 
an overlapping pattern of contacts with neighbouring zinc fingers (Fairall et al., 1993; 
Wolfe et al., 2000). Exchanging the amino acids at those positions will create a new 
ZF protein with a different binding specificity. Tandem arranged zinc fingers in the 
zinc finger binding protein are not independent functional units, but influence each 
other in their DNA specificity. This makes the design of a zinc finger binding protein 
non-trivial, especially for non-specialist researchers. Additionally, the overlapping 
contacts between adjacent fingers consist of Arginine residues, which enable a 
strong natural interaction with Guanines, limiting the flexibility of the target (Pavletich 
& Pabo, 1991). To facilitate the ZF design, a library of characterized ZFs is available 
from the “zinc finger consortium” (http://www.zincfingers.org/). 
The most commonly used ZF construct, is the Zinc finger nuclease (ZFN). It consists 
of the nuclease FokI fused to a ZF protein. FokI cuts DNA as a dimer, therefore two 
ZFN are needed, whose binding sites face each other (Bitinaite et al., 1998; Y. G. 
Kim et al., 1996). This leads to a double strand break, which is repaired by the cells 
non-homology end joining (NHEJ) or homology directed repair. The efficiency of 
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ZFNs is low: the mutation rate of the desired target is around 10% (Gabriel et al., 
2011; Kim et al., 2012; Kim et al., 2010). Double strand breaks are also prone to 
cause cell toxicity, if they occur in vital gene regions. Because they are highly 
mutagenic and the DNA binding specificity is not high, ZFN also exhibit off-target 
activity, which again can lead to cell toxicity (Beumer et al., 2006). Furthermore, to be 
useful in clinical applications zinc fingers have to be extensively screened (Carroll, 
2011; Perez et al., 2008; Urnov et al., 2005).  
Cas9/CRISPR 
The primary function of the Cas9/CRISPR system in vivo is to provide sequence 
specific und acquired immune defence in bacteria and archaea (Sorek et al., 2008). 
Of the three known types of Cas9/CRISPR mechanisms, the type II system is the 
best studied one.  
 
 
Figure 4: CRISPR/Cas9 system. A duplex of CRISPR RNA (crRNA) and the trans-activating CRISPR 
RNA (tracrRNA) recognizes the target DNA, which is then cleaved by the endonuclease domain of 
Cas9. From Doudna and Charpentier, 2014. Reprinted with permission from AAAS. 
Cas9/CRISPR is composed of two main elements (Figure 4): (1) DNA repeats 
interspaced by sequences derived from viruses (Clustered regularly interspaced 
short palindromic repeats (CRISPR)) and (2) the protein Cas9. Foreign DNA is first 
detected and added to the CRISPR array. The CRISPR locus is then transcribed and 
spliced. The processed product is called CRISPR-RNA (crRNA). The crRNA retains a 
portion of the spacers and the repeats and carries a short sequence motif, termed 
protospacer adjacent motif (PAM), which is essential to distinguish the viral DNA 
from the bacterial one. Additionally another non-coding RNA, the trans-activating 
CRISPR RNA (tracrRNA), is transcribed from the CRISPR locus. Thirdly, the crRNA 
forms a complex with the tracrRNA and directs Cas9 to the viral target DNA, the so 
called protospacer (O'Connell et al., 2014). The specificity of this interaction stems 
from Watson-and-Crick base pairing of the crRNA and the protospacer (Ran et al., 
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2013). Finally, the nuclease domain of the Cas9 protein makes double stranded 
breaks to the DNA with a two nucleotide overhang within the protospacer.  
Changing the sequence of the spacer region to target different loci in a genome turns  
the system into a programmable DNA cleaving enzyme (Jinek et al., 2012). For 
biotechnology purposes the system was simplified by linking together the crRNA and 
the tracrRNA to create a single RNA, called single guided RNA (sgRNA).  
At present the CRISPR/Cas9 is the preferred system for DNA editing as it does not 
because require protein engineering and is easily adapted. The sole required design 
element is the sgRNA, which is only limited by the short (3-5 bp) PAM DNA 
sequence. Furthermore “multiplexing”, that is introducing multiple sgRNAs, allows to 
simultaneously target different sites in the genome in the same cell/organism.  
Because of the reliance on DNA-RNA base pairing, the CRISPR/Cas9 system can 
bind to other sequences than the desired ones (“off-targets”). Usually up to 5 
mismatches are tolerated (Mali et al., 2013), sometimes even more (Wu et al., 2014). 
While binding of Cas9 can be observed to up to 6000 different targets in the genome, 
off-target cleavage is quite low (Wu et al., 2014). Several strategies are used to 
improve the specificity of the CRISPR/Cas9 system and thus to avoid or minimize 
these off-target effects. To optimize the sgRNA for less off-targets is not trivial, as 
demonstrated by several papers describing different conclusions about the design of 
the sgRNA (Fu et al., 2013; Hsu et al., 2013). Therefore, preferentially a nickase 
version of the Cas9 protein is used, which requires two sgRNAs to create a double 
strand break (Mali et al., 2013). Analogous to ZFN, the binding sequences have to 
face each other. While off-target prediction is not an easy task in itself, differences in 
expression levels can additionally affect the off-target occurrences (Mali et al., 2013).  
A nuclease deficient Cas9 (dCas9) that is unable to cleave DNA, was used to fuse 
other functional domains, like activation domains or epigenetic modifiers to target 
genome sites analogous to the ZF protein (Qi et al., 2013). However, due to the high 
potential for off-target-bindings, the CRISPR/Cas9 system is not ideally suited for 
such purposes.  
dTALEs 
The strictly modular organisation of the TALE DNA binding domain provides the 
conceptual basis to compose designer TALEs (dTALEs) with the desired target 
specificity. Through different fusion proteins, dTALEs are able to activate, repress, 
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cut, modify, recombine and mark DNA (reviewed in de Lange et al. 2014a). 
Countless kits and tools are available for the researcher to compile a dTALE with the 
desired binding sequence (Cermak et al., 2011; Morbitzer et al., 2011; Reyon et al., 
2012). Although only few reactions are necessary to assemble a dTALE construct, 
cloning and designing dTALEs is still not trivial for a non-specialist researcher. In 
theory, almost any sequence can be targeted (Meckler et al., 2013). The base 
preference for T in the N-terminus (T-0 limitation, see page 13) can be omitted by 
using different N-termini designed for different bases or strong binding RVDs and 
therefore the dTALE is able to bind any of the bases (Doyle et al., 2013; Lamb et al., 
2013). Polarity effects (repeats at the N-terminus contribute more to the specificity 
than those at the C-terminus) and the influence of RVDs on adjacent repeats are the 
major obstacles in dTALE-design (Mali et al., 2013; Meckler et al., 2013; Miller et al., 
2015; Rogers et al., 2015), as these can lead to off-target binding of TALEs (Lin et 
al., 2015; Mali et al., 2013; Mendenhall et al., 2013).  
Viral vectors are often used to integrate foreign DNA into mammalian organisms. It 
was observed that by viral transport (adenoviral, lentiviral) into a mammalian system, 
dTALE DNA repeats can be recombined and lost (Cai et al., 2014; Holkers et al., 
2013). The reason for this instability is probably that the almost sequence identical 
repeats are prone to polymerase slippage. This stability issue was tackled by 
synonymous codon exchanges (Yang et al., 2013), but could not be completely 
solved because of limitations due to codon usage.  
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Objectives 
Previous research has discovered homologues to the TALE protein, called TALE-
likes (de Lange, et al. 2013; Hopkins et al., 1992). While the TALE-likes from 
Ralstonia (RipTALs) were already described, the TALE-likes found in Burkholderia 
(Bats) and other organisms (MOrTLs) are not characterized yet. The aim of this study 
was to conduct a biochemical analysis of the Bat and MOrTL proteins using in vitro 
and in vivo approaches. These studies were intended to clarify if these TALE-like 
proteins act as functional DNA binding proteins and if they bind DNA according to the 
TALE code. A further goal was to localize Bat proteins in a human cell system and to 
investigate, if they can activate a reporter system in the human cells either by 
themselves or by creating a Bat fusion protein with an additional activation domain. A 
Bat activator was created in order to test if the Bat repeat array can be changed to 
target a new sequence of interest. Finally, we investigated if TALE-likes can be used 
to create chimeras with known TALE-likes.  
The overarching goal of these analyses was to compile a pool of TALE-like 
sequences, which can be used to create custom DNA binding proteins for a variety of 
biotechnological applications. 
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Discussion 
Bats and MOrTLs expand the group of known TALE-likes 
A few years ago it was believed that TALEs are unique in their function as modular 
DNA-binding proteins, whereby one module can bind a base in a one to one fashion. 
With the characterization of RipTALs (de Lange et al., 2013; Li et al., 2013), we 
learned that this class of proteins is not limited to the genus Xanthomonas, but that 
other organisms have proteins with similar characteristics. Universally, these proteins 
were classified as TALE-likes (page 7). In our previous work, we identified at least 
two new groups of TALE-likes, named Bats and MOrTLs (de Lange and Wolf et al., 
2014b; de Lange and Wolf et al., 2015)  
Bats are able to bind DNA in a sequence specific fashion 
Bats originate from the obligate endosymbiotic bacterium Burkholderia rhizoxinica, 
whose host Rhizopus microspores is a fungal plant pathogen (Lackner et al., 2009). 
In this mutualistic symbiosis, the bacterial endosymbiont produces an antimitotic 
macrolide called rhizoxin, which causes “rice seedling blight”, a severe plant disease 
that is affecting rice plants in Asia. Recently, the complete genome sequence of B. 
rhizoxinica was made available to the public by high-throughput sequencing (Lackner 
et al., 2011a; Lackner et al., 2011b). Three predicted proteins with homologies to 
TALEs were identified based on the sequenced genome. For two of them, 
designated Bat1 and Bat2, we demonstrated binding to their predicted DNA target in 
vitro whereas the third B. rhizoxinica protein, Bat3, was not able to bind DNA in an 
affinity assay (figure 2 (a) in de Lange and Wolf et al., 2014b). An explanation for that 
could be the reduced number of repeats of Bat3 (6) compared to Bat1 (20) or Bat2 
(26), which might be insufficient to effectively bind DNA. In agreement with this 
assumption, TALEs with less than ten repeats did not activate promoter-reporter 
constructs that contain corresponding binding sites (Boch et al., 2009).   
Although the Bat proteins share less than 40% identity with the consensus core 
repeat of TALEs from Xanthomonas, Bat1 and Bat2 bind to DNA targets predicted by 
the TALE code. As demonstrated in a competition assay, the base discrimination of 
Bat proteins is very stringent and appears similar to that of TALEs. In this competition 
assay, Bases 6-10 of a competitor DNA were replaced with the least favoured bases 
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for the corresponding binding element according to the TALE code. The competitor 
DNA containing the mismatches was not able to out-compete the TALE code-
predicted DNA probe of Bat1, even if this off-target competitor was added in 200-fold 
excess (figure 2 (e) in de Lange and Wolf et al. 2015). We performed the same 
experiment with a TALE, which had the same binding site preference as Bat1 and it 
also couldn’t be outcompeted with the same off-target sequence (figure 4 (e) in de 
Lange and Wolf et al., 2015). The measured specificity of Bats fits to previously the 
observed polarity effect for TALEs, which showed that altering DNA binding 
sequences at the 5’ end has a stronger impact than mismatches in the 3’ end (Mali et 
al., 2013; Meckler et al., 2013; Miller et al., 2015). 
The specificity of the protein-DNA interaction in TALEs is predominantly defined by 
the 13th amino acid of the repeat. Despite the low sequence identity, between TALEs 
and Bats, our data indicate that the Bats discriminate nucleotides exactly like TALEs, 
with similar specificity. This is in agreement with the Bats crystal structure and their 
structural model, which revealed a high level of similarity to the three dimensional 
structure of TALEs (Stella et al., 2014).  
The biological function of Bats is unknown 
For a long time it was not known how the natural TALE is contributing to the 
pathogenicity of Xanthomonas species. Their nuclear localization and the presence 
of an acidic activation domain demonstrated that TALEs are in planta transcription 
factors that activate host genes to promote disease (Kay et al., 2007; Marois et al., 
2002; Van den Ackerveken et al., 1996). At present, neither the localization nor the 
DNA targets of Bats are known. It is possible that Bats either act in the 
endosymbiotic bacterium, the fungal pathogen, the fungal host plant, or in several of 
these organisms. Given that Bats lack an obvious C-terminal activation domain it 
seems unlikely that they function as transcription factors. Yet, in the absence of 
molecular targets it will be difficult to substantiate this hypothesis experimentally.  
In contrast to the other TALE-like proteins (TALEs and RipTALs), the N-terminus of 
Bats, which is followed by the repetitive DNA binding domain, consists of only 17-18 
amino acids, with no predicted functional domains. The N-termini of TALEs and 
RipTALs have been shown to constitute functional type III translocation signals (de 
Lange et al., 2013; Mukaihara & Tamura, 2009; Rossier et al., 1999). These allow the 
bacteria to translocate effector proteins into plant cells, where they can activate 
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certain genes. For Bats we couldn’t detect any obvious type III translocation signals 
correlated with the Burkholderia genus type of translocation signals with prediction 
programs based on known secretion systems (Rainbow et al., 2002; Samudrala et 
al., 2009). If there is indeed no type III secretion system sequence present, it is 
unlikely that Bats are translocated into eukaryotic systems, be it the symbiotic fungi 
or plants.  
Supporting this hypothesis, no nuclear localisation signal (NLS) was predicted in 
Bats. It is possible, that Bats harbour a cryptic NLS, undetected by current 
algorithms, but most NLSs are conserved and can function across kingdoms (Chang 
et al., 2013; Guralnick et al., 1996; Lassner et al., 1991; Rhee et al., 2000; 
Vanderkrol & Chua, 1991). Therefore and because the natural system to study Bats, 
consisting of the bacterium B. rhizoxinica, the fungus R. microspores and the host 
plant, is not accessible in our lab, we decided to test the localization in a human cell 
system by transfection of HEK293T cells with the original Bat1 construct. However, 
no exclusive localisation to the nucleus or to other cell organelles was observed 
(figure 3 (b) in de Lange and Wolf et al., 2014b). This may suggest that Bats do not 
function in a eukaryotic cell system; instead it is possible that, if they are expressed, 
they act directly in B. rhizoxinica, where no translocation to the nucleus or to 
mitochondria would be required.  
The affinity of Bats was demonstrated to be more than 10-times lower than that of 
most TALEs to their perfect DNA binding site (figure 2 (b) in de Lange and Wolf et al., 
2014b; Meckler et al., 2013; Strauss et al., 2012). This could be another indicator that 
Bats are not transported to the outside of the bacterium, unlike TALEs. TALEs are 
secreted by a type III secretion system, which is limited in the amount of protein to be 
translocated (Enninga et al., 2005; Mills et al., 2008). The probability of binding a 
certain DNA site depends both on the affinity and the amount of proteins in the cell 
(Aurell et al., 2007; Bintu et al., 2005; Stormo, 1998; Stormo & Fields, 1998). Hence 
a high affinity can be important for proteins that are translocated via a type III 
secretion system, because of their limited abundance in the target cell. If the Bats are 
not translocated, but instead are acting as regulatory proteins in the bacterium itself, 
a lower binding affinity could actually be advantageous, as it could allow for 
regulation of Bat DNA binding activity by altering the available protein concentration 
in the cell. 
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By removing the activation domain, TALEs can function as transcriptional repressors 
(Blount et al., 2012). As no activation domain is predicted in the C-terminus of Bats, 
Bats could naturally act as repressors of gene expression. Alternatively, it is also 
possible that Bats recruit other proteins or signal molecules required for their native 
function. An example for this kind of regulation can be found in human cells, where a 
nuclear oncoprotein recruits factors to a DNA binding protein in order to repress 
transcriptional activation (Luo et al., 1999). It is possible that for the Bats’ native 
function, additional bacterial, fungal or plant factors are required, which are absent 
from the assayed human cell system (figure 3 (b) in de Lange and Wolf et al., 
2014b). Another option is that the transport of Bat proteins depends on the presence 
of helper proteins, which bind to the Bat and transport it to the plant or fungus. This 
so called “piggy-back” mechanism has been described for several other proteins 
(Wagstaff & Jans, 2009).  
Further research, including the study of Bats in their natural context, will be required 
to untangle the native function of Bats’ and to analyse if they are indeed expressed 
and active in the bacterial system.  
acBats can be used to address functional differences between Bats and TALEs 
In order to study the DNA binding properties of the Bats, we synthetically fused them 
to a transcriptional activation domain. These so called activator Bats (acBats) 
enabled us to study Bats in vivo by using simple promoter-reporter assays. 
The analysis of TALEs by promoter-reporter assays was carried out predominantly 
using a GUS-reporter. A disadvantage of standard GUS assays is that the 
expression of TALEs is not monitored and thus the data are not normalized. We 
therefore decided to use two distinct fluorophores to measure reporter activity and 
expression of the TALE-like protein in a single cell assay. Fluorescent reporters are 
an invaluable tool to study gene expression and are also commonly used to assess 
functionality of TALEs. The fluorescent readout was quantified by flow cytometry and 
both protein expression and transcriptional activation could be monitored through two 
distinct fluorophores, thus rendering protein extraction and quantification 
unnecessary. Additionally with more than 10,000 single cells measured, the 
reproducibility of the assay was very high. A chimeric protein consisting of an 
activation domain, a NLS and Bat1 protein, was capable to drive expression of a 
GFP reporter in the human cell line HEK293T (figure 3 (b) in de Lange and Wolf et 
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al., 2014b). In contrast to the Bat wildtype protein these chimeras could be studied as 
transcriptional activators (acBats), thus simplifying experimental comparisons of Bats 
and TALEs. Compared to an equivalent dTALE construct, the fluorescence read out 
of the Bat-fusion protein was lower (figure 3 (c) in de Lange and Wolf et al., 2014b). 
The comparatively weak fluorescence of the reporter could indicate that Bat1 has a 
lower DNA binding affinity than most TALEs (Mali et al., 2013; Meckler et al., 2013). 
Meckler et al., 2013 demonstrated that TALEs with a lower affinity to a DNA 
sequence also showed reduced fluorescence output in a reporter assay. Our analysis 
using microscale thermophoresis (MST) confirmed that the binding affinity to its DNA 
target was lower for Bat1 than that generally reported for TALEs to their perfect 
binding sequence (figure 2 (b) in de Lange and Wolf et al., 2014b; Meckler et al., 
2013). Another explanation for the low fluorescence of the reporter after the acBat 
induction could be due to a structural clash of the acBat with the C-terminal activation 
domain. It could be that the fusion of the activation domain hinders binding to the 
DNA or assembly of the transcription machinery.   
In summary, the established fluorescence in vivo reporter system provides a 
convenient tool to study functional differences between Bats and TALEs. In the future 
this reporter system could be used to characterize even minor differences in DNA 
binding of TALE-likes in a fast and reliable fashion.  
N- and C-terminal truncations of non-canonical repeats of Bat1 have an impact 
on reporter activation 
Besides the almost identical canonical repeats of TALEs, which are responsible for 
direct specific DNA binding, TALEs contain non-canonical repeats in the N- and C-
terminus, which are highly divergent at the sequence level. Due to the lower 
sequence homology in comparison to the core repeats they are also called cryptic 
repeats (Mak et al. 2012). 
We studied the possible contribution of the Bat1 N- and C-termini for binding DNA by 
analysis of truncation derivatives using the established human cell reporter assay 
(see page 25). For the Bat1 protein both N-terminal and C-terminal truncations 
reduced the fluorescence of the reporter considerably (figure 5 (b) in de Lange and 
Wolf et al., 2014b), indicating that the deleted regions contribute to DNA binding. In 
the case of the N-terminal acBat deletion construct, the reporter activity was reduced 
by 56% in comparison to the full length acBat1. For TALEs, removal of the cryptic 
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repeats in the N-terminus has a more drastic impact: For instance N-terminal 
truncations of TALEs can abolish all detectable DNA affinity (Gao et al., 2012) or 
reduce the DNA affinity tenfold compared to a full length TALE (Kay et al., 2007).  
 
Figure 5: Sequence alignment of the repeat -1 and 0 of the TALE AvrBs3 and Bat1. Identical 
amino acids are marked with red boxes. 
One explanation for the reduced affinity is that the N-terminus of TALEs is necessary 
for positioning the protein on the DNA and sliding it to the target sequence (Cuculis et 
al., 2015). The N-terminus of TALEs makes a significant, but non-base specific 
contribution to the DNA binding, an observation that we couldn’t confirm for Bats 
(figure 5 (b) in de Lange and Wolf et al., 2014b). The N-termini of Bats and TALEs 
differ both in size as well as in protein sequence. The comparison of the -1 and 0 
repeat of AvrBs3 and Bat1 shows only a limited sequence homology of 20-30% 
(Figure 5), which is even lower than the overall protein homology. A homology below 
30% generally indicates low conservation and potentially altered protein function 
(Koonin & Galperin, 2003; Pearson, 2013). It is therefore possible that the Bat-N-
terminus does not contribute as much to the overall DNA binding affinity as the N-
terminus of TALEs. The hypothesis that differences in the N-termini lead to changes 
in affinity could be tested by domain-swap experiments, where the N-terminus of 
Bat1 would be exchanged with the N-terminus of a TALE. Yet, it is possible that the 
Bat and TALE N-termini are functional only in their native context and thus the results 
of such experiments would have to be evaluated with caution.  
The C-terminal truncation construct of Bat1 (the removal of the last +1 cryptic repeat) 
was barely able to activate the reporter above background level (33% of acBat) 
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(figure 5 (b) in de Lange and Wolf et al., 2014b). Again, this is in contrast to the 
observation made for TALEs, where removal of the C-terminal cryptic repeats did 
only have a minor or no effect on their activity (Mussolino et al., 2011; Römer et al., 
2009).  
 
 
Figure 6: Sequence alignment of the consensus repeat of Bats and the +1 repeat of Bat1. Same 
amino acids are marked with red boxes. 
The primary structure of the +1 repeat of Bat1 is similar to that of the other canonical 
repeats, but their homology is very low (~33%) indicating a potentially different role in 
binding (Figure 6). It is possible that the highly positively charged residues at the C-
terminus of Bat1 contribute more to the binding to the negatively charged DNA 
phosphate backbone than the C-termini of TALEs. 
 
 
Figure 7: Comparison of the C-terminus non canonical repeats of Bat1 and AvrBs3. Seven of 
the thirty amino acids (~23%) of the C-terminus of Bat1 are charged, while only 7 of 69 amino acids 
(~10%) of the non-canonical C-terminus repeats of the TALE AvrBs3 are charged. Red letters indicate 
amino acids with charged residues. 
A positively charged molecular surface is predicted to be crucial for DNA binding 
proteins to form an electrostatic interaction with the negatively charged DNA 
backbone (Marcovitz et al., 2015). Especially arginine is a common amino acid in 
DNA binding proteins that mediates the DNA – protein recognition (Gordan et al., 
2013; Rohs et al., 2009; West et al., 2010). The N-terminus of TALEs, which is 
responsible for strong DNA binding, is highly positively charged. In comparison, the 
positively charged amino acids of the Bat1 C-terminus are, except for one, arginine 
residues, suggesting a strong contribution of the C-terminus in its interaction with 
DNA binding (Figure 7).  
  
29 
Truncations of canonical repeats of Bat1 reduce reporter activation 
Efficient transactivation by TALEs required the presence of least 10 canonical 
repeats (Boch et al., 2009). In Bats, repeat truncations also reduced the activity of 
the Bat1 activator, (figure 5 (a) in de Lange and Wolf et al., 2014b) suggesting that 
Bat and TALE repeats collectively contribute to DNA binding. Loss of two C-terminal 
repeats (latter half of repeat 20 and repeat +1 were retained) caused a 40% 
reduction of reporter activity as compared to full length acBat1. Larger truncations 
(acBat1 lacking four, six or eight repeats) resulted in derivatives incapable of 
activating the fluorescent reporter above background levels (figure 5 (a) in de Lange 
and Wolf et al., 2014b). In contrast to TALEs, where deletions down to 15 canonical 
repeats usually do not alter the TALE activity in vivo Briggs et al., 2012; Cermak et 
al., 2011, Bats were affected more severely by the loss of repeats (figure 5a in de 
Lange and Wolf et al., 2014b). It is possible that due to the highly diverged repeats, 
Bats are not as modular as TALEs. Accordingly, truncations may cause more severe 
structural and functional disturbances in Bats than in TALEs. A loss of repeats could 
interfere with the protein’s overall stability, thus leading to a drop in its activity. An 
alternate explanation could be that every repeat of the Bats contributes to the binding 
affinity of the full length protein. Losing repeats at the C-terminus could therefore 
result in an annihilation of the reporter’s fluorescence signal (figure 5a in de Lange 
and Wolf et al., 2014b).  
In conclusion, it seems that the structural characteristics of Bat repeats are different 
compared to those of TALEs and therefore the repeat structure of Bats probably 
follows a more complicated model.  
MOrTLs are likely fragmented genes 
The genetic diversity in marine microbial communities was assessed by the 
metagenomic Sorcerer II Ocean sampling expedition (Rusch et al., 2007). Two of the 
approximately 6000 open reading frames (ORFs), that couldn’t be matched to any 
known genes, were later characterized as TALE-likes (Juillerat et al., 2014). Just like 
TALEs, RipTALs and Bats, it is thought that these sequences are bacterial in origin, 
because of the size exclusion of the harvesting filter (de Lange and Wolf et al., 2015). 
Therefore we named them MOrTLs (marine-organism TALE–likes). 
The two TALE-likes ORFs, MOrTL1 and MOrTL2 share only about 37 % homology 
with TALEs and 33 % with each other (supplementary figure 1 in de Lange and Wolf 
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et al. 2015). It is possible that MOrTL1 and MOrTL2 stem from different marine 
microbial organisms, because of their low homology.  
To characterize the proteins, we tried to express and purify MOrTL1 and MOrTL2 in 
an E.coli system. Because MOrTL2 precipitated in inclusion bodies and couldn’t be 
purified (supplementary figure 3 (a) in de Lange and Wolf et al., 2015), DNA-protein 
binding experiments could only be performed with MOrTL1. By electro mobility shift 
assay (EMSA) we could demonstrate that MOrTL1 was able to bind DNA 
(supplementary figure 3 (b) de Lange et al., 2015). However, a very high amount of 
MOrTL1 protein (concentration over 0.8 µM of MOrTL1) was required for an electro 
mobility shift, indicating that the DNA binding affinity of the protein is very low. 
Interestingly, we could observe shifts with different migration patterns (supplementary 
figure 3 (b) in de Lange et al., 2015, potentially indicating a DNA to protein binding 
ratio other than the 1:1 ratio of TALEs to DNA. There are two possible explanations 
for this (Figure 8): (1) Multiple MOrTL1 proteins could attach to the target DNA via 
unspecific binding, resulting in the different shifts in the EMSA. (2) MOrTL1 could 
aggregate to form different multimers, which stick unspecifically to the DNA and 
produce different shift variants. It is known that TALEs in higher concentrations can 
aggregate and form dimers (Schreiber et al., 2015). The different shift species are 
therefore possibly an artificial effect resulting from the high protein concentrations, 
which are usually lower in living cells (Kim & O'Shea 2008, Sanguinetti et al. 2006, 
Liao et al. 2003, Gao et al. 2004). Additionally, as the MOrTL1 protein was purified 
from E.coli, the different shift species could be the result of interactions with native 
E.coli proteins of different molecular weight.  
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Figure 8: MOrTL1 EMSA hypothesis. DNA is detectable via fluorophore labelling. (A) the protein 
size of MOrTL1 is small enough to bind the DNA multiple times. Therefore different binding species 
can be observed. Alternatively (B), most TALEs tend to build aggregates. Therefore it is possible, that 
an aggregation product can produce different binding species, resulting in an observable laddering 
effect. 
Efficient TALE DNA binding was demonstrated to require at least 10 repeats 
(Schreiber & Bonas, 2014; Streubel et al., 2012). As MOrTL1 and MOrTL2 consist of 
only 8 and 10 repeats respectively, a low DNA binding affinity does not seem 
surprising. It is therefore possible that binding to the target DNA is not efficient 
enough in physiological protein concentrations.  
In TALEs, an important contribution to the DNA-binding ability is provided by the N-
terminus (Gao et al., 2012) and the C-terminus seems to have a similar role in Bats 
(figure 3 (a) in de Lange and Wolf et al., 2014b, see page 26). The two MOrTL 
proteins contain only short non-repeat N- or C-termini, which is different compared to 
those of TALEs, RipTALs and Bats. Interestingly, both N- and C-termini of MOrTLs 
show a higher resemblance to repeat fragments than any other N- or C- termini of the 
known TALE-likes (de Lange and Wolf et al., 2015). It is therefore probable that the 
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available MOrTLs sequences are incomplete and fragmented. The native full length 
gene products could code for longer N- and/or C-termini, which would be needed for 
the full functionality of the proteins.  
Because of the potentially incomplete sequence information, we decided to conduct 
follow-up experiments not with the predicted MOrTL1 and MOrTL2 proteins, but 
instead created chimeras containing repeats of MOrTL1 and MOrTL2 embedded in 
the repeat array of known TALE-Likes.  
TALE-likes for biotechnological applications 
Artificial dTALEs and their derived fusion proteins became one of the key tools in 
biology and biotechnology. With around 1000 publications since the year 2009, the 
interest in this technology is still high. The applications are manifold, ranging from 
cancer treatment to removing retro-viruses from the genome (reviewed in de Lange 
et al., 2014a). Nevertheless, many open questions and potential challenges 
regarding off-targets, affinities and specificities of TALEs remain (see page 19). The 
creation of new custom TALEs with different binding properties is a promising 
approach to generate optimized DNA binding proteins for many specific applications. 
A potential way to harness the advantages of both TALEs and TALE-likes and 
generate TALE variants with novel properties is to assemble chimeric versions 
containing sequences of both protein classes. An overview of the TALE like chimeras 
used in de Lange and Wolf et al. 2015 is shown in Figure 9.  
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Figure 9: Overview of TALE-likes and TALE-like chimeras. The predicted binding sequence is 
depicted beneath every protein. dTALE Bat1 is a designer TALE with the same binding site as Bat1, 
but with 17 canonical repeats. dTALE Bat1M1(3-7) and dTALE Bat1M2(4-8) are based on the dTALE 
Bat1, but have the repeats 6-10 exchanged with MOrTL repeats (MOrTL1 repeats 3-7 and MOrTL2 
repeats 4-8 respectively). Bat1M1(3-7) and Bat1M2(2-6) are based on the Bat1 protein, but repeats 6-10 
are exchanged with MOrTL repeats (MOrTL1 repeats 3-7 and MOrTL2 repeats 2-6 respectively). 
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Repeats of TALE-likes are compatible among each other 
We demonstrated that chimeric proteins combining Bats and TALEs are indeed 
functional. Using a T-DNA construct, DNA of TALE-Bat chimeras was delivered via 
A. tumefaciens into Nicotiana benthamiana and the expressed constructs 
successfully activated a GUS-reporter (figure 8 in de Lange and Wolf et al., 2014b). 
The structure of Bats (Stella et al., 2014) and its striking similarity to TALEs can 
explain the high level of compatibility between TALEs and Bats, despite their overall 
low homology (figure 1 in de Lange and Wolf et al., 2014b). It is likely that Bat 
repeats in a TALE backbone can make direct contacts to the DNA despite 
differences in the repeat lengths.  
We integrated an array of MOrTL repeats into Bat1 and TALE backbones, and 
analysed the chimeras’ specific DNA binding properties by EMSAs, Thermophoresis 
and in an in vivo reporter system (Figure 9, figure 2-5 in de Lange and Wolf et al. 
2015). All of the chimeric constructs, except for the one consisting of MOrTL2 
repeats in the dTALE backbone, bound the target DNA with the expected specificity 
according to the RVD code of TALEs. The dTALE-Bat1M2(4-8) protein could also be 
outcompeted by an off-target DNA sequence (figure 4 (e,f) in de Lange and Wolf et 
al., 2015), however, this was not observed for any of the other chimeras. Additionally 
the affinity of the dTALE-Bat1M2(4-8) construct was lower (5.4 µM ± 1 µM) than of the 
other tested constructs and those of TALEs in general (figure 4 (d) in de Lange and 
Wolf et al., 2015). The affinity of dTALE chimeras (MOrTL repeats in a dTALE 
backbone) was lower than the affinity of Bat1 chimeras (MOrTL repeats in a Bat1 
background). A reason for that could be an imperfect fit of the MOrTL repeats in the 
dTALE backbone, whereas the Bat backbone might provide a better structural match. 
The amino acid sequence of the MOrTL repeats is slightly more similar to Bat 
repeats than to TALE repeats (figure 1 in de Lange et al., 2015). A suboptimal 
interface between the repeats and the backbone could explain the observed reduced 
affinity. It was previously reported that in highly diverged repeats, the repeat order 
can influence binding specificity and measured activity (figure 6 in de Lange and Wolf 
et al., 2014b). This is in agreement with our observation that shuffling of Bat1 repeats 
in the Bat1 protein resulted in a loss of function (repeat order change) (figure 6 (a) in 
de Lange and Wolf et al., 2014b). It is conceivable, that the difference is caused by 
reduced protein stability, as a result of introducing foreign repeats into the TALE-
likes. However, molecular dynamics (MD) simulations indicated that the proteins are 
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stable (figure 6 in de Lange and Wolf et al., 2015). Moreover, no change in the 
melting points between the MOrTL-Bat chimeras and the dTALE-MOrTL chimeras 
compared to the Bat1 and dTALE proteins could be observed, also suggesting 
similar levels of protein stability (table 1 in de Lange and Wolf et al., 2015).  
In summary we were able to create functional chimeras with TALEs and both new 
TALE-like groups (Bats and MOrTLs) that could specifically bind to DNA according to 
the TALE-code. These chimeras can be used to create new DNA binding proteins 
with novel properties.  
Programmability of TALE-likes 
One possibility to use TALE-likes for biotechnological applications is to adapt them to 
bind new DNA sequences. As we showed de Lange et al., 2014b, Bat proteins have 
a high inter-repeat diversity, which allows the use of different reprogramming 
strategies, unlike for TALEs, where the sequence identity of each repeat is almost 
the same. We followed two designs approaches: (1) We retained the complete Bat 
backbone and only changed the RVDs (RVD-switch) and (2) we translocated whole 
repeats within the Bat proteins (Rep-switch) (figure 6 in de Lange and Wolf et al., 
2014b). To reduce variables in the assay, we attempted to keep the binding 
sequence for the new acBats as close as possible to the predicted Bat1 DNA binding 
sequence; even though we changed repeats and RVDs. The activation of the 
constructs was not affected or at least not in a predictable pattern in comparison to 
the full length acBat (figure 6 in de Lange and Wolf et al., 2014b). Changing the 
RVDs of the repeats 7, 8 and 9 (RVD switch) (figure 6 (a) in de Lange and Wolf et al., 
2014b, dBatRVDswitch2) increased the activity of the dBat in comparison to the 
acBat1 protein. For all the other dBatRVDswitch proteins, the activation was 
decreased or close to the activation observed for acBat1 protein (figure 6 (a) in de 
Lange and Wolf et al., 2014b). For the Rep-switch strategy none of our constructs 
showed a higher GFP activation as the acBat1 protein (figure 6 (b) in de Lange and 
Wolf et al., 2014b). The limited available permutations of the acBat1 construct (four 
Rep-switch and four RVD-switch constructs), however, were probably insufficient to 
detect a clear trend. In one Bat1 RVDswitch construct (dBatRVDswitch2) activation 
of the reporter was higher than in the original acBat1 construct. This indicates that 
the repeat scaffold is probably not co-evolved with its RVD for an optimal binding. 
Therefore adjustment of DNA binding properties is likely not as straightforward in 
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Bats as in TALEs. Previous other experiments also demonstrated (de Lange et al., 
2013; Miller et al., 2015; Rogers et al., 2015) that sometimes the non RVD backbone 
and the position of the repeat in context of the protein can influence the binding 
specificity and general affinity.  
We created designer Bats according to the RVD-switch and Rep-switch design 
strategies that bind a sequence in the promoter of the human Sox-2 gene (Zhang et 
al., 2011). These two dBats showed the same level of activation of the reporter as 
observed for the optimal sequence of the acBat1-construct. In order to compare the 
results, the dBat construct was designed with the same number of repeats as the 
corresponding dTALE construct. However, as native Bats contain more repeats than 
TALEs, the assembled dBat construct might not be long enough to bind the DNA 
efficiently.  Concordantly, the truncation of repeats was correlated with a reduction of 
acBat activity (figure 5 (a) in de Lange and Wolf et al., 2014b) and discussed here 
(see page 29). A dBat construct with a higher number of repeats should probably 
result in increased activation of the reporter gene. Using an off-target reporter we 
could demonstrate sequence specific activation of the reporter gene, making it 
possible to design dBats to bind to new targets. This reprogrammability was also 
confirmed in other publications (Beurdeley et al., 2013; Juillerat et al., 2014). 
MOrTLs are likely to have the same structural properties as the other TALE-likes and 
are predicted to form the same connections to the DNA as TALEs and Bats (figure 6 
in de Lange and Wolf et al., 2015). It is therefore likely that MOrTLs are also 
programmable. However, the known MOrTL protein sequences will probably be 
insufficient for biotechnological applications, as we demonstrated that the identified 
MOrTLs act only as low affinity DNA binding proteins by themselves (supplementary 
figure 3 (b) in de Lange and Wolf et al., 2015). A valid alternative would be the use of 
chimeras composed of MOrTLs and TALE-like repeats (figure 2 and 4 in de Lange et 
al., 2015).  
Bats have no zero base preference  
The -1 repeat in most natural TALEs shows a preference for a thymidine base at 
position 0 of the binding site (Boch et al., 2009; Moscou & Bogdanove, 2009; 
Schreiber & Bonas, 2014). The affinity to the DNA target is mediated by a tryptophan 
in the -1 repeat at amino acid position 232 (Mak et al., 2012). This base preference 
was shown to sometimes hinder active binding of a customized dTALE to its desired 
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target (Römer et al., 2010), while other data indicated that if the perfect binding 
sequence is present (from the -1 repeat downstream), the -1 repeat can be tolerated 
by any nucleotide (Meckler et al., 2013). The TALE-likes from Ralstonia, RipTALs, 
have sequence specificity for guanine at the 0 position of their binding site (de Lange 
et al., 2013). Indiscriminate binding to all the four DNA bases was recently achieved 
by synthetically designed -1-repeats, which are based on the N-terminus of a 
Xanthomonas TALE (Doyle et al., 2013; Lamb et al., 2013).  
While TALEs and RipTALs show different specificities at the base 0, we could not 
detect any statistically significant difference in the Bat1 construct in affinity 
measurements with different oligonucleotides altered at base 0 (figure 2 (c) in de 
Lange and Wolf et al., 2014b). This observation was confirmed by in vitro studies 
(Stella et al., 2014) and by an in vivo reporter system (Juillerat et al., 2014). It is 
possible that the affinity of position -1 to DNA is below the detection limit of the 
affinity measurement. As shown before, it is difficult to assess the affinity of the -1-
repeat (Gao et al., 2012). The affinities of the N-terminus of TALEs at repeat position 
-1 to different nucleotide were indistinguishable, while structural evidence indicated a 
strong binding of thymine with the tryptophan at amino acid position 232 (Mak et al., 
2012). 
Nevertheless, at present, all the evidence indicates that no base preference at the 
repeat position -1 in the Bat proteins exists (de Lange and Wolf et al., 2014b; Juillerat 
et al., 2014). Therefore the Bat N-terminus could be used to create novel TALEs with 
a wobble position at the -1 repeat and therefore allow for flexible target site selection.  
Engineering genetically stable repeats   
Gene therapy with viral vectors has great potential in treating a range of human 
diseases like cancer and permanent viral infections. With the development of new 
tools for site-specific genome editing and transcriptional controlling, a viral 
transportation system seems to be one of the solutions to introduce DNA into the 
human cells to perform gene editing. TALEs with their DNA repeats are prone to 
recombination in nature and in retroviral vectors (Yang et al., 2005a; Yang & Gabriel, 
1995a), likely because of their repetitive repeat sequence. For efficient control of 
genome editing it is necessary that the integrity of the TALE constructs is maintained, 
without loss or shuffling of repeats. One strategy to prevent recombination is the use 
of different synonymous codons (Yang et al., 2013). However, even with the 
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degenerated DNA code, it is almost impossible to generate highly diverged repeats. 
Another drawback is that an organism’s codon usage can lead to inefficient protein 
production, wrongly folded proteins or even to amino acid changes in the protein 
(Novoa & de Pouplana, 2012; Plotkin & Kudla, 2011; Spencer & Barral, 2012). The 
natural variation in TALE repeats is probably insufficient to substantially increase 
their DNA sequence stability (about 99% sequence identity) (Boch et al., 2009; 
Moscou & Bogdanove, 2009). By using TALE-likes either as full length binding 
proteins as demonstrated for Bats (see page 35) or by using single repeats of other 
TALE-likes in a dTALE or Bat background, TALE-likes can contribute to the 
sequence variability of the repeats.. These adaptions could provide DNA sequences 
coding for functional DNA binding proteins that are more stable in viral assays. 
Bats are more compact and stable than TALEs 
Bats were proven to be fully functional as full length DNA binding proteins (de Lange 
and Wolf et al., 2014b; Juillerat et al., 2014; Stella et al., 2014). Because of their 
smaller size compared to TALEs (figure 1 in de Lange and Wolf et al., 2014b), they 
could be a preferred option for many medical and biotechnological applications. As a 
general rule, smaller proteins are translated more efficiently with fewer failures in 
their amino acid code. Additionally, shorter mRNAs are also transcribed more 
quickly. Moreover, only small proteins and other biomolecules are able to effectively 
penetrate membranes and therefore lead to high bioavailability (Gupta et al., 2005).  
We demonstrated that Bat proteins are less temperature sensitive than TALEs. In an 
in vitro experiment, the measured melting point of Bat1 was around 44°C, while for 
the dTALE construct and its derivates it was around 30°C (table 1 in de Lange and 
Wolf et al., 2015). For medical applications in the human body under physiological 
conditions, this could negatively impact their usefulness. An assay in human cells 
demonstrated that cells grown at 37°C expressing TALENs showed decreased 
activity compared to cells grown at 20°C (Miller et al., 2015). A reason for the 
increased stability of the Bat1 protein could be the presence of two positive amino 
acid stripes along the DNA backbone (Stella et al., 2014) in comparison to one stripe 
in TALEs. Bat1 also dissociates two times slower as AvrBs3 from its DNA (Stella et 
al., 2014).  
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It is possible that TALEs may be more stable under native conditions. However, 
based on the experimental evidence, Bats could still offer an overall advantage in 
stability. 
Outlook 
TALE-likes offer great potential to improve the generation of customized and 
optimized DNA binding proteins for biotechnological applications. To that end, three 
different strategies can be employed: 
(1) Using full length proteins such as dBats (see page 35) as new binding domains. 
dBats could offer a higher protein stability, as discussed on page 38. 
(2) Creating repeat chimeras consisting of TALE and TALE-like repeats. Repeats of 
TALE-likes exhibit a lower repeat sequence identity compared to TALEs. Therefore, 
working chimeras (de Lange and Wolf et al., 2014b, de Lange and Wolf et al., 2015, 
discussed on page 34) could be viable options to increase the sequence diversity of 
repeats without loss of specificity, which is necessary for gene targeting. The 
assembly of chimeras is straightforward, as all the new TALE-likes bind the DNA 
according to the known TALE-code. By creating MOrTL1 and Bat1 chimeras, we 
could demonstrate that TALE-likes can have similar affinities and temperature 
stability.  
(3) Integrating single amino acid polymorphisms into TALEs. TALE-like repeat 
polymorphisms could be used as a template to create new functional repeats by 
exchanging single amino acids in existing TALE repeats. One major advantage with 
this strategy is the avoidance of repetitive and therefore potentially unstable DNA 
sequences (see page 37). Moreover, potentially tuneable TALEs with new properties, 
including different affinities, kinetics and base specificities stemming from different 
repeat backbones can be created. Adjustment of these properties could be used to 
fine tune gene expression and to assemble more elaborate gene cascades. 
The need to improve the current PDPs is there: Off-targets, bioavailability (protein 
size) and protein stability are some of the major challenges that have to be tackled 
before therapeutic genome editing will be feasible and save in humans using TALEs. 
Random testing of all possible combinations of amino acids in repeats is tedious. Our 
work on TALE-likes offers a starting point by providing a set of compatible, yet 
diverse repeat elements that can be used to improve programmable DNA binding 
proteins. 
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ABSTRACT
The tandem repeats of transcription activator like
effectors (TALEs) mediate sequence-specific DNA
binding using a simple code. Naturally, TALEs are
injected by Xanthomonas bacteria into plant cells to
manipulate the host transcriptome. In the laboratory
TALE DNA binding domains are reprogrammed and
used to target a fused functional domain to a ge-
nomic locus of choice. Research into the natural di-
versity of TALE-like proteins may provide resources
for the further improvement of current TALE technol-
ogy. Here we describe TALE-like proteins from the
endosymbiotic bacterium Burkholderia rhizoxinica,
termed Bat proteins. Bat repeat domains mediate
sequence-specific DNA binding with the same code
as TALEs, despite less than 40% sequence identity.
We show that Bat proteins can be adapted for use
as transcription factors and nucleases and that se-
quence preferences can be reprogrammed. Unlike
TALEs, the core repeats of each Bat protein are highly
polymorphic. This feature allowed us to explore alter-
native strategies for the design of custom Bat repeat
arrays, providing novel insights into the functional
relevance of non-RVD residues. The Bat proteins of-
fer fertile grounds for research into the creation of
improved programmable DNA-binding proteins and
comparative insights into TALE-like evolution.
INTRODUCTION
When the DNA binding code of transcription activator like
effectors (TALEs) was published in 2009 (1,2), a doorway
was opened for researchers to build custom DNA-binding
proteins. In nature, TALE proteins are injected by mem-
bers of the plant pathogenic bacterial genus Xanthomonas
into host cells. They act as eukaryotic transcription fac-
tors, inducing expression of targeted host genes that pro-
mote bacterial disease. This relies on a set of functional
domains within the protein (3). Upon injection into host
cells, nuclear localisation signals (NLSs) target TALEs to
the plant nucleus. There the central domain of the protein,
composed of tandem-arranged repeats, mediates sequence-
specific binding to the promoters of target genes. A C-
terminal transcriptional activation domain (AD) mediates
promoter activation. The unique repeat array, mediating in-
teraction of TALEs with DNA, has received great atten-
tion in the past years. Functional arrays are typically com-
posed of 10–30 repeats, each 33–35 amino acids in length
(3). Within repeats, variation is almost exclusively limited
to positions 12 and 13, termed the repeat variable di-residue
(RVD; 2). One repeat binds one base with specificity deter-
mined by the RVD. The TALE code refers to this 1-to-1
correlation and the base preferences defined by the distinct
RVDs, providing a simple guide for users. By modifying re-
peat number and RVD composition users can design cus-
tom TALE repeat arrays that target nucleotide sequences
of desired length and base composition.
Since the inter-repeat polymorphisms of TALE repeat ar-
rays are almost solely limited to the RVDs, reprogramming
of base specificity is straightforward. As a consequence of
the almost identical amino acid composition, each TALE
repeat forms a near identical structure irrespective of its po-
sition in the array (4,5). Accordingly, each repeat is com-
petent to make almost exactly the same inter-repeat in-
teractions regardless of the residues occupying the RVD
positions (4,5). Thus, changes to repeat number or posi-
tion do not perturb the network of inter-repeat interactions
that stabilize the superhelical structure formed by tandem-
arranged repeats. This allows each repeat to be treated as a
*To whom correspondence should be addressed. Tel: +49 7071 29 7 8745; Fax: +49 7071 29 50 42; Email: thomas.lahaye@zmbp.uni-tuebingen.de
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functionally independent module and isolates the RVD as
the only position within the repeat of interest to the user.
Functional domains of choice can be fused to the TALE
DNA binding domain and targeted to a predefined DNA
sequence. By now TALE-activators, repressors and nucle-
ases have been used extensively (6) andmore recently TALE
fusions mediating targeted epigenetic modifications have
also been described (7–9).
Work on the TALE-like proteins of Ralstonia
solanacearum, termed RipTALs, has revealed that they too
act as eukaryotic transcription factors and that RipTAL
target specificity is linked to RVDs as in TALEs (10).
Comparative analysis of TALE and RipTAL repeat arrays
also revealed functional differences, due to non-RVD
polymorphisms, which could be used to improve custom
TALE repeat arrays. Considering the ever-increasing use of
TALEs across fundamental and applied biology, it seems
sensible to further explore the natural diversity of this
protein class in order to identify new functional features of
benefit to users.
Burkholderia rhizoxinica is an obligate endosymbiotic
bacterium of the fungal plant pathogen Rhizopus mi-
crosporus (11). The genome of B. rhizoxinica strain HKI
0454 has been sequenced (12) and among the predicted pro-
teins are three with similarity to TALEs that we have termed
Bat (Burkholderia TALE-like) proteins. The gene encod-
ing the predicted Bat1 protein (Uniprot E5AV36, Gen-
Bank RBRH 01844) is located on megaplasmid pBRH01
while the predicted Bat2 (Uniprot E5AW45, GenBank
RBRH 01776) and Bat3 proteins (Uniprot E5AW43, Gen-
Bank RBRH 01777) are encoded on neighbouring, non-
overlapping open reading frames within plasmid pBRH02.
Evidence for DNA binding activity and use as a pro-
grammable DNA binding domain has been demonstrated
recently for Bat1 (alternatively designated BurrH; 13,14).
We investigated DNA binding properties of the three Bat
proteins, showing that Bat2 as well as Bat1 binds DNAwith
the same code as TALEs. We quantified the interaction of
Bat1 with its predicted target DNA bearing the four pos-
sible zero bases and found that, unlike TALEs and Rip-
TALs, Bat1 has no sequence preference at this position.
Bat proteins share limited sequence identity with TALEs
and also show greater inter-repeat diversity than TALEs or
the recently described RipTALs. However, alignments be-
tween repeats of these different proteins reveal a core set
of conserved residues that might be of use to identify fur-
ther members of this class. We show that the Bat proteins
can be used as modular DNA binding domains to medi-
ate targeted transcriptional activation or site-directedDNA
cleavage. However, in contrast to TALEs, no two repeats of
any Bat proteins are identical, with inter-repeat similarity
dropping below 50% in some cases. Because of this alter-
native approaches are possible for the customisation of the
DNA binding repeats. We explored two options: exchang-
ing whole repeats along with their RVDs or exchanging
RVDs only. We found that while one strategy seems prefer-
able, both are viable. In the process we gained evidence to
suggest that polymorphisms at non-RVD positions affect
binding domain function. Our observations suggest that the
Bat proteins may offer a more compact alternative to the
TALE platform for programmable DNA binding.
MATERIALS AND METHODS
Assembly of Bat1 and TALE expression constructs
Genes encoding the three Bat proteins were synthesized
with Escherichia coli codon usage (GenScript) in sepa-
rate BsaI-site flanked subunits (Supplementary Figure S4).
For E. coli protein production, these modules were as-
sembled via BsaI cut-ligation into a pENTR/D-TOPO
(Life Technologies) derivative bearing BsaI sites (overlaps
CACC-AAGG) within the LR recombination sites, cre-
ated using primers listed in Supplementary Table S2. The
genes were then transferred into pDEST-17 (Life Tech-
nologies). For human cell transfection and in vitro cleav-
age assays bat encodingmodules were assembled along with
BsaI-site-flanked modules encoding HA-NLS and NLS-
3xFLAG-VP64 AD domains (acBat1, human cell reporter)
or 3xHA/HA-NLS and HA-FokI (in vitro cleavage). Se-
quences are in Supplementary Figure S5. These were as-
sembled into a modified pVAX vector (Life Technolo-
gies) with combined Cytomegalovirus (CMV)/Sp6 pro-
moter and BsaI sites (AATG-GCTT), details and sequences
for mutational primers given in Supplementary Table S2.
The acBat1 truncation derivatives tested in Figure 5 were
carried out using polymerase chain reaction (PCR) on the
individual synthesized blocks of Bat1 prior to assembly, us-
ing the primers listed in Supplementary Table S2. To cre-
ate the acBat1 derivatives tested in Figure 6 modified as-
sembly blocks were synthesized with the same codon usage
as wild-type acbat1 (GenScript). To create the pSOX2 tar-
geted dBats tested in Figure 7, a DNA fragment encoding
the N- and C-terminal non-core-repeat sections of Bat1 was
synthesized with the same codon usage as wild-type acbat1
(GenScript; Supplementary Figure S11) and assembled into
the pVAX vector along with HA-NLS, NLS-3xFLAG-
VP64 constructs. The repeats were ordered as two blocks
for each dBat (Supplementary Figure S11) and added into
the expression vector between N- and C-terminally encod-
ing regions via BpiI cut-ligation.
The repeat domains of dTALEBat1mimic and dTALESOX2
were created using a previously described method (15). The
assembly of dTALEBat1mimic required modifications to the
toolkit. These included a novel level 2 vector, pUC57-CD-
DEST, to allow assembly of more than 17 core repeats. This
was created using PCR mutagenesis of pUC57 to insert
the BsaI sites using primers listed in Supplementary Table
S2. Repeats 4 NT, 5B NN, 4 ND, 7C NT, 1C NR, 3 ND,
7D NS and D 12 N* were created via PCR mutagenesis on
described repeat modules (15) or amplification from the re-
peats of avrbs3 using the primers listed in Supplementary
Table S2.
dTALEUPT AvrBs3 3x Bat1 rep2/6/8 /17 were created as previ-
ously described (10) with trimers synthesized by GenScript
with the sequences listed in Supplementary Figure S14,
while dTALEUPT AvrBs3 3x NI/NN/NG were created with the
aforementioned TALE assembly toolkit (15). Repeat do-
mains were assembled into pENTR-D-TALE rep BpiI-
AC (15) and then dTALEs transferred into T-DNA binary
vector pGWB641 (16) via LR recombination (Life Tech-
nologies).
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Protein purification
Genes encoding the three N-terminally His tagged Bat pro-
teins (Supplementary Figures S4 and S5) were expressed in
E. coli Rosetta (DE31) pLaqI (Novagen) as previously de-
scribed (17). In short, cells were induced at 30◦Cwith IPTG
for 3 h. After purification from cell lysate via TALON resin
(Clontech), proteins were dialysed against storage buffer
(480 mMKCl, 1.6 mMEDTA, 1 mMDTT, 12 mMTris-Cl,
pH 7.5; Slide-A-Lyzer, Thermo Scientific) and concentrated
(Amicon Ultra, Millipore).
Electrophoretic mobility shift assay
Equal amounts of 100 M 5’ Cy5 labelled forward strand
and unlabelled reverse strand oligonucleotides (Metabion)
were mixed 1:4 with annealing buffer (TALE storage buffer
without DTT or SodiumAzide). After heating to 100◦C for
10 min the mixture was allowed to cool to room tempera-
ture, then diluted 1/20 in annealing buffer. 2 l of 1 M
Bat protein was mixed with 16 l electrophoretic mobility
shift assay (EMSA) buffer (15 mMTris-Cl, 75 mMKCl, 2.5
mM DTT, 0.063% NP-40, 62.5 ng/l dI.dC, 0.125 mg/ml
BSA, 6.25% glycerol, 6.25 mM MgCl, 0.125 mM EDTA)
and incubated 5 min at room temperature. 2 l of target
DNA were added followed by a further 30 min incubation.
Total binding reactions were run on a 6% native polyacry-
lamide TBE-gel for 1 h at 100V, 4◦C. Cy5 labelled DNAwas
visualized with the FMBIO III Multi View (Hitachi).
Microscale thermophoresis
Binding affinity was measured using the Monolith NT.115
from Nanotemper Technologies. Bat1 was labelled with
the protein labelling kit RED (Nanotemper) according to
the manufacturer’s instructions. Differing concentrations
of unlabelled Bat1 target DNA (prepared as above) were
incubated with 100 nM Bat1 protein in microscale ther-
mophoresis (MST) buffer (Tris 20 mM [pH 7.4], NaCl 150
mM, 10 mM MgCl2 and 0.05% Tween). Samples were
loaded into NT.115 Hydrophilic Capillaries. Measurements
were performed at room temperature, using 40% LED
and 20% IR-laser power. Data analysis and Kd calcula-
tions were performed using Nanotemper Analysis software,
v.1.4.17 and Origin 9.1.
Assembly of target plasmids in vivo and in vitro reporters
For the analysis of reporter activation in human cells target
sites were assembled into a BsaI-digested pUC57 derivative
with BsaI sites (TAGA-GGAT) preceding a minimal CMV
promoter followed by a dsEGFP reporter gene (18; Sup-
plementary Figure S6). Target sites were introduced as an-
nealed primers (Metabion, annealing as for EMSAs), with
matching four base pair overlaps, and were ligated into the
BsaI cleaved vectors.
To create the target for the in vitro cleavage assay, BEBat1
was introduced into the transcriptionally silent Capsicum
annuum Bs3 promoter, previously cloned into pUC57, via
mutagenesis PCR (see Supplementary Table S2 for primers
and Supplementary Figure S6 for target sequences). The
Bs3 promoter derivatives used in Figure 8 were delivered in
modified binary vector pGWB3* upstream of a uidA (GUS)
reporter gene as previously described (10).
Transfection of HEK293T cells
HEK293T cells were grown in Dulbecco’s modified Eagle’s
medium––high glucose (Sigma-Aldrich) supplementedwith
10% FBS (Sigma-Aldrich), penicillin (100 U/ml) and strep-
tomycin (100 g/ml) in a 10% CO2 atmosphere. 5 × 105
cells were transiently transfected using Fugene (Promega)
according to the manufacturer’s instructions. Cells were
transfected with 3 g of Bat/TALE expression vector and
300 ng of the dsEGFP reporter plasmid.
Immunohistochemistry and microscopy
For microscopic analysis HEK293T cells were mounted
on poly-L-lysine coated glass slides. Forty-eight hours af-
ter transfection, the cells were fixed with 4% formalde-
hyde in phosphate buffered saline (PBS) for 10 min. Af-
ter permeabilisation with 0.5% Triton X-100 for 10 min,
the cells were incubated with 3% bovine serum albumin
(BSA) in PBS for 30 min. After 1 h incubation with the
primary antibody (1/200 diluted mouse monoclonal an-
tibody ANTI-FLAG M2 (Sigma-Aldrich) in PBS supple-
mented with 0.05% Tween-20 (PBS-T) and 3% BSA), cells
were washed three times with PBS-T. Cells were then incu-
bated with 1/600 Alexa Fluor 594 rabbit Anti-Mouse IgG
(Invitrogen) in PBS-T with 3% BSA for 1 h. After wash-
ing three times with PBS-T, nuclei were counterstained with
4,6-diamidino-2-phenylindole (DAPI) and stored in 90%
Glycerol in PBSwith 0.25%DABCO. Images were acquired
and processed using a Leica TCS SP5 confocal microscope
equippedwith anHCXPLAPOCS63x 1.2Water objective.
Images were processed using Leica AF and ImageJ (14).
FACS analysis of transfected HEK293T cells
Flow cytometry measurements of GFP and Alexa Fluor
594 were performed with a Becton-Dickinson FACS-Aria
II. HEK293T cells were harvested, pelleted by centrifuga-
tion at 500 x g for 5 min at room temperature and gently
washed with PBS. Cells were fixed with 4% formaldehyde
in PBS for 10 min, pelleted by centrifugation at 500 x g
for 5 min and permeabilized with 0.5% Triton X-100 for 10
min. After pelleting, the cells were incubated in 3% BSA for
30 min and then with mouse monoclonal antibody ANTI-
FLAG M2 (Sigma-Aldrich, 1/100 dilution in PBS-T with
3% BSA) for 1 h. Subsequently, the cells were pelleted and
washed three times with PBS-T and incubated with Alexa
Fluor 594 rabbit anti-mouse IgG (Invitrogen, 1/500 dilu-
tion with PBS-T with 3% BSA) for 1 h. The cells were then
pelleted and washed three times with PBS-T, stored in 500
l PBS and analysed with FACS. Data were analysed using
FlowJo V 10.0.6 (Tree Star). dsEGFP values for cells with
above-threshold (Supplementary Figure S13) Alexa Fluor
594 fluorescence were used in Figures 3, 5–7.
In vitro nuclease assay
bat1-FokI and TALE-FokI genes were expressed in vitro
using the Sp6 Quick coupled Transcription/Translation
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system (Promega) as per manufacturer’s instructions. Tar-
get DNA was PCR amplified from the previously assem-
bled Bs3p derivatives using primers listed in Supplemen-
tary Table S2 and purified (GeneJET Gel extraction and
DNA clean up Microkit, Life Technologies). Two hun-
dred nanogram of PCR product was incubated with 5 l
transcription/translation product for 3 h at 37◦C in cleav-
age buffer (1x restriction enzyme buffer 4, New England
Biosciences, 1 ml/ml BSA, 500 nM NaCl). Reactions were
terminated by heating to 60◦C and DNA was separated
(with kit as above). One hundred nanogram of DNA pu-
rified from the cleavage reaction was run on a 2% agarose
gel. DNAwas visualized via ethidium bromide staining un-
der UV light. Size estimation was made in comparison to
a standard ladder (GeneRuler 100 bp plus, Fermentas) and
band intensities were measured with ImageJ (14).
GUS assays
dTALE or reporter constructs were transformed into
Agrobacterium tumefaciens (GV3101) via electroporation.
Strains were grown overnight in YEB medium containing
rifampicin and kanamycin (each 100 g/ml; for pGWB3*
containing strains) or rifampicin and spectinomycin (each
100 g/ml; for pGWB641 containing strains), collected
by centrifugation, resuspended in inoculation medium (10
mMMgCl2, 5 mMMES, pH 5.3, 150 M acetosyringone)
and adjusted to an OD600nm of 0.8. For GUS assays equal
amounts ofA. tumefaciens strains containing 35S-promoter
driven dTALE genes and reporter constructs containing
corresponding binding boxes fused to the reporter gene
uidA (GUS) weremixed prior to inoculation. Leaf tissuewas
harvested after 48 h and GUS quantification was carried
out as described (10).
RESULTS
Three TALE-like proteins are encoded in the genome of B.
rhizoxinica strain HKI-0454
The Bat polypeptides are formed entirely of repetitive se-
quences with similarity to those of TALEs (Figures 1A,
Supplementary Figures S1 and S2), excluding 17–18 amino
acids at the very N-terminus (non-repetitive N-terminal do-
main; NND). This contrasts from all known TALEs and
RipTALs, which possess N-terminal and C-terminal non-
repetitive domains of between 100 and 300 amino acids each
(Supplementary Figure S2) that are crucial to transloca-
tion and their in planta function as transcriptional activa-
tors (3,10). The Bat proteins can be divided into a set of core
repeats all >45% identical to each other at the amino acid
level and cryptic repeats not reaching this threshold (Figure
1B, Supplementary Figures S1 and S3; alignments gener-
ated with Clusal Omega 19,20). Core repeats are so named
as they form the central, and largest, section of the studied
polypeptides. Bat1, Bat2 and Bat3 have 20, 26 and 6 core
repeats, respectively. The core repeats are framed by two N-
terminal (−1, 0) and one C-terminal (+1) cryptic repeat in
each Bat protein. The sequence identities of the various do-
mains of the Bat proteins to each other are given in Supple-
mentary Table S1.
Figure 1. Sequence-based comparison of TALE-like proteins. (A) Com-
parison of TALE (AvrBs3) and Bat architecture. The lengths of all do-
mains are drawn to the indicated scale, except the dashes representing core
repeats. TALE domains are shown in blue and Bat domains in purple.
Rectangles indicate the N-terminal non-repetitive domain of each while a
triangle indicates the non-repetitive C-terminal domain of TALEs includ-
ing the transcriptional AD. Ovals represent core repeats, hexagons repre-
sent cryptic repeats (repeat number is indicated above). (B) Alignment of
Bat1 core repeats, generated with Clustal Omega and Boxshade. Repeats
are shown in order of appearance in the polypeptide. Repeat numbers are
given on the left and positions within the repeat, including the RVD (in-
dicated by an orange bar) above. (C) A consensus repeat generated from
this alignment is compared to similarly generated consensus repeats from
Bat2, Bat3, Brg11 (RipTAL) and AvrBs3 (TALE). From these a set of 10
hyper-conserved residues termed the consensus TALE-like repeat (CTR)
was generated. The RVD positions are excluded from this. Repeat residues
previously identified as involved in stabilising intra-molecular interactions
from structural studies in TALEs (4) are highlighted with red lettering in
the AvrBs3 consensus repeat, while the residues forming the first and sec-
ond alpha helices (4) are underlined.
Consensus core repeats were deduced for each of the three
Bat proteins (Figure 1B and Supplementary Figures S3).
Bat1, 2 and 3 consensus repeats are 73–94% identical (Fig-
ure 1C, Supplementary Table S1). Each of the three Bat
core repeat consensus sequences is less than 40% identi-
cal to equivalent consensus repeats of AvrBs3 and Brg11
(AvrBs3 from X. campestris pv. vesicatoria and Brg11 from
R. solanacearum GMI1000 are used here as the represen-
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Figure 2. In vitro interaction studies of Bat proteins with predicted DNA
targets. (A) Electrophoretic mobility shift assays were carried out for Bat1,
2 and 3 using 5’Cy5 labelled double-stranded DNA, bearing target se-
quences deduced from the TALE code. Each protein (100 nM) was tested
against each target DNA (10 nM). Cy5 fluorescence was visualized af-
ter running through a native polyacrylamide gel. A shifted band, running
slower on the gel, indicates the protein–DNA complex. (B) The interac-
tion between Bat1 and its target (BEBat1) was quantified using microscale
thermophoresis. The fluorescence ratio over the thermophoretic jump is
shown on the y-axis against DNA concentration. Standard deviation for
four repetitions is indicated.Measurements were made with 40%LED and
20% laser power. The dark grey line indicates the Kd fit. (C) This was re-
peated for BE Bat1 derivatives bearing A (grey bar), C (filled stripes) or G
(spotted) at the zero position. The Kd was calculated in each case and is
shown compared to that with BEBat1 (T0, empty bar).
Figure 3. A Bat1 derived transcriptional activator (acBat1) is functional
in a human cell reporter assay. (A) Schematic drawing showing the do-
main composition of acBat1. NLSs (yellow bars), a 3xFLAG tag (red cres-
cent line) and a VP64 AD (green triangle) were fused onto Bat1 (purple)
via flexible linkers (orange). This was introduced into HEK293T cells via
transfection alongside a DNA reporter (grey) bearing BE Bat1 (purple) up-
stream of a dsEGFP coding sequence (green). Transcriptional activation
of the reporter (green arrow) follows binding to BE Bat1, leading to produc-
tion of dsEGFP protein (green star). acBat1 is detected via the 3xFLAG
epitope with use of an Alexa Fluor 594 labelled secondary antibody. (B)
Alexa Fluor 594, dsEGFP and DAPI fluorescence are shown for trans-
fected cells. acBat1 is compared to derivatives lacking AD (acBat1AD)
or NLSs (acBat1NLSs) and to a dTALE created with the same NLSs
and AD and with the same core repeat number and RVD composition as
Bat1 (dTALEBat1mimic). The scale bar indicates 10 m. (C) FACS analysis
was used to quantify dsEGFP fluorescence for transfected cells express-
ing acBat1, AD derivative or dTALEBat1mimic as well as cells transfected
with the reporter only. dsEGFP values are shown for the whole population
(curves) as well as boxplots showing fold changes in fluorescence intensity
compared to the reporter control. Boxplot whiskers represent the 2.5% and
97.5% data limits.Median values are written next to or inside each box plot
and shown graphically with thick black lines.
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Figure 4. In vitro assessment of Bat1-FokI nuclease activity. Bat1- and
TALE-FokI fusion proteins were expressed in vitro and equal volumes
of transcription-translation product were incubated with a purified PCR
product bearing two copies of BEBat1 in reverse complement, separated
by 5–19 base pairs. A target with a control sequence replacing the Bat1
target boxes was also used. After 3 h incubation at 37◦C DNA was puri-
fied from the nuclease reactions and run on a 2% agarose gel to discrimi-
nate cleaved and uncleaved DNA (indicated with arrows and illustrations
on left side). Cleavage efficacy was calculated from the ratio of cleaved to
uncleaved DNA band intensities in each lane with ImageJ (14). Full and
striped bars indicate activities of the Bat1-FokI and TALEN constructs
respectively. ND = none detected.
tative TALE and RipTAL, respectively). The Bat proteins
thus form a highly diverged subgroup of the protein class
referred to throughout this publication as ‘TALE-likes’ to
mean TALEs, RipTALs and Bat proteins. Despite the high
sequence diversity of repeats among TALE-like proteins, 10
residues are conserved in almost all TALE-like repeats and
formwhat we term the ‘consensus TALE-like repeat’ (CTR;
Figure 1C). The CTR includes residues clustering around
the RVD as well as other residues, such as V22 and L29,
able to form stabilising intra-molecular bonds in the crys-
tal structure of DNA-bound TALE dHAX3 (Figure 1C; 4).
Given their sequence conservation, the CTR residues are
likely to make key contributions to the structure and func-
tion of the TALE repeat.
Bat1 and 2 mediate sequence-specific DNA binding with a
code matching the TALE code
TALEs and RipTALs mediate sequence-specific DNA
recognition with each core repeat recognising one DNA
base and specificity determined by RVDs (the TALE code).
We tested whether Bat proteins function similarly. In Bat
proteins inter-repeat variability is not limited to the RVDs
(positions 12 and 13), in fact position 12 varies very little
and the diversity peaks between positions 23–30 (Figure 1B
and Supplementary Figure S3). However, we continue to re-
fer to positions 12 and 13 in Bat repeats as the RVD for con-
sistency. The base specificities of most RVDs found in the
Bat proteins are known from studies on TALEs and Rip-
TALs allowing us to predict target sequences in each case.
The single NR repeat (RVDs and their corresponding re-
peats are referred to with the single letter amino-acid code
throughout) of Bat1 and the three repeats of Bat2 lacking
both RVD residues were paired to Guanine and Thymine,
based on presumed molecular similarities to NK and N*
repeats, respectively.
Genes encoding His-tagged versions of the three Bat pro-
teins were synthesized, expressed in E. coli (see Supplemen-
tary Figures S4 and S5 for sequences), purified and assayed
for binding capabilities in EMSAs against their predicted
binding elements (BEBat1, BEBat2 and BEBat3) (Figure 2A;
sequences in Supplementary Figure S6). Bat1 and 2 both
produced clear shifts in combination with their predicted
targetDNAs only (Figure 2A). Bat3, which has only six core
repeats, was unable to produce a clear shift with any of the
target DNAs (Figure 2A). Previous tests with TALEs have
shown little activity with TALEs possessing fewer than 10
core repeats (1). It thus seems likely that Bat3 is either non-
functional as aDNA-binding protein ormediates veryweak
interactions, not detectable in this assay.
Bat1 and 2, those displaying DNA binding with a clear
sequence preference, are more similar to each other than ei-
ther is to Bat3 (Supplementary Table S1). The Bat1 and 2
consensus core repeats are 94% identical. Considering the
close homology of Bat1 and 2, DNA binding properties are
likely conserved and only Bat1 was further characterized.
Bat1 binds its predicted target with an affinity within the up-
per boundary of TALE–DNA interactions and without base
discrimination at the zero position
MST experiments were carried out to measure the bind-
ing strength of Bat1 with BEBat1. We found a disassociation
constant (Kd) of 132 nM (Figure 2B). Affinities of TALEs
with their target DNAs have been measured at 0.3 to>1000
nM (17), depending on the RVD composition. Yet, stronger
interactions than that shown in Figure 2B are thought to
be necessary for the in vivo function of TALEs. For exam-
ple, the interaction of TALE AvrBs4 with its target site in
the promoter of the pepper Bs4C resistance gene was previ-
ously measured by MST to have a Kd of 18.1 nM while the
interaction with the homologous sequence from the non-
activated bs4C allele had a Kd of 181.5 nM (21). Given
that the affinity of Bat1 to BEBat1 is similar to the affinity
of AvrBs4 to the non-activated bs4C allele, it is too low to
suggest a strong interaction when assuming near-identical
physiological conditions. This assumption may not be valid
as, for example, the concentration of Bat proteins at the na-
tive site of action may differ from that of TALEs on de-
livery by Xanthomonas bacteria. Alternatively, BEBat1 may
not represent the optimal binding sequence or additional
endogenous factors may promote interaction in vivo.
BEBat1 was created in accordance with the TALE require-
ment for a thymine at the zero position (T0 preference).
However, the RipTALs do not share the T0 preference and
instead activate only G0 targets (10). Therefore, we carried
out further MST experiments with the different N0, bases
to clarify whether the T0 preference holds for Bat1 or if an-
other base is preferred. We found that in fact no significant
differences were seen in the Kds of the different N0 base
target DNAs (Figure 2C and Supplementary Figure S7 and
Table S3). This accords with the results of Juillerat et al. (22)
using an in vivo reporter system. All further experiments
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Figure 5. Functional analysis of acBat1 repeat truncations. Tests were carried out as described (Figure 3). Flow cytometry measurements of dsEGFP
fluorescence are displayed as population distributions (top) or box plots (centre). Distinct colour codes are used throughout the whole figure and correspond
to indicated constructs. Boxplots show fold changes in fluorescence intensity compared to the reporter control with whiskers representing the 2.5% and
97.5% data limits.Median values are written next to or inside each box plot and shown graphically as thick black lines. Cartoon representations of the tested
truncations are shown below. Dashed lines with scissors indicate fixed (black) and variable (coloured) truncation points. Bat repeats and fused domains of
acBat1 are represented as in Figure 3A. (A) Within the repeats grey or purple indicate truncated or retained regions, respectively. (B) N- (NTD) or C-
(CTD) terminal truncations were tested. NND is the short non-repetitive N-terminal domain at the N-terminus of Bat1.
were carried out using T0 targets to allow optimal condi-
tions for comparison to TALE controls.
The fusion of NLSs andAD are sufficient to convert Bat1 into
a targeted transcription factor in human cells and in planta
Having demonstrated that Bat1 binds its predicted target se-
quence in vitro, we developed a Bat1 derivative to function
in vivo as a transcriptional activator and tested this with re-
porter assays. A Bat1 transcriptional activator (acBat1) was
created through translational fusion of a viral NLS and a
VP64 AD. A 3xFLAG epitope tag between NLS and VP64
domain (Supplementary Figure S5) allowed for antibody-
based protein detection using an Alexa Fluor 594-tagged
secondary antibody. We measured the ability of acBat1 to
activate a dsEGFP-based reporter gene (18) in human cells
(HEK293T; Figure 3A). A custom TALE-activator con-
struct was tested in parallel. Termed dTALEBat1mimic, it has
the same repeat number and RVD composition as Bat1 and
the same fused domains (Figure 3A, Supplementary Fig-
ures S5 and S8). Immunostaining showed that the acBat1
and dTALEBat1mimic both localized to the nucleus, while
acBat1-NLS, lacking the NLSs, did not localize to the
nucleus. This demonstrates that NLSs must be added to
Bat1 in order to target it to the nucleus in human cells
(Figure 3B). dsEGFP expression in cells expressing acBat1
showed that it is able to activate the reporter. By contrast,
cells expressing a derivative lacking the AD (acBat1-AD)
showed onlyAlexa Fluor 594 fluorescence, but did not show
dsEGFP fluorescence indicating that the reporter was not
activated (Figure 3B). Fusion of an AD is thus necessary to
convert Bat1 into a functional transcriptional activator in
human cells.
acBat1 induced the reporter 5-fold, while the
dTALEBat1mimic induced the reporter 20-fold (Figure
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Figure 6. Functional analysis of designer (d)Bat constructs generated by RVD (A) or repeat switch (B). dBats were tested using flow cytometry with a
transcriptional activation reporter as described (Figure 3). dsEGFP fluorescence values are displayed as population distributions (top) or boxplots (centre).
dsEGFP values are normalized to the reporter only control (Supplementary Figure S13), which was BEBat1 for all constructs except RVD switch 1 and 2
(Supplementary Figure S6). Boxplots show fold changes in fluorescence intensity compared to the reporter control with whiskers representing the 2.5%
and 97.5% data limits. Median values are written next to or inside each box plot and shown graphically as thick black lines. dBat design is outlined below
in each case. Coloured boxes indicate the repeats (ovals) modified in a given dBat. In the case of the RVD switch (A) modified repeats are highlighted with
darker grey. RVDs are shown and colour coded by type. Arrows indicate the rearrangement of RVDs between repeats. In the case of the repeat switch (B)
repeats are coloured to indicate that each has a unique set of non-RVD residues. Arrows indicate movement of whole repeats within the array.
3C). This may indicate that dTALEBat1mimic has a higher
affinity for BEBat1 than acBat1 does. Alternatively, the
activity of the C-terminally fused VP64 AD may be
differentially affected by the architecture of each fusion
protein.
To study functionality of acBat1 in planta, a correspond-
ing T-DNA construct was delivered via A. tumefaciens into
Nicotiana benthamiana leaves. In this assay, constitutively
expressed acBat1 activated a co-delivered uidA reporter
gene downstream of a promoter bearing BEBat1 (Supple-
mentary Figure S9). In analogy to the results observed in
human cells, the dTALEBat1mimic control was able to acti-
vate the reporter in plant cells to 3-fold higher levels than
acBat1. In sum, we were able to show that acBat1 can tran-
scriptionally activate a promoter with its target sequence in
both human and plant cells.
Fusion of a FokI domain to the C-terminus of Bat1 creates a
sequence-specific DNA nuclease
The most common approach for the creation of TALE-
nucleases (TALENs) is a C-terminal translational fusion to
a FokI endonuclease domain. Since the FokI endonuclease
is active only as a dimer, interaction of two FokI domains
is achieved by placing neighbouring TALEN target sites on
opposite strands in reverse orientation promoting interac-
tion of the FokI monomers after DNA binding. The FokI
dimer catalyses formation of a double-strand break in the
DNA spacer region between the two TALEN target sites.
We created an analogous architecture using Bat1 to con-
fer DNA binding specificity and compared its activity in an
in vitro cleavage assay against the corresponding TALEN
(dTALEBat1mimic-FokI; sequences given in Supplementary
Figure S5). As target DNA we used a PCR product bear-
ing two copies of BEBat1 in reverse orientation on oppo-
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Figure 7. Functional analysis of designer (d)Bat constructs targeting the
human SOX2 promoter. dBats were tested using flow cytometry with
a transcriptional activation reporter as described (Figure 3). Population
curves for dsGFP fluorescence are shown (top) as well as boxplots of flu-
orescence intensities (bottom) compared to the reporter control (logarith-
mic scale). Boxplots show fold changes in fluorescence intensity compared
to the reporter control with whiskers representing the 2.5% and 97.5%
data limits. Median values are written next to each box plot and shown
graphically as thick black lines. Two dBats, designed based on the RVD
(dBatSOX2 RVD switch) or repeat switch (dBatSOX2 repeat switch), and an equiv-
alent dTALE were tested.
site strands. We generated derivatives differing only in the
length of the DNA spacer separating the targets (Supple-
mentary Figure S6) in order to determine the spacing be-
tween the two target sites that would result in the highest
activity of the Bat-FokI fusion proteins. As a negative con-
trol, we tested a template with a control sequence instead of
the Bat1 target sites.
Bat1-FokI and dTALEBat1mimic-FokI were expressed in
vitro and equal volumes of reaction product were incubated
with the target DNA. After 3 h at 37◦C the DNA was size
fractionated on a 2% agarose gel (Figure 4). Both Bat1
and TALE nucleases were able to cleave the target con-
structs. By contrast, the controls lacking target sites were
not cleaved, indicating that Bat1-FokI, like the TALEN,
is target specific in its DNA cleavage. The highest efficacy
shown by Bat1-FokI was 35% cleavage (11 bp spacer) while
dTALEBat1mimic-FokI had amaximum efficacy of 86% cleav-
age (19 bp spacer; Figure 4). That dTALEBat1mimic-FokI
showed greater flexibility with respect to spacer length may
relate to the previously optimized architecture employed
(18). TALEN architecture is known to play a decisive role
in spacer preference (23). Similarly, alternative Bat1 trunca-
tions or peptide linkers might allow for the creation of Bat1
nucleases with greater flexibility in spacer length.
Figure 8. Functional analysis of Bat1 repeats within the context of a TALE
repeat array. Trimers of identical Bat1 repeats or TALE repeats with the
same RVDs as the Bat1 repeats were embedded into the repeat domain of
the 17-repeat TALE AvrBs3 that targets the pepper Bs3 promoter (Bs3p).
Repeats 5–7 (3xRVDNI in AvrBs3) where replaced either by TALE repeat
trimers with the RVDs NN or NG or by trimers of Bat1 repeats 2, 6, 8 and
17. This is shown in cartoon form with dTALE regions shown in light grey
with the trimer of Bat1 repeats or dTALE repeats shown aswhite ovals. The
grey rectangle and triangle indicate the nativeN- andC-terminal regions of
AvrBs3, respectively. RVDs are given in each case and the matching bases
in the target box underneath. The resulting chimeras (striped bars) were
tested for their ability to activate a Bs3p derivative bearing the match-
ing binding site upstream of a uidA (GUS) reporter gene and compared
to non-chimeric dTALEs (filled bars) with the same RVDs. Dashed lines
separate groups of constructs all with the same RVDs and tested against
the same reporter. Barred lines indicate standard deviation. Two-tailed t-
tests were used to compare chimeric and non-chimeric dTALEs for each
reporter. A double asterisk indicates a P-value of below 0.02 and n.s. indi-
cates a P-value of above 0.05.
The paradigm underlying the modification of core and cryptic
TALE repeats cannot be applied to Bat1
In both natural (3) and custom TALEs, the number of core
repeats is flexible, within a certain range. The number and
position of cryptic N- and C-terminal repeats are typically
inflexible, though alternative repeat −1 modules have re-
cently been described (24,25). We tested acBat1 deletion
derivatives to test if this paradigm applies to Bat1.
First, we tested variants of acBat1 lacking 2 (18–20),
4 (16–20), 6 (14–20) or 8 (12–20) core repeats (Figure
5A and Supplementary Figure S10). The later half of repeat
20 and repeat +1 were retained in each case. These trunca-
tions were tested against the BEBat1 reporter and produced
varied levels of reporter activation (Figure 5A). acBat1-
18–20 was able to activate the reporter more than 2-fold,
corresponding to 40% activity of wild-type acBat1. The
other truncation derivatives were unable to activate the re-
porter to levels above background. If we assume that each
repeat contributes a certain amount of affinity to the Bat1–
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BEBat1 interaction then fewer than 17 repeats may simply
be insufficient for an interaction strong enough to lead to
reporter activation. This is in accordance with results from
TALE repeat arrays showing that a certain number of core
repeats are necessary for downstream reporter gene acti-
vation (1). Alternatively, the novel interface formed within
the last repeat in each truncation derivative may create un-
favourable intramolecular interactions, reducing protein ac-
tivity. This explanation would not apply to TALEs where
repeats are near identical and repeat order does not change
the interface between repeats. Given the numerous non-
RVD polymorphisms between Bat1 repeats, deletion or in-
sertion of core repeats will always create novel repeat inter-
faces and should be experimentally validated before use in
downstream applications.
We next tested acBat1 derivatives where the 82 residues
N-terminal of core repeat 1 (acBat1NTD; lacking repeats
0 and −1), or the 30 residues C-terminal of core repeat
20 (acBat1CTD, lacking repeat +1) were deleted (Figure
5B and Supplementary Figure S10). Whilst acBat1NTD
showed a modest reduction in activity (56% of acBat1),
acBat1CTDwas barely able to activate the reporter above
background (Figure 5B). This does not match expectations
based on TALEswhere only the cryptic N- but not the cryp-
tic C-terminal repeats are essential for DNA binding (26).
By contrast, our results suggest that the cryptic C-terminal
Bat1 repeat +1, in contrast to the corresponding cryptic
TALE repeat +1, makes an unexpectedly strong contribu-
tion to activity and thus should be retained for the creation
of active Bat1-based transcriptional activators.
Despite high inter-repeat diversity designer Bat1 proteins
(dBats) with wild-type levels of activity can be assembled
The non-RVD residues of Bat1 repeats are highly polymor-
phic. This provides a means to study the functional rel-
evance of non-RVD polymorphism in the native Bat1 as
well as being relevant for the creation of Bat1 derivatives
with novel specificity (dBats). We hypothesize that non-
RVD polymorphisms may have two functionally relevant,
non-mutually-exclusive, effects. (i) The formation of unique
but functionally equivalent repeat interfaces that stabilize
the superhelical structure formed by tandem-arranged re-
peats (4,5) (superstructural hypothesis). (ii) The creation of
unique scaffolds optimized for the native RVD residues in
each case (RVD scaffold hypothesis).
We used two different dBat designmethods to test our hy-
potheses. These are the repeat switch and the RVD switch.
Sequences of the dBats created can be found in Supplemen-
tary Figure S11. In the repeat switch whole repeats, includ-
ing their native RVDs, were exchanged. This creates new
interfaces between repeats but leaves RVDs in their native
repeat context. If the superstructural hypothesis is correct
then the repeat switch is likely to modify evolved repeat in-
terfaces possibly yielding less active DNA-binding proteins.
In the RVD switch it is only the RVDs that are changed
while all non-RVDs remain unchanged. This design will not
change repeat interfaces but will place RVDs in non-native
repeat scaffolds. If the RVD scaffold hypothesis is correct
then the RVD switch will reduce activity due to RVDs be-
ing sub-optimally oriented in relation to the paired DNA
bases.
RVD composition and target sequence are key parame-
ters determining affinity of TALE–DNA interactions and
these were kept constant in our dBat tests as far as possi-
ble. For the repeat switch tests, we exchanged repeats with
RVDs paired to the same base in BEBat1 allowing the wild-
type target construct to be used in each case. For the RVD
switch constructs, where possible we exchanged RVDs with
the same target base (dBat RVD switch 3 and 4) and tested
these constructs against BEBat1. Where this was not possi-
ble exchanges were made between repeats in close proxim-
ity to one another to reduce any influence from an N- to
C-terminal polarity effect as known for TALEs (17,27–29).
These were then tested against BEBat1 derivatives with the
appropriate minormodifications in base composition. Thus
any differences we see in activity are likely to be linked to
effects arising from manipulation of repeats and not to dif-
ferences in RVD composition or target sequence.
We found that despite the minor modifications in each
case the different dBat constructsmediated strikingly varied
levels of reporter activation. Of the four RVD switch con-
structs two were superior in activation level compared to
acBat1 (2.9x and 1.4x relative to acBat1; Figure 6A). The
other two dBat derivatives were slightly reduced in their ac-
tivity as compared to acBat1 (0.56x and 0.72x relative to
acBat1; Figure 6A). Overall, the impact on activity of the
RVD switch constructs showed no single trend with some
superior and some inferior to the wild type. Of the four re-
peat switch constructs none reached the activation level of
acBat1 (Figure 6B). Notably, dBat repeat switch 3, in which
core repeats 11 and 12 were exchanged, was unable to in-
duce the reporter above background levels. Thus the repeat
switch constructs all showed reduced activity compared to
the wild type, and some dramatically so.
These data support that inter-repeat interfaces are unique
and optimized (superstructural hypothesis) though whether
the same is true for RVD scaffolds is not clear. That the
RVD switch constructs performed differentially suggests
that RVD scaffold can have a functional impact. However,
the natural scaffold does not seem to be the optimal one in
every case.
Custom dBats can be created to target a novel, user-defined
sequence
We next tested whether the Bat1 repeat array could be fully
customized to target a sequence of interest. Based on the
two alternative strategies described above, dBatSOX2-RVD
switch and dBatSOX2-repeat switch were created to activate
a dsEGFP reporter driven from a minimal CMV promoter
containing a binding element taken from the human SOX2
promoter (Supplementary Figures S6, S8 and S11 for pro-
tein and reporter sequences). The SOX2 protein prevents
determination in human neural stem cells and has previ-
ously been a target for dTALE studies (30). Both dBat re-
peat arrays were limited to 18 repeats instead of the wild-
type 20 to bring them in line with the length of custom
TALE repeat arrays commonly produced with our toolkit
(15). The same NLS and VP64 fusions were used as for the
assays displayed in Figure 3A. Both dBats were able to ac-
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tivate the reporter to similar levels (Figure 7) suggesting
that both the RVD and repeat switch strategies can yield
successful constructs. dBatSOX2-repeat switchmediated 4.8x
reporter activation and thus was slightly more active than
the dBatSOX2-RVD switch (4.4x reporter activation). How-
ever, as seen previously (Figure 6), results can be surpris-
ingly varied even between very similar dBat constructs and
any potential design should be tested first in a reporter sys-
tem before further application. Cross-reactivity assays test-
ing the SOX2 dBats on the BEBat1 reporter showed that they
were unable to activate the non-target reporter above back-
ground (Supplementary Figure S12) indicating that target
specificity is maintained in the dBats. Further work on the
creation of Bat1-based arrays and fusion proteins may im-
prove activity levels. In conclusion, wewere successfully able
to reprogram the Bat1 protein for the creation of transcrip-
tional activators with novel specificity.
TALE-Bat1 chimeras show varied activity but may be a
means to harness the sequence diversity of Bat1 repeats
While the activation achieved with the SOX2 dBats was
encouraging a custom TALE-activator for the SOX2 pro-
moter (dTALESOX2) activated the reporter more than 200-
fold (Figure 7). It may be possible to improve the activation
levels achieved with dBats through further work on con-
struct design and indeed Bat1 nuclease activities matching
the corresponding activities of corresponding TALE nucle-
ases were previously reported (22). However, another pos-
sibility is to create chimeric proteins to combine desirable
features of both the Bat and TALE repeat scaffold.
We tested the principle of creating TALE-Bat chimeric re-
peat domains utilising a simple assay approach previously
used in our lab to test chimeric TALE-RipTAL repeat ar-
rays (10). Three identical copies of different Bat repeats were
used to replace three repeats in a dTALE targeting the pep-
per Bs3 promoter (Bs3p). These were then tested in planta
against a reporter construct bearing a Bs3p fragment up-
stream of a uidA (GUS) gene. Three different reporters were
used with triple A, G or T at the position that should be
bound by the inserted Bat repeats in order to test repeats
with different RVDs. In each case comparison was made
to a dTALE assembled using only TALE repeats with the
same RVD as the Bat repeats. As with earlier dBat tests
we found strikingly different results for different constructs
(Figure 8).
dTALEAvrBs3 3xBat1 rep2, a dTALE bearing three copies of
Bat1 repeat 2 (RVD NI) at the test positions, gave a sig-
nificantly weaker induction of the reporter compared to
the control with TALE repeats only (dTALE AvrBs3 3xNI).
dTALEAvrBs3 3xBat1 rep8 (RVD NN) was barely able to elicit
any detectable activation, unlike its TALE repeat equivalent
(dTALEAvrBs3 3xNN). In contrast, dTALEAvrBs3 3x Bat1 rep6
(RVDNI) and dTALEAvrBs3 3xBat1 rep17 (RVDNG) activated
their reporters to a level not significantly different from the
TALE repeat control constructs. It is not possible to clarify
whether differences in functionality arise from performance
differences betweenBat or TALE repeats in their native con-
firmations or if the differences arise due to the formation
of novel and likely unfavourable inter-repeat interactions
in these chimeric constructs (see superstructural hypothesis
above). The functionality of any potential chimeric binding
domain is likely to depend on both the particular repeats
utilized and their arrangement within the repeat domain.
However, we have demonstrated that such chimeric repeat
domains containing some Bat1 repeats can be functional to
the same level as TALE repeat equivalents paving the way
for further development and applied uses.
DISCUSSION
The Bat proteins, together with the TALEs and RipTALs,
form the TALE-like protein class. Like the other TALE-
likes, Bat proteins mediate sequence-specific DNA binding
with specificity predicted from the established TALE code.
This functional similarity likely correlates to a structural
similarity since DNA recognition proceeding via the TALE
code relies on a particular structure that places position 13
of each repeat in close proximity to a single DNAbase (4,5).
Indeed modelling the structure of Bat1 based on the known
structure of TALE Pthxo1 binding to its target DNA (5)
suggests that the whole Bat1 polypeptide would form a se-
quence aligning closely to the TALE core repeat domain
(Supplementary Figure S15).
Comparison of the core repeats of distinct TALE-likes
enabled us to define a set of conserved residues, the CTR,
as a unifying feature of the TALE-like proteins (Figure 1C).
TheCTRcould be a useful tool to scan databases for further
TALE-likes. In addition, the conservation of CTR residues
suggests that they have an important functional relevance.
Intriguingly, the CTR residues do not include some repeat
residues such as K16, which have been shown to provide
a large contribution to non-base-specific DNA binding, or
H33, suggested as key to stabilisation of the TALE repeat
(31). Conversely, some CTR residues such as L29 cannot
currently be linked to a certain key function. Thus, inves-
tigation of the TALE-likes provides an interesting window
into the opportunities for and constraints on sequence di-
versification whilst maintaining protein function.
We have demonstrated that the Bat1 protein itself can be
taken as a targeting module for transcriptional activation
(Figure 3) and nuclease function (Figure 4). The repeat ar-
ray can also be reprogrammed to target a sequence of in-
terest (Figure 7). Unlike the reprogramming of TALEs, al-
ternative design strategies must be considered to generate
Bat1 repeat arrays with desired base specificity and we have
successfully employed two conceptually distinct design ap-
proaches (Figure 6). However, Bat1 and derivative fusion
proteins were outperformed by equivalent TALE fusions
(Figures 3, 4 and 7). This may relate to the relatively low
affinity of Bat1 for BEBat1 (Figure 2B) compared to known
affinities of TALEs for their natural target boxes. However,
the TALE platform has been optimized over several years.
The creation of high activity TALE-nucleases, in particular,
has been a focus of many labs. Thus, with further work to
improve activity, the Bat platform may prove a more com-
pact alternative to TALEs for targeted DNA binding with-
out any zero base preference to be taken into account (Fig-
ure 2C). Alternatively, Bat repeats could be assembled along
with TALE repeats to create chimeric DNA-binding pro-
teins with novel properties. At the very least the inclusion
of some Bat repeats into TALE repeat arrays would lower
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sequence identity between repeats, useful for some cloning
strategies, and possibly alleviating the previously reported
problem of recombinatorial repeat loss (32). That Bat1 re-
peats can be integrated into a dTALE whilst retaining func-
tionality is shown in Figure 8, but since no two Bat1 re-
peats are identical, so too must each Bat1-TALE chimera
be treated as novel and requiring experimental validation
before further use.
Functionally relevant differences between TALEs and
Bat proteins were discovered upon attempting to modify
the repeat domain. Bat1 showed surprisingly little tolerance
to reductions in repeat number below 18 repeats (Figure
5A). These results seem to be in agreement with analysis
of TALE proteins where a minimum number of repeats was
needed to achieve in vivo function (1). The conclusion that
has been drawn from such analysis is that each TALE repeat
contributes something towards affinity and that a certain
number of repeats are required to achieve the affinity nec-
essary for in vivo function. However, the situation for Bat
proteins is more complex. Due to the numerous non-RVD
polymorphisms between each repeat (Figure 1B), a novel in-
terface is formed when truncations are made within the re-
peat domain and these could have functionally deleterious
consequences. Indeed the results of rearrangements within
the repeat domain (Figure 6B) suggest that this is so.
A further difference between Bat1 and TALEs is the rel-
ative impact of truncations of the N- and C-terminal cryp-
tic repeats. The N-terminal cryptic repeats of TALEs make
a decisive contribution to DNA affinity such that their re-
moval fully ablates DNA binding (26). By contrast, the lim-
ited evidence available suggests that the C-terminal cryp-
tic repeats of TALEs contribute little to affinity and speci-
ficity. This includes the independently observed (17,27–29)
N- to C-terminal reduction along the binding domain of
contribution to base specificity. In addition, TALE fusion
proteins with truncations in C-terminal cryptic repeat +2
(Supplementary Figure S2) are active (18) suggesting that
any affinity contribution is not decisive. Thus in TALEs
the N-terminal cryptic repeats seem to contribute more to
DNAbinding than theC-terminal cryptic repeats. This con-
trasts to our findings based on truncations of the N- and
C-terminal cryptic repeats of acBat1. We found that the N-
terminal truncation had a modest impact on reporter ac-
tivation and did not contribute to specificity (Figures 2C,
5B and Supplementary Figure S7 and Table S3), whilst the
truncation of the single C-terminal cryptic repeats almost
entirely ablated activity (Figure 5B). This repeat may be
important for DNA binding and the high proportion of
positively charged residues (8/30; Supplementary Figure
S1) is in agreement with a possible contribution to inter-
action with the negatively charged DNA phosphate back-
bone. Sequence comparison of the cryptic repeats of Bats
and AvrBs3 (see Supplementary Figures S1 and S2) showed
that the 0 repeats share a few residues (L1, L7 and K8) not
found in theCTR (Figure 1C) but no such unique conserved
residues can be found among the –1 or +1 repeats. Together
with the results shown in Figure 5B it appears that, at both
the sequence and functional level, at least the cryptic re-
peats –1 and +1 of Bats and TALEs are likely to be non-
homologous.
Through the exploration of dBat assembly strategies,
we gained insights into the functional significance of Bat1
non-RVD polymorphisms. These polymorphisms provided
amolecular handle to question differentmodels. The results
of these experiments are possibly specific to Bat proteins but
most likely are relevant to the non-RVD polymorphisms of
other TALE-like proteins. The RVD switch constructs (Fig-
ure 6A) tested the importance of the RVD scaffold formed
by all the non-RVD residues of a repeat, while the repeat
switch constructs tested the importance of inter-repeat in-
teractions (Figure 6B). We found that all repeat switch con-
structs were less active than the wild type (Figure 6B). This
supports the hypothesis that the non-RVD polymorphisms
of adjacent Bat1 repeats lead to the formation of unique
but functionally equivalent interfaces between repeats. Our
model for the structure of Bat1 bound toDNA suggests that
unique bonds are indeed formed between varied residues
of Bat1 repeats (Supplementary Table S4). Perturbation of
these possibly co-evolved residues would likely impair pro-
tein function. The performances of the RVD-switch con-
structs (Figure 6A) were mixed, with some activating the re-
porter better than the wild-type acBat1. This speaks against
the idea that each repeat scaffold has co-evolved with its
RVD for optimal activity. The data do, however, support
previous findings from RipTALs (10) and TALEs (33) that
certain non-RVDpolymorphisms can have profound effects
on repeat activity. These effects can be negative or positive
and must be investigated individually. The quantity of non-
RVD polymorphisms in Bat1 repeats compared to TALEs
(3) or RipTALs (10) thus complicates the creation of de-
signer DNA binding domains but also represents an as yet
unexploited pool of potentially beneficial repeat variants.
Comparing the diversity of Bat and TALE repeats also
raises evolutionary questions. The consensus core repeats or
TALEs and Bats are less than 40% conserved (Figure 1C) at
the sequence level, but at the functional level Bat and TALE
repeats are apparently very similar. This shows that the se-
quence composition of TALE-like repeats is not heavily
constrained by functional requirements. If most polymor-
phisms are functionally equivalent we would expect that,
over time, inter-repeat polymorphisms would accumulate.
The high levels of inter-repeat polymorphism in the Bat pro-
teins (Figure 1B and Supplementary Figure S3) are con-
sistent with this assumption. What is surprising is the rel-
ative sequence uniformity of TALE repeats. This suggests
that TALE repeats are under the influence of a selective
pressure to maintain sequence conservation, not felt by Bat
proteins. However, while the non-RVDs of each TALE re-
peat are highly uniform the RVD composition and repeat
number are highly diverse (3). These observations may be
mutually explanatory. It is known that repeat regions of
TALE genes can evolve via intra- and inter-molecular re-
combination (34,35). It may be, therefore, that the sequence
conservation between individual TALE repeats promotes
this recombination and subsequent diversification of repeat
number and RVD composition. This property may be pos-
itively selected for in TALE genes. These assumptions and
hypotheses require further testing, but comparison to non-
XanthomonasTALE-likes will likely prove a helpful one. In-
deed the RipTALs, which show intermediate sequence di-
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versity and limited structural diversity (10), provide an in-
teresting third group for comparison.
We have shown that the Bat proteins are a highly di-
vergent subgroup within a class referred to as the TALE-
likes, which they help to define. Moreover, Bat specificity
can be programmed with a code matching to known TALE
and RipTAL repeat specificity (Figure 2A). Bat proteins
thus represent an alternative platform for programmable
sequence-specificDNA targeting. In addition, the highly di-
verse Bat repeats may prove a valuable reservoir for novel
residue combinations with beneficial properties. More than
this they provide an out-group for comparative analysis into
function and evolution ofRipTALs andTALEs. Further re-
search into the Bat proteins is thus likely to reap rewards for
both fundamental and applied research.
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Supplementary Figure 1: Annotated amino acid sequences of Bat1, Bat2 and Bat3 
Annotated sequences of the three predicted Bat proteins. Each is formed of a short 
Non-repetitive N-terminal Domain (NND) followed by an array of cryptic (-1, 0, +1) 
and core repeats (1, 2, 3…).  Consecutive repeats are numbered (left side). The RVDs 
(residues at repeat positions 12 and 13) are marked as boldface black letters on grey 
background. Blue lettering is used for the positively charged residues within repeat 
+1. 
>Bat1 (from Burkholderia rhizoxinica strain HKI-0454 plasmid pBRH01, GenBank 
NC_014718.1, RBRH_01844; Uniprot E5AV36) 
 NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>Bat2 (from Burkholderia rhizoxinica strain HKI-0454 plasmid pBRH02, GenBank 
NC_014723.1, RBRH_01776; Uniprot E5AW45) 
   NND MPATSMHQEDKQSANGLN 
-1 LSPLERIKIEKHYGGGATLAFISNQHDELAQV 
 0 LSRADILKIASYDCAAQALQAVLDCGPMLGKRG 
 1 FSRADIVRIAGNGGGAQALYSVLDVEPTLGKRG 
 2 FSQVDVVKIAG--GGAQALHTVLEIGPTLGERG 
 3 FSRGDIVTIAGNNGGAQALQAVLELEPTLRERG 
 4 FNQADIVKIAGNGGGAQALQAVLDVEPALGKRG 
 5 FSRVDIAKIAG--GGAQALQAVLGLEPTLRKRG 
 6 FHPTDIIKIAGNNGGAQALQAVLDLELMLRERG 
 7 FSQADIVKMASNIGGAQALQAVLNLEPALCERG 
 8 FSQPDIVKMAGNSGGAQALQAVLDLELAFRERG 
 9 FSQADIVKMASNIGGAQALQAVLELEPALHERG 
10 FSQANIVKMAGNSGGAQALQAVLDLELVFRERG 
11 VRQADIVKIVGNNGGAQALQAVFELEPTLRERG 
12 FNQATIVKIAANGGGAQALYSVLDVEPTLDKRG 
13 FSRVDIVKIAG--GGAQALHTAFELEPTLRKRG 
14 FNPTDIVKIAGNKGGAQALQAVLELEPALRERG 
15 FNQATIVKMAGNAGGAQALYSVLDVEPALRERG 
16 FSQPEIVKIAGNIGGAQALHTVLELEPTLHKRG 
17 FNPTDIVKIAGNSGGAQALQAVLELEPAFRERG 
18 FGQPDIVKMASNIGGAQALQAVLELEPALRERG 
19 FSQPDIVEMAGNIGGAQALQAVLELEPAFRERG 
20 FSQSDIVKIAGNIGGAQALQAVLELEPTLRESD 
21 FRQADIVNIAGNDGSTQALKAVIEHGPRLRQRG 
22 FNRASIVKIAGNSGGAQALQAVLKHGPTLDERG 
23 FNLTNIVKIAGNGGGAQALKAVIEHGPTLQQRG 
24 FNLTDIVEMAGKGGGAQALKAVLEHGPTLRQRG 
25 FNLIDIVEMASNTGGAQALKTVLEHGPTLRQRD 
26 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAL---LLERQ 
>Bat3 (from Burkholderia rhizoxinica strain HKI-0454 plasmid pBRH02 GenBank 
NC_014723.1, RBRH_01777; Uniprot E5AW45) 
   NND MPVTSVYQKDKPFGARLN 
-1 LSPFECLKIEKHSGGADALEFISNKYDALTQV 
 0 LSRADILKIACHDCAAHALQAVLDYEQVFRQRG 
 1 FARADIIKITGNGGGAQALKAVVVHGPTLNECG 
 2 FSQADIVRIADNIGGAQALKAVLEHGPTLNERD 
 3 YSGADIVKIAGNGGGARALKAVVMHGPTLCESG 
 4 YSGADIVKIASNGGGAQALEAVAMHGSTLCERG 
 5 YCRTDIAKIAGNGGGAQALKAIVMHGPTLCERG 
 6 YSRTDIVKIADNNGGAQALKAVFEHGPALTQAG 
+1 RSNEDIVNMAARTGAAGQIRKMAAQ---LSGRQ 
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Supplementary Figure 2: Annotated amino acid sequences of AvrBs3 and Brg11 
AvrBs3 and Brg11 are the first characterised TALE and RipTAL respectively (36, 
10). Annotated amino-acid sequences are given for Brg11 and AvrBs3. N-terminal 
and C-terminal non-repeat regions and the central repeat array are displayed in 
separate paragraphs but are part of contiguous polypeptides. Consecutive repeats are 
numbered (left side). Repeats can be divided into cryptic (-1, 0, +1, +2) and core (1, 2, 
3…). The RVDs (residues at repeat positions 12 and 13) are marked as boldface black 
letters on grey background.  
>AvrBs3 (from Xanthomonas campestris pv. vesicatoria strain 71-21; GenBank 
CAA34257.1) 
MDPIRSRTPSPARELLPGPQPDGVQPTADRGVSPPAGGPLDGLPARRTMSRTRLPSPPAPSP
AFSAGSFSDLLRQFDPSLFNTSLFDSLPPFGAHHTEAATGEWDEVQSGLRAADAPPPTMRVA
VTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKR-GGVTAVEAVHAWRNALTGAPLN 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL-GGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMSRHGLLQLFRRVGVTELE
ARSGTLPPASQRWDRILQASGMKRAKPSPTSTQTPDQASLHAFADSLERDLDAPSPMHEGDQ
TRASSRKRSRSDRAVTGPSAQQSFEVRVPEQRDALHLPLSWRVKRPRTSIGGGLPDPGTPTA
ADLAASSTVMREQDEDPFAGAADDFPAFNEEELAWLMELLPQ  
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>Brg11 (from Ralstonia solanacearum strain GMI1000; GenBank NP_519936.1) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDTPRTEA
RSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPAVSSPRFSAGSSAAITDPFPSLPPTPVLY
AMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACPQAFASPPRAPRS
ARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTT
LTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQY GERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLDLRGVPYA 
 6 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LNTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQIVAIASHDGGKPALEAVWAKLPVLRGAPYA 
+1 LSTAQVVAIACI-SGQQALEAIEAHMPTLRQASHS 
+2 LSPERVAAIACI-GGRSAVEAVRQGLPVKAIRRIRR 
EKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQATRPALLRLLSSVGVTE
IEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACSP
HRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSHIRADSAASVPANLHLG
TRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSADLASFEAEPFGVGP
LDFHLDWLLQILET 
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Supplementary Figure 3: Amino acid alignments of Bat2 and Bat3 core repeats. 
Alignments of the core repeats of Bat2 and Bat3 were created in Clustal Omega (34, 
35) and Boxshade was used for formatting. White lettering on a black background 
indicates a consensus residue. Black lettering on a grey background indicates a 
residue similar to the consensus residue. Black lettering on a white background 
indicates a residue neither identical nor similar to the consensus residue. Repeats are 
shown in order of appearance in the polypeptide and numbered accordingly. The 
consensus repeat is shown below each alignment.  
>Alignment of Bat2 core repeats 
01 FSRADIVRIAGNGGGAQALYSVLDVEPTLGKRG 
02 FSQVDVVKIAG--GGAQALHTVLEIGPTLGERG 
03 FSRGDIVTIAGNNGGAQALQAVLELEPTLRERG 
04 FNQADIVKIAGNGGGAQALQAVLDVEPALGKRG 
05 FSRVDIAKIA--GGGAQALQAVLGLEPTLRKRG 
06 FHPTDIIKIAGNNGGAQALQAVLDLELMLRERG 
07 FSQADIVKMASNIGGAQALQAVLNLEPALCERG 
08 FSQPDIVKMAGNSGGAQALQAVLDLELAFRERG 
09 FSQADIVKMASNIGGAQALQAVLELEPALHERG 
10 FSQANIVKMAGNSGGAQALQAVLDLELVFRERG 
11 VRQADIVKIVGNNGGAQALQAVFELEPTLRERG 
12 FNQATIVKIAANGGGAQALYSVLDVEPTLDKRG 
13 FSRVDIVKIAG--GGAQALHTAFELEPTLRKRG 
14 FNPTDIVKIAGNKGGAQALQAVLELEPALRERG 
15 FNQATIVKMAGNAGGAQALYSVLDVEPALRERG 
16 FSQPEIVKIAGNIGGAQALHTVLELEPTLHKRG 
17 FNPTDIVKIAGNSGGAQALQAVLELEPAFRERG 
18 FGQPDIVKMASNIGGAQALQAVLELEPALRERG 
19 FSQPDIVEMAGNIGGAQALQAVLELEPAFRERG 
20 FSQSDIVKIAGNIGGAQALQAVLELEPTLRESD 
21 FRQADIVNIAGNDGSTQALKAVIEHGPRLRQRG 
22 FNRASIVKIAGNSGGAQALQAVLKHGPTLDERG 
23 FNLTNIVKIAGNGGGAQALKAVIEHGPTLQQRG 
24 FNLTDIVEMAGKGGGAQALKAVLEHGPTLRQRG 
25 FNLIDIVEMASNTGGAQALKTVLEHGPTLRQRD 
26 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
   FSQADIVKIAGNGGGAQALQAVLELEPTLRERG 
> Alignment of Bat3 core repeats 
01 FARADIIKITGNGGGAQALKAVVVHGPTLNECG 
02 FSQADIVRIADNIGGAQALKAVLEHGPTLNERD 
03 YSGADIVKIAGNGGGARALKAVVMHGPTLCESG 
04 YSGADIVKIASNGGGAQALEAVAMHGSTLCERG 
05 YCRTDIAKIAGNGGGAQALKAIVMHGPTLCERG 
06 YSRTDIVKIADNNGGAQALKAVFEHGPALTQAG 
   YSRADIVKIAGNGGGAQALKAVVMHGPTLCERG 
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Supplementary Figure 4: Nucleotide sequences of synthesised Bat1, Bat2 and Bat3 
genes 
Genes encoding the three predicted proteins were synthesised with E. coli codon 
usage (GenScript). Each was synthesised as a series of separate blocks flanked by 
BsaI sites allowing ordered assembly via BsaI cut-ligation into target vectors. BsaI 
recognition sites are underlined, while bold typeface marks the overlaps created upon 
digest.  Start and stop codons are distinguished with the use of lowercase italics.  
>Bat1 block 1 
GGTCTCTCACCatgAGCACCGCCTTCGTGGACCAAGATAAGCAAATGGCAAATCGCC
TGAACCTGTCACCGCTGGAACGTAGCAAAATTGAAAAACAATATGGCGGTGCAACCA
CGCTGGCTTTTATTAGCAACAAACAGAATGAACTGGCACAAATCCTGAGCCGTGCTG
ATATTCTGAAAATCGCGTCTTACGACTGCGCAGCACATGCACTGCAGGCTGTCCTGG
ATTGTGGCCCGATGCTGGGCAAACGCGGTTTTAGCCAGTCTGACATTGTCAAGATCG
CCGGTAACATTGGCGGTGCACAGGCACTGCAAGCAGTGCTGGATCTGGAAAGTATGC
TGGGCAAACGTGGTTTCTCCCGCGATGACATTGCGAAGATGGCCGGCAATATCGGCG
GTGCACAGACCCTGCAGGCCGTGCTGGATCTGGAATCAGCCTTTCGTGAACGCGGCT
TCTCGCAGGCCGACATTGTTAAAATCGCCGGTAACAATGGCGGTGCACAAGCTCTGT
ATAGTGTGCTGGATGTTGAACCGACCCTGGGTAAACGTGGTTTTTCACGCGCTGACA
TTGTTAAGATCGCCGGTAACACCGGCGGTGCCCAAGCACTGCACACGGTCCTGGATC
TGGAACCGGCCCTGGGCAAGCGTGGTTTCTCCCGCATTGATATCGTTAAGATCGCAG
CTAACAACGGTGGTGCTCAAGCCCTGCACGCTGTCCTGGATCTGGGTCCGACGCTGC
GCGAATGTGGGTGAGACC 
>Bat1 block 2 
GGTCTCTTGGGTTCTCGCAGGCAACCATCGCAAAAATCGCTGGCAATATCGGCGGTG
CTCAGGCTCTGCAAATGGTGCTGGATCTGGGTCCGGCTCTGGGCAAACGTGGTTTTA
GCCAGGCAACCATTGCTAAGATCGCCGGTAACATTGGCGGTGCACAGGCACTGCAAA
CGGTCCTGGATCTGGAACCGGCGCTGTGCGAACGCGGCTTCTCTCAGGCCACCATCG
CAAAAATGGCTGGTAACAATGGCGGTGCACAGGCTCTGCAAACGGTTCTGGATCTGG
AACCGGCCCTGCGTAAACGCGATTTTCGTCAGGCGGACATTATCAAGATTGCCGGTA
ATGACGGTGGCGCCCAGGCACTGCAAGCAGTGATCGAACATGGCCCGACCCTGCGCC
AACACGGTTTCAACCTGGCAGACATTGTTAAGATGGCTGGTAATATCGGTGGTGCTC
AAGCTCTGCAAGCGGTGCTGGACCTGAAGCCGGTGCTGGACGAACATGGTTTGAGAC
C 
>Bat1 block 3 
GGTCTCTGGTTTCTCTCAACCGGATATCGTCAAGATGGCGGGCAACATTGGTGGTGC
TCAAGCCCTGCAAGCCGTCCTGTCACTGGGTCCGGCGCTGCGTGAACGTGGCTTTAG
CCAGCCGGATATTGTCAAAATCGCCGGTAACACCGGCGGTGCACAGGCACTGCAAGC
AGTGCTGGATCTGGAACTGACGCTGGTTGAACATGGCTTCTCTCAACCGGACATTGT
TCGCATCACCGGTAATCGTGGCGGTGCCCAAGCTCTGCAAGCGGTGCTGGCTCTGGA
ACTGACCCTGCGTGAACGAGGATGAGACC 
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>Bat1 block 4 
GGTCTCTAGGATTTAGCCAACCGGACATCGTGAAAATCGCGGGCAATAGCGGCGGTG
CTCAAGCTCTGCAAGCGGTCCTGGATCTGGAACTGACGTTTCGTGAACGCGGCTTTA
GCCAGGCGGATATTGTCAAAATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATG
CTGTGCTGGATCTGGAACGTATGCTGGGCGAACGTGGTTTCTCTCGCGCAGACATTG
TGAACGTTGCTGGCAACAATGGCGGTGCGCAGGCCCTGAAAGCCGTGCTGGAACACG
AAGCCACGCTGAATGAACGTGGCTTTAGTCGCGCAGATATTGTCAAGATCGCGGGTA
ACGGTGGCGGCGCACAAGCACTGAAGGCGGTTCTGGAACACGAAGCGACCCTGGATG
AACGCGGCTGAGACC 
>Bat1 block 5 
GGTCTCTCGGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGGTGGTGGTG
CCCAGGCTCTGAAGGCTGTGCTGGAACATGGTCCGACGCTGAACGAACGTGGCTTTA
ATCTGACCGATATTGTTGAAATGGCGGCCAACAGTGGCGGTGCACAGGCTCTGAAAG
CGGTCCTGGAACACGGCCCGACGCTGCGTCAACGTGGTCTGAGCCTGATTGACATCG
TGGAAATTGCATCTAACGGCGGTGCGCAGGCCCTGAAAGCTGTCCTGAAGTATGGTC
CGGTGCTGATGCAAGCAGGTCGTAGCAATGAAGAAATCGTGCACGTTGCCGCTCGTC
GTGGTGGTGCTGGCCGTATCCGTAAGATGGTTGCTCCGCTGCTGGAACGTCAGtagA
AGGTGAGACC 
>Bat2 block1 
GGTCTCTCACCatgCCGGCCACCTCGATGCACCAAGAAGATAAACAGTCCGCAAACG
GTCTGAACCTGAGCCCGCTGGAACGTATTAAAATTGAAAAACATTATGGCGGTGGCG
CGACCCTGGCCTTTATTAGTAACCAGCACGATGAACTGGCACAAGTGCTGAGCCGTG
CTGACATTCTGAAAATCGCCTCTTATGACTGTGCTGCTCAAGCTCTGCAAGCGGTGC
TGGACTGCGGCCCGATGCTGGGTAAACGCGGCTGAGACC 
>Bat2 block2 
GGTCTCTCGGCTTTTCCCGTGCTGATATTGTCCGTATTGCTGGTAATGGTGGTGGTG
CCCAAGCTCTGTATTCTGTCCTGGATGTTGAACCGACGCTGGGTAAACGTGGCTTTA
GCCAGGTTGATGTGGTTAAAATTGCGGGCGGTGGCGCACAAGCACTGCATACCGTCC
TGGAAATCGGTCCGACGCTGGGTGAACGTGGCTTCTCTCGCGGTGACATTGTTACCA
TCGCCGGCAACAATGGTGGCGCACAGGCTCTGCAAGCAGTTCTGGAACTGGAACCGA
CGCTGCGTGAACGCGGTTTTAACCAGGCGGATATTGTCAAAATCGCCGGTAATGGTG
GCGGTGCACAGGCACTGCAAGCAGTCCTGGATGTGGAACCGGCTCTGGGTAAACGTG
GCTTTTCCCGCGTGGACATTGCAAAAATCGCTGGCGGTGGCGCCCAAGCCCTGCAGG
CAGTTCTGGGTCTGGAACCGACCCTGCGTAAACGCGGCTTCCACCCGACGGACATTA
TCAAAATTGCGGGTAACAATGGTGGTGCCCAAGCACTGCAAGCAGTTCTGGATCTGG
AACTGATGCTGCGTGAACGCGGCTTTAGCCAGGCAGACATTGTGAAAATGGCTTCTA
ACATCGGTGGCGCCCAAGCTCTGCAAGCGGTTCTGAATCTGGAACCGGCCCTGTGCG
AACGCGGTTTCTCACAGCCGGATATCGTCAAAATGGCCGGTAACTCGGGTGGCGCCC
AAGCGCTGCAAGCAGTGCTGGATCTGGAACTGGCTTTTCGTGAACGCGGCTTCAGTC
AGGCGGACATTGTGAAAATGGCCTCCAATATCGGCGGCGCACAAGCACTGCAAGCTG
TCCTGGAACTGGAACCGGCTCTGCACGAACGCGGCTTTAGTTGAGACC 
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>Bat2 block3 
GGTCTCATAGTCAAGCAAATATCGTCAAAATGGCGGGTAATAGTGGTGGTGCCCAAG
CCCTGCAAGCGGTCCTGGATCTGGAACTGGTCTTTCGTGAACGTGGCGTGCGCCAGG
CGGATATTGTGAAAATCGTTGGTAACAATGGCGGTGCACAGGCTCTGCAAGCAGTCT
TTGAACTGGAACCGACCCTGCGTGAACGCGGCTTCAACCAGGCTACGATTGTTAAAA
TCGCAGCAAATGGCGGTGGCGCACAAGCACTGTATAGCGTCCTGGATGTGGAACCGA
CCCTGGACAAACGTGGTTTCTCTCGCGTTGATATTGTCAAAATCGCAGGTGGCGGTG
CCCAAGCTCTGCATACCGCTTTTGAACTGGAACCGACGCTGCGTAAACGCGGCTTCA
ACCCGACCGACATTGTCAAAATCGCCGGTAATAAAGGCGGTGCACAGGCACTGCAAG
CAGTGCTGGAACTGGAACCGGCTCTGCGTGAACGCGGCTTTAACCAGGCAACGATTG
TGAAAATGGCGGGTAATGCCGGCGGTGCACAAGCTCTGTACAGTGTGCTGGATGTTG
AACCGGCACTGCGTGAACGTGGTTTCTCCCAGCCGGAAATTGTTAAAATCGCCGGTA
ACATCGGCGGTGCGCAAGCCCTGCATACGGTTCTGGAGTTAGAACCGACCCTGCACA
AACGTGGCTTTAACCCGACCGATATTGTGAAAATCGCGGGTAATAGCGGCGGTGCCC
AGGCCCTGCAGGCGGTTCTGGAACTGGAACCGGCGTTTCGTGAACGCGGCTTCGGTC
AGCCGGACATTGTTAAAATGGCCAGCAATATCGGCGGTGCCCAAGCCCTGCAAGCCG
TCCTGGAACTGGAACCGGCCCTGCGTGAACGTGGTTTTAGCCAGTGAGACC 
>Bat2 block4 
GGTCTCTCCAGCCGGATATTGTGGAAATGGCGGGTAACATCGGCGGCGCTCAAGCCC
TGCAAGCTGTCCTGGAACTGGAACCGGCCTTTCGTGAACGCGGCTTTAGCCAGTCTG
ATATTGTTAAAATCGCGGGTAACATTGGCGGTGCACAGGCACTGCAAGCAGTTCTGG
AACTGGAACCGACCCTGCGCGAAAGCGATTTCCGTCAGGCAGACATTGTGAACATCG
CTGGCAATGACGGTTCTACCCAAGCGCTGAAAGCCGTTATTGAACATGGCCCGCGTC
TGCGCCAGCGTGGTTTTAACCGCGCGAGTATTGTCAAAATCGCCGGCAATTCCGGCG
GTGCACAGGCTCTGCAAGCAGTGCTGAAACACGGCCCGACCCTGGATGAACGTGGTT
TCAACCTGACGAATATTGTTAAAATCGCCGGTAACGGCGGTGGCGCACAGGCACTGA
AAGCTGTCATTGAACATGGCCCGACCCTGCAGCAACGCGGTTTTAATCTGACGGATA
TCGTGGAAATGGCGGGCAAAGGTGGCGGTGCACAAGCTCTGAAAGCAGTTCTGGAAC
ACGGTCCGACCCTGCGTCAGCGTGGTTTCAACCTGATTGACATCGTCGAAATGGCGT
CCAATACGGGCGGTGCGCAAGCCCTGAAAACCGTTCTGGAACATGGTCCGACGCTGC
GCCAGCGTGATCTGTCACTGATTGACATCGTGGAAATTGCATCGAATGGTGGTGCAC
AGGCTCTGAAAGCTGTCCTGAAATATGGCCCGGTGCTGATGCAGGCAGGTCGTAGCA
ATGAAGAAATCGTGCACGTTGCCGCTCGTCGTGGTGGTGCGGGCCGTATTCGTAAAA
TGGTTGCTCTGCTGCTGGAACGCCAAtaaGGTGAGACC  >Bat3 block 1 
GGTCTCTCACCATGCCGGTCACCAGCGTCTACCAAAAAGATAAACCGTTCGGCGCAC
GTCTGAACCTGAGCCCGTTTGAATGTCTGAAAATTGAAAAACATAGCGGCGGTGCGG
ATGCCCTGGAATTTATTTCTAACAAATATGACGCCCTGACCCAGGTGCTGAGTCGTG
CAGATATTCTGAAAATCGCTTGCCACGACTGTGCCGCCCACGCTCTGCAAGCTGTGC
TGGACTATGAACAAGTTTTTCGCCAACGCGGCTGAGACC  >Bat3 block 2 
GGTCTCTCGGCTTCGCTCGTGCAGATATTATTAAAATCACGGGTAACGGCGGTGGTG
CCCAAGCCCTGAAAGCAGTGGTTGTCCATGGTCCGACGCTGAACGAATGCGGTTTTT
CACAGGCGGATATTGTCCGTATCGCCGACAATATTGGCGGTGCGCAAGCCCTGAAAG
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CGGTGCTGGAACATGGCCCGACCCTGAACGAACGTGATTATTCGGGTGCAGACATTG
TGAAAATCGCTGGTAATGGCGGTGGCGCACGTGCTCTGAAAGCAGTGGTTATGCACG
GTCCGACGCTGTGTGAAAGCGGTTACTCTGGCGCGGATATTGTTAAAATCGCAAGTA
ACGGTGGCGGTGCACAGGCACTGGAAGCAGTCGCTATGCATGGTTCCACCCTGTGCG
AACGTGGCTATTGTCGCACGGACATTGCGAAAATCGCCGGCAACGGCGGTGGCGCAC
AAGCACTGAAAGCAATTGTCATGCACGGTCCGACCCTGTGTGAACGCGGCTACAGCC
GCACGGATATTGTGAAAATCGCAGACAACAATGGTGGCGCACAGGCTCTGAAAGCTG
TTTTCGAACATGGTCCGGCACTGACCCAAGCTGGCCGCAGTAACGAAGATATCGTTA
ATATGGCCGCACGCACGGGCGCAGCGGGTCAGATTCGTAAAATGGCGGCACAACTGT
CGGGTCGTCAAtaaGGTGAGACC 
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Supplementary Figure 5: Sequences of translational fusions for protein 
purification, transcriptional activation reporters and nuclease assay. 
Only the sequences specific to each expression construct are shown. The sequence of 
the relevant Bat protein or derivative or TALE derivative fills the position indicated. 
Epitopes used for purification or antibody binding are indicated with a red 
background. NLSs are indicated with a yellow background. Green background marks 
an activation domain and mustard-brown a nuclease domain.  
>Protein expression and purification 
MSYYHHHHHHLESTSLYKKAGSAAAPFT – Bat1, Bat2 or Bat3 coding 
sequence – STOP 
>Human cell transcriptional activation assay: Full construct 
MGYPYDVPDYASRPKKKRKVGIHAM – Bat1, dBat or dTALE coding 
sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEASGSGRADALDD
FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINSR – STOP 
>Human cell transcriptional activation assay: ΔAD 
MGYPYDVPDYASRPKKKRKVGIHAM – Bat1 coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEAS – STOP 
>Human cell transcriptional activation assay: ΔNLSs 
START – Bat1 coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSGRADALDDFDLDMLGSDALDD
FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINSR – STOP 
>Planta transcriptional activation assay: Full construct 
START – Bat1 or dTALE coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEASGSGRADALDD
FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINSR – STOP 
>Planta transcriptional activation assay: ΔAD 
START – Bat1 coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEAS – STOP 
>In vitro nuclease assay 
MGLINIFYPYDVPDYAGYPYDVPDYAGSYPYDVPDYAAQCSG – Bat1 coding 
sequence –  
GGQLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVYGYRGKHL
GGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYVEENQTRNKHINPNEWW
KVYPSSVTEFKFLFVSGHFKGNYKAQLTRLNHITNCNGAVLSVEELLIGGEMIKAGTLTLEE
VRRKFNNGEINF 
MGYPYDVPDYASRPKKKRKVGIHAS – TALE coding sequence -  
GSQLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVYGYRGKHL
GGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYVEENQTRNKHINPNEWW
KVYPSSVTEFKFLFVSGHFKGNYKAQLTRLNHITNCNGAVLSVEELLIGGEMIKAGTLTLEE
VRRKFNNGEINF 
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Supplementary Figure 6: Target and reporter sequences used in this study. 
Sequences of binding elements used for electrophoretic mobility shift assays (Figure 
2). Only forward strand shown, the binding element is highlighted with bold lettering 
BEBat1/BEBat1 T-0 TAGACTAAGAGAAGCAAAGACGTTATATGC 
BEBat2 TAGACTTTGTTGAAAAGTTGTAAAAACATTATATGC 
BEBat3 TAGACATAGATTATTATATTTGTAACAAGTAAATGC 
BEBat1 C-0 TAGACCAAGAGAAGCAAAGACGTTATATGC 
BEBat1 G-0 TAGACGAAGAGAAGCAAAGACGTTATATGC 
BEBat1 A-0 TAGACAAAGAGAAGCAAAGACGTTATATGC 
Sequences of reporters and binding elements used in assessments of 
transcriptional activation (Figures 3, 5-7 and S8) 
pCMV-BE-dsEGFP – transcriptional activation reporter in human cells. (Figures 3, 
5-7, S8). Green highlighting is used for the dsEGFP coding sequence and italics for 
the subsequence polyA signal. Grey highlighting for the minimal CMV promoter. The 
bold-N positions are filled by one of the four binding elements listed. 
BEBat1   AAGAGAAGCAAAGACGTTAT 
BEdBatRVDswitch1 AGAGAAAGCAAAGACGTTAT 
BEdBatRVDswitch2 AAGAGAGCAAAAGACGTTAT 
BEpSOX2  TTTATTCCCTGACAGCCCC 
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CTAGACTNNNNNNNNNNNNNNNNNNNNNATGCGGATCCACGTATGTCGAGGTAGGCG
TGTACGGTGGGAGGCCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGGTACCGCCACCATGGGCTTAATTAATATAATTAATAATCCACTTAAGAATTCTT
TAAAGTGGATTATTAATTATAGGACCGGTATTACCCTGTTATCCCTAGTGAGCAAGG
GCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAA
ACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGC
TGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCG
TGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGC
AGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCT
TCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACA
CCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCC
TGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACA
AGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCA
GCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGC
TGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACG
AGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCG
GCATGGACGAGCTGTACAAGAAGCTTAGCCATGGCTTCCCGCCGGAGGTGGAGGAGC
AGGATGATGGCACGCTGCCCATGTCTTGTGCCCAGGAGAGCGGGATGGACCGTCACC
CTGCAGCCTGTGCTTCTGCTAGGATCAATGTGTAGCTAAGTAAGATCCTTCGAGCAG
ACATGATAAGATACATTGATGAGTTTGGACAAACCACAACTAGAATGCAGTGAAAAA
AATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCT
GCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGG
AGGTGTGGGAGGTTTTTTAAAGCAAGTAAAACCTCTACAAATGTGGTAAAA 
Bs3p-BEBat1-uidA for in planta assessment of transcriptional activation (Figure S8). 
Blue indicates the coding sequence of the uidA reporter gene, which is a part of the 
vector pGWB3* (10). BEBat1 is embedded within the pepper Bs3 promoter (italics) 
and is distinguished with bold typeface. In this construct a guanine base is paired with 
the 20th repeat of acBat1 and dTALEBat1mimic. 
TCATAGTCAAGCTAACGAAACTTATGCAAGGGAAATATGAAATTAGTATGCAAGTAA
ACTCAAAGAACTAATCATTGAACTGAAAGATCAATATATCAAAAAAAAAAAAAAAAC
AATAAAACCGTTTAACCGATAGATTAACCATTTCTGGTTCAGTTTATGGGTTAAACC
ACAATTTGCACACCCTGGTTAAACAATGAACACGTTTGCCTGACCAATTTTATTATA
TAAACCTAACCATCCTCACAACTAAGAGAAGCAAAGACGTTAGGTTCAAGTTATCAT
CCCCTTTCTCTTTTCTCCTCTTGTTCTTGTCACCCGCTAAATCTATCAAAACACAAG
TAGTCCTAGTTGCACTATATTTCAAGGGTGGGCGCGCCGACCCAGCTTTCTTGTACA
AAGTGGTTCGATCTAGAGGATCCCCGGGTGGTCAGTCCCTTATGTTACGTCCTGTAG
AAACCCCAACCCGTGAAATCAAAAAACTCGACGGCCTGTGGGCATTCAGTCTGGATC
GCGAAAACTGTGGAATTGATCAGCGTTGGTGGGAAAGCGCGTTACAAGAAAGCCGGG
CAATTGCTGTGCCAGGCAGTTTTAACGATCAGTTCGCCGATGCAGATATTCGTAATT
ATGCGGGCAACGTCTGGTATCAGCGCGAAGTCTTTATACCGAAAGGTTGGGCAGGCC
AGCGTATCGTGCTGCGTTTCGATGCGGTCACTCATTACGGCAAAGTGTGGGTCAATA
ATCAGGAAGTGATGGAGCATCAGGGCGGCTATACGCCATTTGAAGCCGATGTCACGC
CGTATGTTATTGCCGGGAAAAGTGTACGTATCACCGTTTGTGTGAACAACGAACTGA
ACTGGCAGACTATCCCGCCGGGAATGGTGATTACCGACGAAAACGGCAAGAAAAAGC
AGTCTTACTTCCATGATTTCTTTAACTATGCCGGAATCCATCGCAGCGTAATGCTCT
ACACCACGCCGAACACCTGGGTGGACGATATCACCGTGGTGACGCATGTCGCGCAAG
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ACTGTAACCACGCGTCTGTTGACTGGCAGGTGGTGGCCAATGGTGATGTCAGCGTTG
AACTGCGTGATGCGGATCAACAGGTGGTTGCAACTGGACAAGGCACTAGCGGGACTT
TGCAAGTGGTGAATCCGCACCTCTGGCAACCGGGTGAAGGTTATCTCTATGAACTGT
GCGTCACAGCCAAAAGCCAGACAGAGTGTGATATCTACCCGCTTCGCGTCGGCATCC
GGTCAGTGGCAGTGAAGGGCGAACAGTTCCTGATTAACCACAAACCGTTCTACTTTA
CTGGCTTTGGTCGTCATGAAGATGCGGACTTGCGTGGCAAAGGATTCGATAACGTGC
TGATGGTGCACGACCACGCATTAATGGACTGGATTGGGGCCAACTCCTACCGTACCT
CGCATTACCCTTACGCTGAAGAGATGCTCGACTGGGCAGATGAACATGGCATCGTGG
TGATTGATGAAACTGCTGCTGTCGGCTTTAACCTCTCTTTAGGCATTGGTTTCGAAG
CGGGCAACAAGCCGAAAGAACTGTACAGCGAAGAGGCAGTCAACGGGGAAACTCAGC
AAGCGCACTTACAGGCGATTAAAGAGCTGATAGCGCGTGACAAAAACCACCCAAGCG
TGGTGATGTGGAGTATTGCCAACGAACCGGATACCCGTCCGCAAGGTGCACGGGAAT
ATTTCGCGCCACTGGCGGAAGCAACGCGTAAACTCGACCCGACGCGTCCGATCACCT
GCGTCAATGTAATGTTCTGCGACGCTCACACCGATACCATCAGCGATCTCTTTGATG
TGCTGTGCCTGAACCGTTATTACGGATGGTATGTCCAAAGCGGCGATTTGGAAACGG
CAGAGAAGGTACTGGAAAAAGAACTTCTGGCCTGGCAGGAGAAACTGCATCAGCCGA
TTATCATCACCGAATACGGCGTGGATACGTTAGCCGGGCTGCACTCAATGTACACCG
ACATGTGGAGTGAAGAGTATCAGTGTGCATGGCTGGATATGTATCACCGCGTCTTTG
ATCGCGTCAGCGCCGTCGTCGGTGAACAGGTATGGAATTTCGCCGATTTTGCGACCT
CGCAAGGCATATTGCGCGTTGGCGGTAACAAGAAAGGGATCTTCACTCGCGACCGCA
AACCGAAGTCGGCGGCTTTTCTGCTGCAAAAACGCTGGACTGGCATGAACTTCGGTG
AAAAACCGCAGCAGGGAGGCAAACAATGA 
Sequences of the PCR templates used to create targets for the nuclease assays 
shown in Figure 4. Only the forward strand is shown. Grey highlighting shows the 
annealing sites for the amplification primers used in the PCR to create the target DNA 
for the nuclease assays. The two copies of BEBat1 in reverse orientation are 
underlined. The italicised bases are one of the five spacers listed below. The entire 
yellow-highlighted region is replaced by the given sequence in the case of the ‘no 
target’ control. 5bp   CTAGC 7bp   TCTAGAC 11bp TACGTCTAGAC 15bp TACGTACGTCTAGAC 19bp AAGCTACGTACGTCTAGAC No target ATTGCCACGGCGACTCTCTTG 
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GCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGC
CCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGC
ATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATG
CGTAAGGAGAAAATACCGCATCAGGCGCCATTCGCCATTCAGGCTGCGCAACTGTTG
GGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATG
TGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAA
AACGACGGCCAGTGAATTCGAGCTCGGTACCTCGCGAATGCATCTAGATATCGGATC
CCGGGCCCGTCGACTGCAGAGGGGTCTCCCCTTGAAATATAGTGCAACTAGGACTAC
TTGTGTTTTGATAGATTTAGCGGGTGACAAGAACAAGAGGAGAAAAGAGAAAGGGGA
TGATAACTTGAATAAGAGAAGCAAAGACGTTATNNNNNNNNNNNNNATAACGTCTTT
GCTTCTCTTAGTTGTGAGGATGGTTAGGTTTATATAATAAAATTGGTCAGGCAAACG
TGTTCATTGTTTAACCAGGGTGTGCAAATTGTGGTTTAACCCATAAACTGAACCAGA
AATGGTTAATCTATCGGTTAAACGGTTTTATTGTTTTTTTTTTTTTTTGATATATTG
ATCTTTCAGTTCAATGATTAGTTCTTTGAGTTTACTTGCATACTAATTTCATATTTC
CCTTGCATAAGTTTCGTTAGCTTGACTATGAGGTGGGAGACCCCTGCATGCAAGCTT
GGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCC
ACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAG
CTAAC 
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Supplementary Figure 7 – MST results for Bat1 measured against BEBat1A-0, -C-0, -G-
0, and -T-0 
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Supplementary Figure 8: Amino acid sequence of dTALEs used in this study 
Core and cryptic repeats are numbered. Grey background and bold typeface highlight 
the RVD residues. In all cases only the TALE-derived amino acids are shown. The 
sequences of fused domains are given in Figure S5. 
>dTALEBat1mimic (for transcriptional activation assays) 
   MDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
   GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
 1 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 2 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 3 LTPEQXVAIASNNGGKQALXTVQRLLPVLCQAHG 
 4 LTPQQVVAIASNTGGKQALXTVQRLLPVLCQAHG 
 5 LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
10 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPQQVVAIASNTGGKQALETVQALLPVLCQAHG 
13 LTPQQVVAIASNRGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
18 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
19 LTPQQVVAIASNSGGKQALETVQALLPVLCQAHG 
+1 LTPQQVVAIASN-GGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL-GGRPALDAVKKGLPHAPALIKR 
   TNRRIPERTSHRVA 
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>dTALESOX2 (for human cell transcriptional activation assay) 
MDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
 1 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 2 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 3 LTPEQXVAIASNNGGKQALXTVQRLLPVLCQAHG 
 4 LTPQQVVAIASNTGGKQALXTVQRLLPVLCQAHG 
 5 LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
10 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPQQVVAIASNTGGKQALETVQALLPVLCQAHG 
13 LTPQQVVAIASNRGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASN-GGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL-GGRPALDAVKKGLPHAPALIKR 
   TNRRIPERTSHRVA 
>dTALEBat1mimic (for nuclease assay) 
MAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
 1 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 2 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 3 LTPEQXVAIASNNGGKQALXTVQRLLPVLCQAHG 
 4 LTPQQVVAIASNTGGKQALXTVQRLLPVLCQAHG 
 5 LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
10 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPQQVVAIASNTGGKQALETVQALLPVLCQAHG 
13 LTPQQVVAIASNRGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
18 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
19 LTPQQVVAIASNSGGKQALETVQALLPVLCQAHG 
+1 LTPQQVVAIASN-GGRPALESIVAQLSRPDPALAA 
+2 LT 
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Supplementary Figure 9: in planta transcriptional activation mediated by acBat1. 
BEBat1 was embedded within a 360 base pair fragment of the silent pepper Bs3 
promoter, using the primers listed in Table S2. This promoter derivative was then 
inserted upstream of uidA in the binary vector pGWB3* as previously described (10).  
Bat1 and TALE derivatives were assembled via BsaI cut-ligation along with the NLSs 
and VP64 activation domain (Figure S5) into pENTR/D-TOPO (Life technologies) 
derivatives bearing BsaI sites. They were then transferred to binary vector pGWB442 
via LR recombination (Life technologies). Agrobacterium tumefaciens strains 
carrying pGWB442acBat1, pGWB442acBat1ΔAD or pGWB442dTALEBat1mimic were 
co-delivered into Nicotiana benthamiana leaves alongside a strain carrying the target 
reporter.  In addition the reporter plasmid was delivered alone as a control. The target 
reporter was a promoter bearing BEBat1 upstream of a uidA reporter gene (Figure S6). 
Leaf discs were harvested after 48 hours and GUS activity quantified (10). Results are 
shown for three biological replicates with error bars indicating standard deviation.   
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Supplementary Figure 10: Amino acid sequences of all acBat1 derivatives (dBats) 
tested in figures 5 and 6.  
Dashes indicate truncated residues. Red font is used to highlight residues truncated or 
rearranged in each case. In all cases repeat numbering is used to identify repeats with 
those in the wild-type Bat1 protein. Grey background and bold typeface highlights the 
RVD residues. NND stands for non-repetitive N-terminal Domain. In all cases only 
the Bat1-derived amino-acids are shown. The sequences of fused domains are given 
in Figure S5. 
>acBat1 Δ18-20 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQ---------------- 
19 --------------------------------- 
20 -----------------ALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>acBat1 Δ16-20 
   NNDMSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQ---------------- 
17 --------------------------------- 
18 --------------------------------- 
19 ---------------------------------     
20 ------------------ALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>acBat1 Δ14-20 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNS-------------------- 
15 --------------------------------- 
16 --------------------------------- 
17 --------------------------------- 
18 --------------------------------- 
19 ---------------------------------     
20 -------------GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>acBat1 Δ12-20 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNT-------------------- 
13 --------------------------------- 
14 --------------------------------- 
15 --------------------------------- 
16 --------------------------------- 
17 --------------------------------- 
18 --------------------------------- 
19 ---------------------------------     
20 -------------GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>acBat1 ΔNTD 
NND  
-1  
 0   
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>acBat1 ΔCTD 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1  
>dBat RVD switch 1 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNNGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNIGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNNGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANTGGAQALHAVLDLGPTLRECG 
6  FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
7  FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
8  FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
9  FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>dBat RVD switch 2 
   NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNNGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNDGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNIGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>dBat RVD switch 3 
   NNDMSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNTGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNIGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>dBat RVD switch 4 
   NNDMSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGN-GGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASNGGGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>dBat Repeat switch 1 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ   
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>dBat Repeat switch 2 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>dBat Repeat switch 3 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>dBat Repeat switch 4 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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Supplementary Figure 11: Nucleotide and amino acid sequences of dBatSOX2-RVD 
switch and -repeat switch. 
Genes encoding the dBats were synthesised with E. coli codon usage (GenScript). 
One block encodes the N- and C-terminal regions including the cryptic repeats, 
separated by BpiI sites, flanked by BsaI sites. This was assembled via BsaI cut-
ligation into the pVAX destination vector. Repeats were encoded on two BpiI flanked 
modules assembled directly into the destination vector via BpiI cut-ligation. BsaI 
recognition sites are underlined and BpiI sites grey-highlighted, while bold typeface 
marks the overlaps created upon digest. 
In the amino acid sequences consecutive repeats are numbered, corresponding to the 
repeats of wild type Bat1. The RVDs (residues at repeat positions 12 and 13) are 
marked as boldface black letters on grey background. The sections encoded by the 
BsaI-flanked N- and C- terminal module are underlined.  
>Bat1 N-BpiI BpiI-C 
GGTCTCTTATGAGCACCGCCTTCGTGGACCAAGATAAGCAAATGGCAAACCGCCTGA
ACCTGTCACCGCTGGAACGTAGCAAAATTGAAAAACAATATGGCGGTGCAACCACGC
TGGCTTTTATTAGCAACAAACAGAATGAACTGGCACAAATCCTGAGCCGTGCTGATA
TTCTGAAAATCGCGTCTTACGACTGCGCAGCACATGCACTGCAGGCTGTCCTGGATT
GTGGCCCGATGCTGGGCAAACGCGGTTTTAGCTAGTCTTCTAGAAGACTAGGCGGTG
CGCAGGCCCTGAAAGCTGTCCTGAAGTATGGTCCGGTGCTGATGCAAGCAGGTCGTA
GCAATGAAGAAATCGTGCACGTTGCCGCTCGTCGTGGTGGTGCTGGCCGTATCCGTA
AGATGGTTGCTCCGCTGCTGGAACGTCAGGGTGTGAGACC 
>dBatSOX2 Repeat switch AB 
GAAGACTTTAGCCGCGCAGATATTGTCAAGATCGCGGGTAACGGTGGCGGCGCACAA
GCACTGAAGGCGGTTCTGGAACACGAAGCGACCCTGGATGAAAGCGGCTTTAGTCGC
GCAGATATTGTCAAGATCGCGGGTAACGGTGGCGGCGCACAAGCACTGAAGGCGGTT
CTGGAACACGAAGCGACCCTGGATGAAAGCGGCTTCTCCCGCGATGACATTGCGAAG
ATGGCCGGCAATATCGGCGGTGCACAGACCCTGCAGGCCGTGCTGGATCTGGAATCA
GCCTTTCGTGAACGCGGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGGT
GGTGGTGCCCAGGCTCTGAAGGCTGTGCTGGAACATGGTCCGACGCTGAACGAACGT
GGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGGTGGTGGTGCCCAGGCT
CTGAAGGCTGTGCTGGAACATGGTCCGACGCTGAACGAACGTGGCTTTCGTCAGGCG
GACATTATCAAGATTGCCGGTAATGACGGTGGCGCCCAGGCACTGCAAGCAGTGATC
GAACATGGCCCGACCCTGCGCCAACACGGTTTTAGCCAGGCGGATATTGTCAAAATC
GCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGTGCTGGATCTGGAACGTATG
CTGGGCGAACGTGGTTTTCGTCAGGCGGACATTATCAAGATTGCCGGTAATGACGGT
GGCGCCCAGGCACTGCAAGCAGTGATCGAACATGGCCCGACCCTGCGCCAACACGGT
TTTAGTCGCGCAGATATTGTCAAGATCGCGGGTAACGGTGGCGGCGCACAAGCACTG
AAGGCGGTTCTGGAACACGAAGCGACCCTGGATGAAAGCGGTTTTAGTCTTC 
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>dBatSOX2 Repeat switch BC 
GAAGACTGGTTTCTCCCGCATTGATATCGTTAAGATCGCAGCTAACAACGGTGGTGC
TCAAGCCCTGCACGCTGTCCTGGATCTGGGTCCGACGCTGCGCGAATGTGGGTTCTC
GCAGGCAACCATCGCAAAAATCGCTGGCAATATCGGCGGTGCTCAGGCTCTGCAAAT
GGTGCTGGATCTGGGTCCGGCTCTGGGCAAACGTGGTTTTAGCCAGGCGGATATTGT
CAAAATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGTGCTGGATCTGGA
ACGTATGCTGGGCGAACGTGGTTTTAGCCAGTCTGACATTGTCAAGATCGCCGGTAA
CATTGGCGGTGCACAGGCACTGCAAGCAGTGCTGGATCTGGAAAGTATGCTGGGCAA
ACGTGGTTTCTCGCAGGCCGACATTGTTAAAATCGCCGGTAACAATGGCGGTGCACA
AGCTCTGTATAGTGTGCTGGATGTTGAACCGACCCTGGGTAAACGTGGTTTTCGTCA
GGCGGACATTATCAAGATTGCCGGTAATGACGGTGGCGCCCAGGCACTGCAAGCAGT
GATCGAACATGGCCCGACCCTGCGCCAACACGGTTTTAGCCAGGCGGATATTGTCAA
AATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGTGCTGGATCTGGAACG
TATGCTGGGCGAACGTGGTTTTCGTCAGGCGGACATTATCAAGATTGCCGGTAATGA
CGGTGGCGCCCAGGCACTGCAAGCAGTGATCGAACATGGCCCGACCCTGCGCCAACA
CGGTTTTAGCCAGGCGGATATTGTCAAAATCGCCGGTAACGACGGCGAAGTCTTC 
>dBatSOX2 RVD switch AB 
GAAGACTTTAGCCAGTCTGACATTGTCAAGATCGCCGGTAACGGTGGCGGTGCACAG
GCACTGCAAGCAGTGCTGGATCTGGAAAGTATGCTGGGCAAACGTGGTTTCTCCCGC
GATGACATTGCGAAGATGGCCGGCAATGGTGGCGGTGCACAGACCCTGCAGGCCGTG
CTGGATCTGGAATCAGCCTTTCGTGAACGCGGCTTCTCGCAGGCCGACATTGTTAAA
ATCGCCGGTAACATTGGCGGTGCACAAGCTCTGTATAGTGTGCTGGATGTTGAACCG
ACCCTGGGTAAACGTGGTTTTTCACGCGCTGACATTGTTAAGATCGCCGGTAACGGT
GGCGGTGCCCAAGCACTGCACACGGTCCTGGATCTGGAACCGGCCCTGGGCAAGCGT
GGTTTCTCCCGCATTGATATCGTTAAGATCGCAGCTAACGGTGGTGGTGCTCAAGCC
CTGCACGCTGTCCTGGATCTGGGTCCGACGCTGCGCGAATGTGGGTTCTCGCAGGCA
ACCATCGCAAAAATCGCTGGCAATGATGGCGGTGCTCAGGCTCTGCAAATGGTGCTG
GATCTGGGTCCGGCTCTGGGCAAACGTGGTTTTAGCCAGGCAACCATTGCTAAGATC
GCCGGTAACGATGGCGGTGCACAGGCACTGCAAACGGTCCTGGATCTGGAACCGGCG
CTGTGCGAACGCGGCTTCTCTCAGGCCACCATCGCAAAAATGGCTGGTAACGATGGC
GGTGCACAGGCTCTGCAAACGGTTCTGGATCTGGAACCGGCCCTGCGTAAACGCGAT
TTTCGTCAGGCGGACATTATCAAGATTGCCGGTAATGGTGGTGGCGCCCAGGCACTG
CAAGCAGTGATCGAACATGGCCCGACCCTGCGCCAACACGGTTTTAGTCTTC 
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GAAGACTAGTTTCAACCTGGCAGACATTGTTAAGATGGCTGGTAATAATGGTGGTGC
TCAAGCTCTGCAAGCGGTGCTGGACCTGAAGCCGGTGCTGGACGAACATGGTTTCTC
TCAACCGGATATCGTCAAGATGGCGGGCAACATTGGTGGTGCTCAAGCCCTGCAAGC
CGTCCTGTCACTGGGTCCGGCGCTGCGTGAACGTGGCTTTAGCCAGCCGGATATTGT
CAAAATCGCCGGTAACGACGGCGGTGCACAGGCACTGCAAGCAGTGCTGGATCTGGA
ACTGACGCTGGTTGAACATGGCTTCTCTCAACCGGACATTGTTCGCATCACCGGTAA
TATTGGCGGTGCCCAAGCTCTGCAAGCGGTGCTGGCTCTGGAACTGACCCTGCGTGA
ACGAGGATTTAGCCAACCGGACATCGTGAAAATCGCGGGCAATAACGGCGGTGCTCA
AGCTCTGCAAGCGGTCCTGGATCTGGAACTGACGTTTCGTGAACGCGGCTTTAGCCA
GGCGGATATTGTCAAAATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGT
GCTGGATCTGGAACGTATGCTGGGCGAACGTGGTTTCTCTCGCGCAGACATTGTGAA
CGTTGCTGACAACAATGGCGGTGCGCAGGCCCTGAAAGCCGTGCTGGAACACGAAGC
CACGCTGAATGAACGTGGCTTTAGTCGCGCAGATATTGTCAAGATCGCGGGTAACGA
TGGCGGCGCACAAGCACTGAAGGCGGTTCTGGAACACGAAGCGACCCTGGATGAAAG
CGGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGATGGCGAAGTCTTC 
>dBatSOX2 RVD switch 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNGGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNGGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNIGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNGGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANGGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNDGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNDGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNDGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNGGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNNGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNDGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNIGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNNGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVADNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNDGGAQALKAVLEHEATLDESG 
18 FSRADIVRIAGNDGGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>dBatSOX2 repeat switch 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
15 FSQADIVKIAGNDGGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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Supplementary figure 12: specificity test with the BEpSOX2 targeted dBats. 
Both dBats were tested against the BEBat1 reporter as described in Materials and 
Methods. The number of cells analysed is indicated below each pseudodensity plot 
and the vertical bar indicates the threshold Alexa Fluor 594 level above which cells 
were considered as expressing the relevant Bat or TALE construct and included in 
downstream analysis. Colour from blue-green to yellow-red indicates increasing cell 
density. The box plots show fold-change in dsEGFP fluorescence intensity relative to 
the reporter only control for the two dBats against either the BEpSOX2 or BEBat1 
reporters. Median values are given next to the boxes in each case.   
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Supplementary Figure 13: Pseudocolour density blots of fluorescence and extended 
boxplots including outliers for experiments shown in Figures 3, 5-7. 
 
dsEGFP and Alexa Fluor 594 fluorescence levels are shown for all cells analysed for 
the preparation of figures 3 and 5-7. Data are sorted by figure and transfected 
constructs are written above the plot in each case. The number of cells analysed is 
indicated below. The vertical bar indicates the threshold Alexa Fluor 594 level above 
which cells were considered as expressing the relevant Bat or TALE construct and 
included in downstream analysis. The x-axis utilises a logical display. Colour from 
blue-green to yellow-red indicates increasing cell density.  Boxplots are also sorted by 
figure and transfected constructs are given beside each plot. dsEGFP fluorescence is 
given relative to the reporter alone and is shown only for those cells with above-
threshold Alexa Fluor 594 levels.   
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Figure 6 
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Supplementary Figure 14: Amino acid sequences of the Bat1 repeat trimers used in 
Figure 8. The sequences corresponding to the Bat repeats are shown in bold and the 
central repeat of the trimer is underlined to allow each repeat to be identified. 
Flanking sequences correspond to sections of AvrBs3 necessary for cloning via the 
previously established toolkit (15). Sequences corresponding to the terminal BpiI 
recognition sites facilitating compatibility with the TALE binding domain assembly 
toolkit are highlighted and are removed during cloning.  
>Bat1 repeat 2 trimer 
EDAETVQRLLPVLCQAHGFSRDDIAKMAGNIGGAQTLQAVLDLESAFRERGFSRDDIAKMAG
NIGGAQTLQAVLDLESAFRERGFSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
LTPEQVVAIASQS 
 
>Bat1 repeat 6 trimer 
EDAETVQRLLPVLCQAHGFSQATIAKIAGNIGGAQALQMVLDLGPALGKRGFSQATIAKIAG
NIGGAQALQMVLDLGPALGKRGFSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
LTPEQVVAIASQS 
 
>Bat1 repeat 8 trimer 
EDAETVQRLLPVLCQAHGFSQATIAKMAGNNGGAQALQTVLDLEPALRKRDFSQATIAKMAG
NNGGAQALQTVLDLEPALRKRDFSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
LTPEQVVAIASQS 
 
>Bat1 repeat 17 trimer 
EDAETVQRLLPVLCQAHGFSRADIVKIAGNGGGAQALKAVLEHEATLDERGFSRADIVKIAG
NGGGAQALKAVLEHEATLDERGFSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
LTPEQVVAIASQS 
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Supplementary Figure 15: Structural predictions for Bat1 based on the structure of 
PthXo1 bound to DNA.  
Homology Model: Created using SWISS-MODEL (38) 
Template: 3UGM PthXo1 
Sequence identity 38.20% 
Range of Bat1 covered by the alignment: 11-767 
GMQE:   0.70,   
QMEANA4:  -6.75,    
Diameter of pore: 16.5-19 Angstroms 
Average inter-repeat angle: 33°  
  
Model of Bat1 wrapped around BEBat1 (silver) based on the structure of PthXo1 
bound to its target DNA shown from N- to C-terminus going down the page. Each 
repeat is coloured individually.  
TALE-like DNA binding proteins from Burkholderia rhizoxinica - SUPPLEMENT  38 
 
 
 
 
Longitudinal and transverse views of the Bat1 structural prediction (green) aligned to 
the structure of PthXo1 (blue). PthXo1 target DNA is shown (silver). Created in 
UCSF Chimera (39). 
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Table S1: Percentage sequence identities of the Bat proteins 
sorted by domain. 
 NND Repeats 
-1/0 
Consensus 
core repeats 
Repeat 
+1 
Bat1 ⇔ Bat2 50 86 94 97 
Bat1 ⇔ Bat3 39 66 73 67 
Bat2 ⇔ Bat3 50 66 76 67 
Consensus core refers to the consensus formed from an alignment 
of all the core repeats of a single Bat protein. Alignments were 
performed on CLC Main Workbench 6.1. (Gap open cost 10.0, 
Gap extension cost 1.0). Percentage identities shown to two 
significant figures. 
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Table S2: A list of primers used in this study 
Primer name Sequence Notes 
pUC57 BB D Fwd GGG GTC TCT TAA CTA 
GTC TTC GGG CCC GTC 
GAC TG 
Used to create modified TALE toolkit level 
2 vector pUC57-CD-DEST. 5’ 
phosphorylated 
pUC57 BB C Rev CCT TGG TCT CAG GGT 
TAG TCT TCC GAT ATC 
TAG ATG C 
Used to create modified TALE toolkit level 
2 vector pUC57-CD-DEST 
Toolkit_N12_Rev ATT GCT GGC GAT GGC 
CAC CAC C 
 
5’ Phosphorylated. Used to modify RVDs 
of TALE toolkit repeats 
Rep7C_13T_Fwd 
 
ACC GGT GGC AAG CAG 
GCG CTG 
 
Used to create modified TALE toolkit 
repeat 7C_NT 
Rep4_13T_Fwd 
 
ACC GGC AAG CAG GCG 
CTT GAG 
 
Used to create modified TALE toolkit 
repeat 4_NT 
Rep3_ 13D_Fwd 
 
GAC GGT GGC AAG CAG 
GCG CTG 
 
Used to create modified TALE toolkit 
repeat 3_ND 
Rep4_13D_Fwd 
 
GAC GGC AAG CAG GCG 
CTT GAG 
 
Used to create modified TALE toolkit 
repeat 4_ND 
Toolkit_13R_Fwd 
 
CGG GGT GGC AAG CAG 
GCG CTG 
 
Used to create modified TALE toolkit 
repeat 1C_NR 
1/2_13*_Fwd 
 
GGC GGC AGG CCG GCG 
C 
 
Used to create modified TALE toolkit 
repeat D1/2_N* 
rep6_mut_6 ½ Fwd
  
CGA GAG ACC CCG GGA 
TCC GAT ATC TAG 
Used to create B overlap on toolkit repeat 6 
(6 ½ B) 
rep_mut_rep ½ Rev  CTA CCA CCT GCT CCG 
GGG TCA GGC 
Used to create B overlap on toolkit repeat 6 
(6 ½ B). 5’ phosphorylated. 
Linker 5-6 ½ Fwd CGG GTC TCT TGA GGG 
GGA GCG TGA GAC CTG 
Used to create Linker 5-6 in pUC57 with 
two BsaI sites. Repeats 5_NN and 6 ½ B 
were then ligated into linker 5-6 to create 
5B_NN 
Linker 5-6 ½ Rev CAG GTC TCA CGC TCC 
CCC TCA AGA GAC CCG 
Used to create Linker 5-6 in pUC57 with 
two BsaI sites. Repeats 5_NN and 6 ½ B 
were then ligated into linker 5-6 to create 
5B_NN 
Toolkit D ½ BpiI Rev GGG GAA GAC CCT AAC 
CCC GCA GCA GGT GG 
Used to create flexible TALE toolkit half 
repeat modules with the D overlap.  
pUC57 ½ BpiI Rev CCC GAA GAC CCA GCG 
CCG GCC TGC 
Used to create flexible TALE toolkit half 
repeat modules with the D overlap. 
Rep7_D-overlap_Fwd TAA CTG AGA CCT GGG 
CCC GTC GAC TGC AG 
Used to create modified TALE toolkit 
repeat 7D_NS 
Rep7_D-overlap_Rev GGC CAT GGG CCT GGC 
ACA GCA CCG 
Used to create modified TALE toolkit 
repeat 7D_NS 
pVAX GoldenGate + 
Sp6 Fwd 
ATC AAT GTG AGA CCT 
TTC CCG GGT TTG GTC 
TCT GCT TGG GCC CGT 
TTA AAC CCG CTG ATC 
AG 
Used to remove the previous TALEN gene 
from a published TALEN expression 
vector (18), replace it with BsaI sites and 
introduce an Sp6 priming site into the 
CMV promoter. 
pVAX GoldenGate + 
Sp6 Rev 
ATC ACT AGC TTC TAT 
AGT GTC ACC TAA ATC 
AGC TTG AGT CTC CCT 
ATA GTG AGT CG 
Used to remove the previous TALEN gene 
from a published TALEN expression 
vector (18), replace it with BsaI sites and 
introduce an Sp6 priming site into the 
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CMV promoter. 
HA-NLS GoldenGate 
AATG Fwd 
TTG GTC TCT AAT GGG 
CTA CCC TTA CGA CGT 
GC 
 
Used to amplify HA-NLS domain from a 
published TALEN construct (18) and 
introduce BsaI sites. 
HA-NLS GoldenGate 
TATG Rev 
AAT GGT CTC ACA TAG 
CGT GGA TGC CCA CTT 
TCC GC 
 
Used to amplify HA-NLS domain from a 
published TALEN construct (18) and 
introduce BsaI sites. 
3xHA goldengate Fwd TTT GGT CTC TAA TGG 
GGT TAA TTA ACA TCT 
TTT ACC CAT ACG 
 
Used to amplify 3xHA from binary vector 
pGWB13 (37) and introduce BsaI sites 
3xHA goldengate Rev TTT GGT CTC ACA TAC 
CGC TGC ACT GAG CAG 
CGT AAT C 
 
Used to amplify 3xHA from binary vector 
pGWB13 (37) and introduce BsaI sites 
FokI GGTG BpiI Fwd TTT GGT CTC TGG TGG 
TCA GCT AGT GAA ATC 
TGA ATT GGA AGA G 
 
Used to amplify FokI nuclease domain 
from a published TALEN construct (18) 
and introduce BsaI sites. 
FokI GGTG BpiI Rev AAT GGT CTC AAA GCT 
TAT CTC ACC GTT ATT 
AAA TTT CCT TCT CAC 
 
Used to amplify FokI nuclease domain 
from a published TALEN construct (18) 
and introduce BsaI sites. 
Bat1_Block 1 TATG 
Rev 
CAT AAG AGA CCA TTG 
GGA TCG GAT C 
 
Used to modify ‘Bat1 Block1’ (Figure S4) 
for cloning into the pVAX derived human 
cell expression vector and remove start 
codon (provided by N-terminal tag). 
Bat1_Block 1 ATGless 
Fwd  
AGC ACC GCC TTC GTG 
GAC CAA G 
 
5’ Phosphorylated. Used to modify ‘Bat1 
Block1’ (Figure S4) for cloning into the 
pVAX derived human cell expression 
vector and remove start codon (provided by 
N-terminal tag).  
Block 5 GGTG Fwd 
phospho 
 
GGT GTG AGA CCG ACC 
CAA TAT C 
 
5’ Phosphorylated. Used to modify ‘Bat1 
Block5’ (Figure S5) to remove stop codon 
and for cloning into the pVAX derived 
human cell expression vector. 
Block5 Last codon 
Rev 
 
CTG ACG TTC CAG CAG 
CGG AG 
 
Used to modify ‘Bat1 Block5’ (Figure S5) 
to remove stop codon and for cloning into 
the pVAX derived human cell expression 
vector.  
acBat1 AD out Rev 
phospho 
 
GCT GGC CTC CAC CTT 
TCT C 
 
Used to remove VP64 activation domain 
from acBat1 C-terminal domain.  
acBat1 AD out Fwd 
 
TAG GCT TTG AGA CCA 
CGA AG 
 
Used to remove VP64 activation domain 
from acBat1 C-terminal domain. 
acBat1 NLS out Rev 
 
CTT GTC ATC GTC ATC 
CTT GTA GTC 
 
Used to remove the NLS from the acBat1 
C-terminal domain. 
acBat1 NLS out Fwd 
 
GGT TCC GGA CGG GCT 
GAC 
 
5’ phosphorylated. Used to remove the 
NLS from the acBat1 C-terminal domain.  
BAT1rep20 2nd Helix 
Fwd 
 
GCC CTG AAA GCT GTC 
CTG AAG TAT G 
 
Used to create acBat1Δ18-20 and 
acBat1Δ16-20 
BAT1rep20 GG Fwd 
 
GGC GGT GCG CAG GCC 
CTG AAA GCT GTC CTG 
Used to create acBat1Δ14-20 and 
acBat1Δ12-20 
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AAG 
 
BAT1 rep18 1st Helix 
Rev 
 
CTG GGC ACC ACC ACC 
ATT ACC CGC 
 
Used to create acBat1Δ18-20 
BAT1 rep16 1st Helix 
Rev 
 
CTG CGC ACC GCC ATT 
GTT GCC AGC AAC GTT C 
 
Used to create acBat1Δ16-20 
BAT1 rep14 1st Helix 
Rev 
 
GCT ATT GCC CGC GAT 
TTT CAC GAT GTC CGG 
TTG 
 
Used to create acBat1Δ14-20 
BAT1 rep12 1st Helix 
Rev 
 
GGT GTT ACC GGC GAT 
TTT GAC AAT ATC CGG 
CTG 
 
Used to create acBat1Δ12-20 
Bat1 NTD out Fwd TTT AGC CAG TCT GAC 
ATT GTC AAG ATC GC 
5’ phosphorylated. Used to create 
acBat1ΔNTD 
Bat1 NTD out Rev CAT AAG AGA CCA TTG 
GGA TCG GAT C 
Used to create acBat1ΔNTD 
Bat1 CTD out Fwd AAG GTG AGA CCG ACC 
CAA TAT C 
 
5’ phosphorylated. Used to create 
acBat1ΔCTD 
Bat1 CTD out Rev ACC TGC TTG CAT CAG 
CAC CG 
Used to create acBat1ΔCTD 
BEBat1 into Bs3p Fwd TGC TTC TCT TAG TTG 
TGA GGA TGG TTA GG 
 
5’ Phosphorylated. Used to create Bs3p 
BEBat1 for GUS assays and for the creation 
of the Bat1-Fok1 target templates.  
BEBat1 into Bs3p Rev AAGACGTTAGGTTCAAGT
TATCATCCCC 
Used to create Bs3p BEBat1 for GUS assays 
and for the creation of the Bat1-Fok1 target 
templates. 
Bat1-Fok1 target 5bp CTA GCA TAA CGT CTT 
TGC TTC TCT TAG 
 
Used to create the 5bp spacer target for the 
nuclease assays.  
Bat1-Fok1 target 7bp TCT AGA CAT AAC GTC 
TT GCT TCT C 
 
Used to create the 7bp spacer target for the 
nuclease assays. 
Bat1-Fok1 target 11bp TAC GTC TAG ACA TAA 
CGT CTT TGC TTC TC 
 
Used to create the 11bp spacer target for 
the nuclease assays. 
Bat1-Fok1 target 15bp TAC GTA CGT CTA GAC 
ATA ACG TCT TTG CTT 
CTC 
 
Used to create the 15bp spacer target for 
the nuclease assays. 
Bat1-Fok1 target 19bp TAA GCT ACG TAC GTC 
TAG ACA TAA CGT C 
 
Used to create the 19bp spacer target for 
the nuclease assays. 
BE Bat1 TAGA Fwd TAG ACT AAG AGA AGC 
AAA GAC GTT ATA TGC 
 
To get BEBat1 into dsEGFP reporter 
 
BE Bat1 CCTA Rev ATC CGC ATA TAA CGT 
CTT TGC TTC TCT TAG 
 
To get BEBat1 into dsEGFP reporter 
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Table S3: p-values for two-tailed t-tests without assuming equal 
variances to establish whether affinities differ between interactions of 
Bat1 with BEBat1 derivatives bearing A, C, G or T at the zero position.  
 A0 C0 G0 T0 
A0     
C0 0.589    
G0 0.860 0.860   
T0 0.231 0.382 0.754  
Sample size n=3. (A0, G0, T0) or 5 (C0). Results shown to three decimal 
places.   
Table S4: Hydrogen bonds formed between repeat residues of Bat1 predicted with UCSF 
Chimera (39). Unless stated, interactions are between side chain and backbone atoms.  
Repeats involved  AA 1 AA 2 Comment 
-1 – 0 Gln 29 Ala 59  
0 – 1 Lys 57 Gly 93  
0 - 1 Tyr 61 Ala 92  
1 – 2 Gly 82 Arg 118 In the inter repeat loop region 
3 – 4 Asn 160 Ala 191  
3 – 4 Gly 162 Thr 194  
2 – 4 Gly 148 Arg 184 In the inter repeat loop region 
4 – 5 Thr 202 His 234  
5 – 6 Lys 222 Gly 258  
6 – 7 Asn 292 Ala 323  
7 – 8 Asn 325 Gly 357  
7 – 8 Gln 349 Arg 343 In the inter repeat loop region 
7 - 8 Asn 326 (N) Asp 359  
8 – 9  Asn 358 Gly 390  
8 – 9 Asn 358 Ala 389  
11 – 12 Lys 420 Gly 456  
11 – 12 Arg 442 Phe 446 (N) Inter repeat connection 
11 – 13 Arg 444 Ser 480 (OH)  
13 – 14 Arg 510 Leu 534 (O)  
13 – 14  Arg 491 Ser 524  
15 – 16 Asn 556 Gly 588  
16 – 17 Asn 589 Gly 621  
16 – 17 Glu 601 Lys 630  
17 – 18 Asp 615 Arg 646 Between two side chains 
17 – 18 Glu 634 Lys 663 Between two side chains 
19 – 20 Glu 700 Lys 728 Between two side chains 
20 - +1 Asn 721 Arg 754 (O)  
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ABSTRACT
Transcription Activator-Like Effectors (TALEs) of
Xanthomonas bacteria are programmable DNA bind-
ing proteins with unprecedented target specificity.
Comparative studies into TALE repeat structure
and function are hindered by the limited sequence
variation among TALE repeats. More sequence-
diverse TALE-like proteins are known from Ralsto-
nia solanacearum (RipTALs) and Burkholderia rhi-
zoxinica (Bats), but RipTAL and Bat repeats are con-
served with those of TALEs around the DNA-binding
residue. We study two novel marine-organism TALE-
like proteins (MOrTL1 and MOrTL2), the first to date of
non-terrestrial origin. We have assessed their DNA-
binding properties and modelled repeat structures.
We found that repeats from these proteins medi-
ate sequence specific DNA binding conforming to
the TALE code, despite low sequence similarity to
TALE repeats, and with novel residues around the
BSR. However, MOrTL1 repeats show greater se-
quence discriminating power than MOrTL2 repeats.
Sequence alignments show that there are only three
residues conserved between repeats of all TALE-like
proteins including the two new additions. This con-
served motif could prove useful as an identifier for
future TALE-likes. Additionally, comparing MOrTL re-
peats with those of other TALE-likes suggests a com-
mon evolutionary origin for the TALEs, RipTALs and
Bats.
INTRODUCTION
Three groups of plant disease associated bacteria have so
far been found to encode sequence-related repeat-array pro-
teins known as TALE-likes. The repeat arrays of TALE-
likes are DNA-binding domains, with each repeat bind-
ing a single DNA base with a common code based on re-
peat residue 13, the base specifying residue (BSR; use of
the term reviewed in (1)). The largest, first discovered and
eponymous group are the TALEs, of plant-pathogenicXan-
thomonas species. Next described and characterised were
the RipTALs of Ralstonia solanacearum (2,3) and lately the
Bats of endofungal bacterium Burkholderia rhizoxinica (4–
6). Of these groups the TALEs and RipTALs are effector
proteins injected into host plants where they mimic eukary-
otic transcription factors (7). The repeats bind specific pro-
moter sequences and a domain at the C-terminus of the pro-
tein mediates activation of host genes whose products pro-
mote bacterial disease. TALEs thus hijack the host’s tran-
scriptional machinery and RipTALs are thought to do the
same (8,9). The Bats lack the domains necessary to function
as eukaryotic transcription factors (6) and their evolution-
ary relationship to the TALEs and RipTALs remains un-
clear. The TALE-likes seem to be united only by possession
of DNA binding repeats with a conserved code.
TALEs are studied for their applications in biotechnol-
ogy as much as for their roles in plant disease (10). The re-
liability of the TALE code allows one to predict the DNA
binding element (BE) for any given TALE and to design a
TALE to match any DNA sequence of interest. Designer
(d)-TALE DNA-binding domains, coupled to a functional
domain of choice are invaluable tools for precision ma-
nipulation of genome (11), transcriptome (12) and even
epigenome (13,14).
One of the potential advantages of the TALE system
over the alternative CRISPR/Cas9 system is the diversity
of BSR–DNA interactions, contrastingwithmore restricted
Watson–Crick base pairing. BSRs bind their cognate bases
with a range of different affinities and specificities, as in-
ferred from studies on arrays with different BSR composi-
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tions (15). In addition, non-BSR polymorphisms might be
useful to tune DNA binding properties and further expand
the diversity of TALE–DNA interactions. One could then
create libraries of dTALEswith a range of binding strengths
for the same DNA element, useful for the regulation of syn-
thetic genetic circuits.
One approach to TALE repeat engineering is random
mutagenesis and screening, as demonstrated successfully in
a recent study by Hubbard et al. (16). Alternatively muta-
tions could be introduced in a more targeted fashion, but
this requires information on the impact of different types
of polymorphisms at different positions in the TALE re-
peat. Natural variation would provide useful information
on what residues can or cannot be tolerated at which po-
sitions and with what effect. However, whilst TALES are
distributed widely among Xanthomonas species, sequence
diversity is very low (17). Yet the first characterised Rip-
TAL, Brg11, is only 41% identical to TALE AvrBs3 (18) in-
cluding numerous repeat sequence polymorphisms. In addi-
tion the polymorphism between individual RipTAL repeats
is greater than that between TALE repeats. We looked at
the DNA recognition properties of each of the repeats of
the RipTAL Brg11 and found differences in reporter acti-
vation strength even when comparing repeats with identical
BSRs, suggesting that non-BSR polymorphisms impact on
repeat–DNA interactions (3). Thus RipTAL repeats could
be useful as a pool of natural sequence diversity for TALE
repeat engineering.
This pool of functionally validated but sequence-diverse
TALE-like repeats was further expanded by the molecular
characterisation of the Bats of bacterium B. rhizoxinica (4–
6,19). Repeats of these proteins are below 40% identical to
TALE repeats, providing an interesting group for compar-
ison. TALE and Bat repeats mediate DNA binding with
broadly the same BSR code and the structures are similar
(19,20), but some functional differences were identified (19).
This makes the Bats a useful comparison group to inform
studies into TALE repeat engineering.
However, residues clustered around the BSR (positions
7–19) are largely invariant across all currently known
TALEs, RipTALs and Bats (6). It seems conceivable that
residues adjacent to the BSRs have a major impact on the
placement of the BSR with respect to the paired base. Ac-
cordingly, these residues may also be those most interesting
for re-engineering attempts aimed at changing DNA bind-
ing properties.
We describe here molecular characterisations of two
novel repeat proteins predicted from marine bacterial
metagenomics sequences (21,22). Repeats of these proteins
show 30–40% protein level sequence similarity to TALE
repeats. We refer to these predicted proteins as MOrTL1
and MOrTL2 (Marine Organism TALE-Likes) to reflect
the limited information we have regarding their provenance.
We show that repeats of both MOrTLs mediate sequence-
specific DNA binding in accordance with the TALE code.
To support the DNA-binding analysis we build homology
models of MOrTL1 and MOrTL2 repeats bound to DNA
and carry out molecular dynamics (MD) simulations to test
the stability of the modelled interactions. The models show
a striking structural similarity to TALE andBat repeats. Yet
MOrTL1 and MOrTL2 repeats bear sequence motifs un-
known fromTALEs, RipTALs and Bats. Repeats of the two
MOrTLs are as distant from one another at the sequence
level as they are from any of the other TALE-likes and show
functional differences: MOrTL1 repeats exert a greater se-
quence discriminating power and, unlikeMOrTL 2 repeats,
they are compatible with both Bat1 and TALE repeats. The
sequence diverse MOrTL1 and MOrTL2 repeats could in-
form future TALE repeat engineering efforts as well as be-
ing useful as comparison groups for evolutionary analyses.
This makes theMOrTLs a fascinating addition to the grow-
ing family of TALE-likes.
MATERIALS AND METHODS
MOrTL construct creation
Genes encoding MOrTL1 (ECG96326) and MOrTL2
(EBN1909), codon optimized for Escherichia coli and with
additional 5′ and 3′ BsaI recognition sites, were synthesized
(GenScript). Sequences are found in Supplementary Figure
S1. Genes were cloned into a modified pENTR D-TOPO
(Life Technologies) vector rendered Golden Gate compati-
ble with the replacement of the native gateway cassette and
Att sites with a gateway cassette flanked by BsaI recognition
sites with the digest-overhangs TATG-GGTG.
To create Bat1 chimeras 5-mer subunits of the synthe-
sized MOrTL genes were polymerase chain reaction (PCR)
amplified with the primers listed in Supplementary Table
S2 bearing BsaI sites corresponding to Block 2 of the pre-
viously described Bat1 cloning system (6). The MOrTL
blocks, along with Bat1 blocks 1 and 3–5, were assembled
into either a Golden Gate compatible pENTR (BsaI over-
laps CACC-AAGG) or pBT102* CACC-AAGG (see be-
low) via BsaI cut-ligation. Chimera sequences are given in
the supplementary material.
To create TALE chimeras 5-mer subunits of the synthe-
sized MOrTL genes were PCR amplified with the primers
listed in Supplementary Table S2 bearing BsaI sites corre-
sponding to the 5B level 2 repeat blocks of the designer
TALE assembly toolkit as previously described (23) but
using Level 2 vectors pUC57-A5-DEST and pUC57–5B-
DEST instead of pUC57-AB-DEST, to allow different A5
and 5B repeat blocks to be combined. A5 and BC Blocks
to target BEBat1 were made with the same TALE toolkit.
A5, 5B and BC blocks were assembled together via BpiI
cut-ligation into pENTR 3xHA-TALE N/C-3xFlag-NLS-
STOP (6) or pBT102* TALE 356/+90-GFP (see below).
Protein expression and purification
Genes were transferred from pENTR into pDEST-17 using
the Gateway recombinase system (Life Technologies). Pro-
teins were expressed and purified as previously described
(6). In short, E. coliRosetta cells were induced at 30◦C with
a final concentration of 0.1 mM IPTG for 3 h. His-tagged
proteins were purified by affinity chromatography with an
A¨KTA Protein Purification System (GE Life Sciences) us-
ing a HisTrap TALON crude column (GE Life Science).
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EMSAs
EMSAs were performed as described previously (6). Com-
plementary pairs of labelled or corresponding unlabelled
oligonucleotides were annealed (list of oligos Supplemen-
tary Table S2). Binding reactions contained 1 pmol of la-
belled probe, 0 pmol, 25 pmol, 50 pmol or 200 pmol of un-
labelled probe and, if not otherwise stated, 4 pmol of pro-
tein. Binding reactions were incubated at room temperature
for 30 min and resolved on a 6% native polyacrylamide gel
for 1 h at 100 V, 4◦C. Labelled DNA was visualized with a
Typhoon FLA 9500 (GE healthcare).
Binding affinity quantifications via MST
Microscale thermophoresis was performed using the
Monolith NT.115 (Nanotemper Technologies). Comple-
mentary pairs of labelled oligonucleotides (Cy5, Eurofins)
were annealed in MST buffer (Tris 20 mM, NaCl 150
mM, 10 mMMgCl2) (18). Affinity measurements were per-
formed by using MST buffer, supplemented with 0.05%
Tween as final concentration. Samples were loaded into
NT.115 premium capillaries (NanoTemper Technologies.
Measurements were performed at 24◦C, 30%LED, 20% IR-
laser power and constant concentration of 50 nMof labelled
oligonucleotides and increasing concentration of purified
protein.
Protein melting point analysis
Protein thermal stability was measured in a label-free fluo-
rimetric analysis using the Prometheus NT.48 (NanoTem-
per Technologies). Briefly, the shift of intrinsic tryptophan
fluorescence of proteins upon temperature-induced unfold-
ing was monitored by detecting the emission fluorescence at
330 and 350 nm. Thermal unfolding was performed in nan-
oDSF grade high-sensitivity glass capillaries (NanoTemper
Technologies) at a heating rate of 1◦C per minute. Protein
melting points (Tm) were calculated from the first deriva-
tive of the ratio of tryptophan emission intensities at 330
and 350 nm.
E. coli repressor reporter system
The repressor reporter system we used is an adapta-
tion of the TALE-based bacterial NOT gate created by
Politz et al. (24), who kindly provided us with plasmids
pCherry (mCherry reporter) and TALE expression plas-
mid pBT102LacO dTALE (dTALE targeting lac operon, down-
stream of synthetic constitutive promoter J23102).
In order to create reporters for each test protein we in-
serted novel BEs into the Trc promoter of pCherry immedi-
ately 3′ of the lac operon (see Supplementary Figures S8 and
S9). This was done via PCR amplification of the whole plas-
mid, using primers listed in Supplementary Table S2 with
each bearing one half of the BE as an overhang. The se-
quences of the novel Trc promoter derivatives we created
bearing different BEs can be found in Supplementary Fig-
ure S9.
We adapted the pBT102LacO dTALE plasmid by remov-
ing the TALE gene and adding Golden Gate cloning sites
in its place. This was done by PCR amplifying the back-
bone of the vector, excluding the TALE gene, and ligating
this together with a PCR amplicon of a gateway cassette
flanked by BsaI recognition sites with overhangs 5′ TATG
– 3′ GGTG (pBT102* TATG-GW-GGTG; Supplementary
Figure S9) or 5′ CACC- 3′ AAGG (pBT102* CACC-GW-
AAGG). pBT102* TATG-GW-GGTG was then made into
a level 3 dTALE vector through the addition of several sub-
units via BsaI-cutligation, 5′ to 3′: Δ356 TALE N-terminal
region, +90 TALE C-terminal region, gfp (pBT102* TALE
356/+90-GFP; see Supplementary Figure S8). dTALE
blocks with or without a block of MOrTL repeats were
then cloned into this vector via BpiI cut-ligation as de-
scribed above. The resulting genes encode C-terminal GFP
fusion proteins. Bat1 repeat blocks alone or together with a
MOrTL repeat block were cloned into the pBT102* CACC-
GW-AAGG vector via BpiI cut-ligation. These constructs
have no GFP tag.
The assay was carried out by co-transforming approx-
imately 25 ng of each plasmid (pCherry and pBT102*)
into chemically competent E. coli Top10 cells (Life Tech-
nologies) and plating onto LB Agar plates containing 12.5
g/mlKanamycin, 50g/mlAmpicillin and 0.1mM IPTG.
The IPTG was added to prevent interference from the en-
dogenous lac repressor of Top10 cells since the mCherry re-
porter gene has a lac operator in its promoter. Plates were
incubated 36 h at 37◦C to achieve stationary phase colonies.
This is important since the growth rates of subsequent liq-
uid cultures would otherwise differ based on the growth
stage of the colonies from which they were inoculated. Sin-
gle colonies were picked into 150 l of liquid LB medium
with the same antibiotic/IPTG concentrations as above, in
wells of a 96 well Greiner plate with black sides but a trans-
parent bottom (Vision plate, 4ttitude). Picking was done by
hand with 200 l pipette tips scraping only the edge of the
colony to avoid taking toomuch bacterial mass into the low
volume liquid cultures since preliminary tests found that too
high an initial inoculum led to very high starting mCherry
values, and frustratedOD 600 normalisation. Cultures were
shaken 3.5 h at 37◦C, 180 rpm, determined in preliminary
experiments to correspond to the late log phase giving the
best reduction of variation via OD600 normalisation of any
tested time point. OD 600 was measured in a plate reader
(TECAN) as well as mCherry fluorescence was measured in
a TECAN Safire2 microplate reader with the following pa-
rameters: Excitation 587 nm, Emission 610 nm, bandwidth
± 12nm, Gain 90, Z-position 6300 m, followed by an OD
600 measurement for normalisation. Boxplots were gener-
ated in RStudio (v. 0.98.501).
Structure modelling
Homologymodels of Bat1M1 (3–7) and Bat1M2 (2–6) were built
using Schro¨dinger Prime (version 3.5; Schro¨dinger, LLC,
New York, NY, 2014). For both chimeras we used PDB
entry 4cja as template structure for modelling the protein.
The template DNA structures were mutated in silico using
the software package 3DNA (version 2.1) (25) in order to
match the optimal bases for both constructs and merged
into the homology models. To investigate the quality and
reliability of the generated models we conducted MD sim-
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ulations of both models using the software package GRO-
MACS (version 4.6.7) (26). The protocol that was applied
to both models used the CHARMM27 all-atom force field
(version 2.0) with CMAP (27,28) and TIP3P as the water
model. In order to neutralize the solvated systems water
molecules were replaced by sodium as counter-ions to ad-
just a zero net charge. The models were energy minimized
in two steps using steepest descent and subsequent conju-
gate gradient. A total of 50 ns were simulated for each sys-
tem with a time step of 2 fs. Neighbour searching was per-
formed every 10 steps. The PME algorithm was used for
electrostatic interactions with a cut-off of 1 nm. A recipro-
cal grid of 72 × 64 × 72 cells was used with fourth-order
B-spline interpolation. A single cut-off of 1 nm was used
for van der Waals interactions to limit the local interac-
tion distance. Temperature coupling was done with the v-
rescale algorithm, while the Berendsen algorithm was used
for pressure coupling. The results were analysed using tools
from the GROMACS package. Figures and videos were
generated using VMD (29) (version 1.9.2) and R (R Core
Team: A language and environment for statistical comput-
ing. 2013. http://www.r-project.org). Potential energy and
RMSD plots are shown in Figure 6A and B. Input files and
parameter settings for both simulations are given in supple-
mentary data files 3–7. PDB files with the final frames of
each MD simulation with and without solvent molecules
are provided as supplementary data files 8–10.
RESULTS
MOrTL1 andMOrTL2 are predicted proteins from amarine
metagenomics database
The term MOrTLs is used throughout to refer to two
predicted proteins: MOrTL1 and MOrTL2, from ma-
rine microbial genomic DNA, sequenced as part of the
Global Ocean Sampling (GOS) expedition (21). MOrTL1
is synonymous with GenBank protein ID ECG96325 and
MOrTL2 with EBN91409. These sequences have been pre-
viously suggested to encode modular DNA binding repeats
(5) but no functional analysis has been reported until now.
Both proteins are tandem repeat arrays, with each repeat 33
amino acids in length; MOrTL1 is formed of 8 repeats, and
MOrTL2 of 10 repeats (Figure 1A and B).
Organisms bearing theMOrTLs sequences were sampled
from the Gulf of Mexico/Yucatan Channel and are most
likely of bacterial origin based on size filtering of the bio-
logical material that was used for recovery of DNA (0.1–0.8
m) (21,22). The biological samples from which MOrTL1
and MOrTL2 were sequenced came from two different lo-
cations. The genes are thus at the very least from two dif-
ferent populations and may be from different organisms.
Both of the contigs in question are orphans not matching
at either end to anything else in the GOS database. Each
contig was sequenced with a read from each end covering
roughly 1 kb in each case. Both reads contain repeat se-
quences and a consensus was built in the centre of the contig
from the two reads in the case of the MOrTL2-containing-
contig. Because of this, the reference sequence in GenBank
(EN814823.1) indicates two open reading frames (ORFs)
separated only by a frameshift in the middle, while the sep-
arate reads suggest incomplete sequencing of a larger repeat
Figure 1. Amino acid sequences of MOrTL1 (ECG96326) and MOrTL2
(EBN19409), and a comparison of consensus TALE-like repeats. (A, B)
Full amino acid sequences of each protein are displayed as a series of
aligned tandem repeats prepared with ClustalW and Boxshade. Identi-
cal amino acids are white text on black background, similar amino acids
present in 50% of sequences are black on grey background, and dashes in-
dicate gaps. Repeat positions 10, 20 and 33 are indicated above each align-
ment, as is residue 13, designated BSR based on our assumption that this
is the base specifying residue. Repeats are numbered down the left-hand
side in each case, excluding the degenerate repeat-like sequences fram-
ing MOrTL1. (C) Consensus core repeats of each TALE-like group. (D)
Heatmap of percentage pairwise sequence similarities of consensus repeats
shown in panel (C).
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protein.We believe the same has happened for theMOrTL1
contig (EM567463.1) although in that case the reference se-
quence suggests an unresolvable run of N’s intervening be-
tween two repeat protein ORFs. Sequences of the individual
reads fromwhich these contigs were assembled can be found
in Supplementary Figure S1.
We compared consensus repeat sequences of MOrTL1
and 2 to consensus repeat sequences of TALEs, RipTALs
and Bats (Alignments Supplementary Figure S2, consen-
sus sequences Figure 1C; pairwise identities Figure 1D).
Pairwise identities for MOrTL1 and MOrTL2 compared
to each other and different TALE-likes are all within 30–
40%. MOrTL1 and MOrTL2 consensus repeats share no
common sequence features not found in other TALE-like
repeats and have the lowest pairwise similarity of any two
consensus repeats in the comparison (Figure 1D).MOrTL1
and MOrTL2 repeats differ at more than 60% of positions
from each other and from all other TALE-likes. Both for
MOrTL1 andMOrTL2 the Bat consensus repeat is the clos-
est relation in terms of sequence identity, though the differ-
ence is slight.
Purified MOrTL1 exhibits low affinity DNA binding:
database sequences are likely incomplete
It has been shown that TALEs with fewer than 10 repeats
are not able to activate reporter genes (30). Thus, there may
be too few repeats in the available MOrTLs sequences as
they are to achieve high affinity DNA binding. In addi-
tion, it has been shown for TALEs and Bats that sequence
divergent repeats in the N- and/or C-terminal region of
the protein make a decisive contribution to DNA bind-
ing (6,31). Such sequences may also exist in the full-length
MOrTL proteins but are not found in the sequences avail-
able. Indeed coding sequences (CDSs) of both MOrTLs
1 and 2 begin in what appears to be the middle of a re-
peat (Supplementary Figure S1D and S1H) supporting
this idea. We therefore considered it likely that the refer-
ence MOrTL sequences would not yield functional pro-
teins. We nevertheless had genes encoding the reference
MOrTL1 and MOrTL2 proteins synthesized. We were able
to express and purify MOrTL1 from Escherichia coli, while
MOrTL2 formed protein aggregates preventing purifica-
tion (Supplementary Figure S3A). MOrTL1 was tested in
electrophoretic mobility shift assays (EMSAs) at a range
of concentrations against a fluorescently labelled oligonu-
cleotide probe bearing a predicted DNA binding element
(BE; BEMOrTL1; Figure 2A) based on the TALE code (Sup-
plementary Table S1). A shift was detectable only with a
MOrTL1 concentration of 822 nM or greater (Supplemen-
tary Figure S3B). Such weak DNA binding is inconsis-
tent with expectations based on other TALE-likes (6,32).
In addition laddering was observed in the gel shift indi-
cating the formation of higher order protein–DNA com-
plexes (Supplementary Figure S3B) again inconsistent with
TALE-likes, which bind their targets in a 1-to-1 ratio with
high sequence specificity.
As previously mentioned, both MOrTLs 1 and 2 are
likely to be fragments of larger, incompletely sequenced
genes (Supplementary Figure S1). We considered it worth
attempting to fuse together the repeats encoded on both
reads of MOrTL2 contig EN814823.1 even if intervening
sequence is lacking. However, the resultant fusion protein
(EBN19408-MOrTL2; sequence in Supplementary Figure
S4) formed insoluble protein inclusions in E. coli, like
MOrTL2, preventing functional analysis.
In vitro assays on chimeric Bat1-MOrTL repeat arrays
demonstrate DNA binding consistent with the TALE code
We next decided to explore a repeat domain chimera ap-
proach that has proved highly informative in the past for
the functional analysis of Bat and RipTAL repeats (3,6).
We chose a Bat1 repeat array framework to work with since
the Bat consensus repeat was the most similar to MOrTL1
and MOrTL2 repeats at the sequence level (Figure 1D).
We tested blocks of five repeats from the central part of
each MOrTL embedded within the repeat domain of Bat1
at positions 6–10 (Bat1M1 (3-7) and Bat1M2 (2-6); Figure 2A).
In each case the integrated MOrTL repeats differ in their
BSR composition from the Bat1 repeats they replace, which
should lead to a modified DNA sequence preference. The
design of each chimera is illustrated in Figure 2A. Note
that repeats of MOrTL1 and MOrTL2 differ from Bat1 re-
peats at distinct positions (Figure 2B). To get a first idea of
DNAbinding properties purifiedBat1 and chimera proteins
were tested in vitro with EMSAs (Figure 2C, Supplemen-
tary Figure S6) against cognate BEs, which we predicted
with the TALE code (Supplementary Table S1). Clear sin-
gle shifts, of similar intensity, were observed for Bat1 and
Bat1-MOrTL chimeras at 200 nM with their cognate BEs
(Figure 2C). We followed this up by using microscale ther-
mophoresis (MST) to quantify the affinity of the binding
and calculate a KD. We found an almost identical affinity
in each case: 126 nM for Bat1M1 (3–7) with its BE and 128
nM for Bat1M2 (2–6) with its BE (Figure 2D, Supplementary
Figure S7). We have previously tested the Bat1–BEBat1 in-
teraction in the same system and found a KD of 132 ± 35
nM (6)). Thus both Bat-MOrTL chimeras were able to bind
their cognate TALE-code predicted BEwith a strength sim-
ilar to the wild type Bat1 protein.
Tests with predicted on-target sequences do not alone
prove adherence to the TALE code. Specificity also needs
to be tested. We designed off-target BEs choosing the worst
predicted match for each of the five repeats in positions
6–10 (MOrTL repeat block in the chimeras) of each con-
struct based on the TALE code (Supplementary Table S1):
G used for Gly at the BSR and T used for Arg, Asp or
Ile at the BSR. Applying this code results in a single off-
target oligonucleotide with GGTTG at the test position for
all three proteins. All other positions in target DNAs were
kept constant to isolate the test repeats and test their speci-
ficity. We first carried out EMSA competition assays for all
three proteins. MST was carried out for the two chimeras
to assess affinities for off-target DNAs. In the EMSA com-
petition assays (Figure 2E) the labelled on-target probe is
mixed with an excess of either on- or off-target competitor
DNA: If the test repeats bind the labelled probe in a spe-
cific fashion then an excess of on-target competitor should
outcompete the on-target probe, leading to a loss of shifted
signal while an excess of off-target competitor should have
a less pronounced impact on probe-protein interaction. As
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Figure 2. Bat1-MOrTL chimera proteins bind predicted target sequences in vitro. (A) Schematic display of repeat arrays of Bat1 (grey polygons), MOrTL1
(dark blue hexagons) and MOrTL2 (dark blue vases). Also displayed are the chimeras containing five repeats of MOrTL1 (repeats 3–7) or MOrTL2
(repeats 2–6) in place of repeats 6–10 of Bat1. BSRs of repeats are given in each case, with an asterisk for repeat 20 of Bat1, which lacks an amino acid
at position 13 with respect to the consensus sequence. Binding elements (BEs) for each TALE-like chimera were predicted using the TALE code and are
given below the cartoon display in each case, with dark blue for bases in the test positions. The off-target sequence, designed to bear mismatch bases for
repeats 6–10 of each construct based on the TALE code, for all Bat1 derived proteins (BEBat1GGTTG) is shown below with red for bases in the test positions
(B) Repeat alignments of consensus Bat, MOrTL1 and MOrTL2 repeats as shown in Figure 1C. Amino acids conserved between Bat1 and the MOrTLs
are highlighted with blue font letters. Electrophoretic mobility shift assays (C, E) were carried out using 5′ Cy5-labelled double-stranded DNA probes
at a final concentration of 50 nM and 200 nM for all proteins indicated. Shifted bands corresponding to the DNA:protein complexes are indicated with
asterisks (*) and free probes with tildes (∼). Each probe (DNA) was incubated in presence (+) or absence (–) of its cognate protein and run in a native 6%
polyacrylamide gel. For the competition assays (E), competitor DNA was added in excess as indicated. In each case the designation of the protein used
is underlined, the probe italicized and the competitor bold and italicized. (D, F) The interaction between the Bat1-MOrTL chimeras and their predicted
on- or off-target DNAs (a) was quantified using microscale thermophoresis. The bound fraction is shown on the y-axis against the protein concentration.
Standard deviation for three replicates is indicated. Measurements were made with 20% LED and 30% laser power. The dark blue line indicates the KD fit.
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seen in Figure 2E this was indeed observed in every case
supporting our hypothesis that repeats of both MOrtTL1
and 2, like Bat1 repeats, have TALE-code-consistent base
preferences. However, the discriminating power of the test
repeats in the MOrTL2 chimera was lower than that of the
other proteins, since a 200x excess of off-target DNA was
able to quench on-target binding by 40% relative to the
no-competitor lane (quantifications: Supplementary Figure
S6). Additionally the protein–DNA interactions with the
off-target probe were quantified withMST (Figure 2F, Sup-
plementary Figure S7). The interaction of Bat1M1 (2–6) with
its off-target BEBat1 GGTTG was determined to have a KD of
>2300 nM and thus was 19 times lower in affinity than the
on-target interaction. In contrast the KD of the Bat1M2 (3–7)
BEBat1 GGTTG interaction was 201 nM, indicating an inter-
action only about half as strong as the on-target interac-
tion. In each case on-target interactions are stronger than
off-target consistent with TALE code base preference but
there are differences in discriminating power. The EMSA
andMST data together suggest thatMOrTL1 and 2 repeats
bothmediate TALE code base preferences but differ in their
discriminating power.
In vivo assays support in vitro findings on Bat1-MOrTL
chimera DNA binding properties
To study the DNA recognition properties of MOrTL re-
peats in vivo we adapted a TALE-based NOT gate in E.
coli (24) to serve as a repressor reporter. In this system
TALE-like proteins are tested for their ability to bind a con-
stitutive Trc promoter and thereby repress expression of a
downstreammCherry reporter (pCherry). Another plasmid
(pBT102) carries either the test TALE-like (Bat1, dTALEor
chimera), a GFP CDS (negative control) or a positive con-
trol dTALE. The positive control TALE is one previously
designed and tested for the lac operon, which forms part
of the Trc promoter upstream of the mCherry CDS. The
negative-control is simply a constitutively expressed GFP
not expected to bind DNA or mediate any repression of the
mCherry reporter (this is unconnected to the use of GFP
as a secondary reporter in one of the assay set-ups explored
by Politz et al. (24)). pCherry and pBT102 plasmids are co-
transformed into E. coli cells and mCherry flourescence is
measured in liquid cultures inoculated from the transfor-
mants. The reduction of mCherry fluorescence of colonies
arising from test and control co-transformations provides
a measure of the strength of the interaction of the tested
TALE-like and their affinity to the BE in the Trc promoter.
Lower fluorescence indicates a stronger interaction. The ex-
perimental set-up is illustrated in Figure 3A.
Bat1, Bat1M1 (3–7) andBat1M2 (2–6) were tested against cog-
nate reporters and fold repression was calculated relative
to the GFP negative control. We found that Bat1 medi-
ated 3.4-fold repression while the chimeric Bat1M1 (3–7) and
Bat1M2 (2–6) mediated 2-fold and 1.8-fold repression, respec-
tively. Thus Bat1M2 (2–6), which binds its target BE with near
identical affinity to Bat1M1 (3–7) in vitro (Figure 2D), shows
a slightly weaker repression in vivo (Figure 3D). This may
reflect the lower discriminatory power of the MOrTL2 re-
peats observed in vitro (Figure 2E, F) leading to more off-
target binding across the E. coli genome quenching the re-
Figure 3. An in vivo reporter confirms that MOrTL repeats embedded in
a Bat1-repeat array recognize predicted binding elements. (A) Schematic
display of the repressor assay: mCherry reporter and expression plasmids
encoding TALE-likes are co-transformed into E. coli. TALE-like chimeras
consist of TALE/Bat-repeats (grey ovals) and MOrTL-repeats (dark blue
ovals). If the TALE-like binds the given BE (blue rectangle) it should re-
press the mCherry promoter, observed as a reduction in mCherry fluores-
cence (red rectangle; cherries). A dTALE that binds the lac operon (LacO,
orange box) within the mCherry promoter provides a positive control for
each reporter. (B–D) Box and whisker plots show mCherry fluorescence
values for Bat1, Bat1M1 (3–7) and Bat1M2 (2–6) tested against reporters bear-
ing corresponding BEs (designation across the top of each plot), normal-
ized to cell density (OD600) and compared to positive (LacO dTALE) and
negative (GFP) control expression plasmids. An off-target reporter was
created with mismatch bases for repeats 6–10 of each construct based on
the TALE code and tested with all test constructs in the same system (E).
Fold repression, based on median values, and P-values of a two-tailed t-
test with unequal variances comparing test and GFP samples are given in
the top left corner of each plot. N = 16 in each case.
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pression effect to some extent. We tested the specificity of
these in vivo interactions assays with the GGTTG off-target
reporter in each case and showed that the reporter was not
repressed by Bat1 or either of the chimeras relative to the
GFP control (Figure 3B–E). Overall there is thus clear evi-
dence that DNA binding of MOrTL repeats embedded in a
Bat1 repeat array is sequence specific with base preferences
consistent with the TALE code.
MOrTL1 and MOrTL2 differ in their compatibility with
TALE repeats
In the interests of potential biotechnological applications
and to gain further fundamental information on MOrTL1
and 2 repeat properties we created additional chimeras
where MOrTLs repeats are embedded in TALE repeat ar-
rays. Specifically we used a dTALE designed to target the
same DNA sequence as Bat1 (dTALE-Bat1). The MOrTL
repeats chosen for the TALE chimeraswere based on ease of
primer placement for cloning, this resulted in the same set of
fiveMOrTL1 repeats being taken (dTALE-Bat1M1 (3–7)) but
a different set of MOrTL2 repeats (dTALE-Bat1M2 (4–8)).
Designs are illustrated in Figure 4A, and construct se-
quences in Supplementary Figure S10.
As for the Bat1 chimeras we predicted BEs for the TALE-
MOrTL chimeras using the TALE code (Supplementary
Table S1). We tested purified proteins at 200 nM against
these BEs in EMSAs (Figure 4C), revealing a single shift
indicative of 1-to-1 DNA binding. This was followed by
MST measurements to determine KD values: 437 nM for
the MOrTL1 chimera dTALE-Bat1M1 (3–7) with its cognate
BE and over 5410 nM for the MOrTL2 chimera dTALE-
Bat1M2 (4–8) (Figure 4D, Supplementary Figure S7). While
the affinity of the dTALE-MOrTL1 chimera for its target
is low compared to what one might expect for a TALE re-
peat array, this array is rich in Ile BSRs known to medi-
ate low affinity DNA binding (15). However the affinity
of the MOrTL2-TALE chimera falls far below the range
of measured on-target TALE-like DNA binding interac-
tions. We therefore tested whether these interactions are in-
deed sequence specific using predicted off-target BEs (note
that the off-target used for the MOrTL2 chimera dTALE-
Bat1M2 (4–8) is distinct from the off-target for the other
constructs due to the particular BSR composition of the
MOrTL2 repeats in this construct (Figure 4A)). EMSA
competition assays (Figure 4E) revealed that the on-target
binding shift for dTALE-Bat1M2 (4–8) can be depleted just
as easily by the off- as the on-target oligonucleotides. MST
with predicted off-target oligonucleotides was also carried
out (Figure 4F, Supplementary Figure S7). These tests show
that dTALE-Bat1M1 (3–7) is highly discriminating, with the
upper plateau of DNA binding to the off-target BE not
even reached at 14 000 nM in the MST measurements (Fig-
ure 4F). In contrast the KD of dTALE-Bat1M2 (4–8) interact-
ing with BEBat1 TTGGT was 6388 nM (Figure 4F), not much
weaker than the on-target interaction (Figure 4D). EMSA
competition assays and MST thus both support the idea
that dTALE-Bat1M2 (4–8) discriminates poorly between on-
and off-target sequences.
In vivo assays support the hypothesis that MOrTL2 repeats
are incompatible with TALE repeats
When the same TALE-MOrTL chimeras were tested in
vivo with the repressor reporter we found similar re-
sults. dTALE-Bat1 and theMOrTL1 chimera dTALE-Bat1
M1 (3-7) performed similarly, repressing their reporters 9.5-
and 11.6-fold, respectively (Figure 5A,B). In contrast the
MOrTL2 chimera dTALE-Bat1 M2 (4–8) mediated only 1.6-
fold repression (Figure 5C).
We considered that the poor performance of MOrTL2
repeats 4–8 in a TALE repeat array (dTALE-Bat1 M2 (4–8))
may be due to an unfortunate choice of the specific repeats
chosen for this construct compared to the Bat1 chimera that
contained MOrTL2 repeats 2–6 (Bat1M2 (2–6)). By con-
trast the same MOrTL1 repeats were used for Bat1 and
TALE chimeras. So we created new TALE chimeras for
MOrTL1 andMOrTL2. In these new chimeras we took the
same MOrTL2 repeats as had previously been used in the
Bat1 chimera (repeats 2–6; Figure 5E), and from MOrTL1
we took a different set of repeats (repeats 2–6 versus 3–7
previously; Figure 5D). We tested these in the repressor as-
say against on- and off-target reporters. These results mir-
rored the results from the first set of chimeras with the new
MOrTL1 chimera mediating 7.1-fold repression of its on-
target reporter (Figure 5D), compared to 1.6-fold for the
MOrTL2 chimera on its on-target reporter (Figure 5E).
In both cases no repression was observed for off-target re-
porters.
MOrTL1 and 2 repeats both mediated sequence-specific
DNA binding interactions of similar strength in the con-
text of a Bat1 repeat array, though the sequence discriminat-
ing power of the MOrTL2 chimera was lower (Figures 2C–
F and 3C,D). In contrast only the MOrTL1 repeats per-
formed well in a TALE repeat array while MOrTL2 repeats
mediated very weak and barely sequence specific DNA
binding in a TALE repeat array independent of the particu-
lar set of MOrTL2 repeats taken for the chimera. This sug-
gests an incompatibility between MOrTL2 repeats and the
surrounding TALE repeat array. ConsensusMOrTL1 and 2
repeats are both overall 35% identical to a consensus TALE
repeat conforming to that used in our dTALEs. However,
conserved residues are at different positions in each case
(Figure 4B). Thus differences in compatibility are not sur-
prising. The higher discriminatory power of MOrTL1 re-
peats (Figure 2E and F) and their compatibility with both
Bat1 (Figures 2 and 3) and TALE (Figures 4 and 5) repeats
makes them better suited for integration into TALE-like re-
peat arrays for biotechnological applications.
Functional differences between MOrTL1 and MOrTL2
chimeras are not due to differences in protein stability
We considered that the different functional properties of
the MOrTL1 and MOrTL2 chimeras and especially the
poor functioning of MOrTL2 repeats in a TALE repeat
array might be the consequence of different protein sta-
bilities. To this end we defined melting points for all pro-
teins in vitro. The results, shown in Table 1 reveal similar
melting points for Bat1 and the two correspondingMOrTL
chimera derivatives, and for dTALE-Bat1 and its two corre-
spondingMOrTL chimera derivatives. WhileMOrTL1 and
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Figure 4. TALE-MOrTL chimeras proteins bind predicted target sequences in vitro. (A) Schematic display of repeat arrays of dTALE-Bat1 (grey ovals),
MOrTL1 (dark blue hexagons) and MOrTL2 (dark blue vases). Also displayed are the chimeras containing five repeats of MOrTL1 (repeats 3–7) or
MOrTL2 (repeats 4–8) in place of repeats 6–10 of Bat1 (grey). BSRs of repeats are given in each case. Binding elements (BEs) for each TALE-like chimera
were predicted using the TALE code and are given below the cartoon display in each case, with blue bases in the test positions. Off-target sequence BEBat1
GGTTG or BEBat1 TTGGT for the dTALE-Bat1 derived proteins are shown below with red for bases in the test positions (B)Alignment of consensus TALE,
MOrTL1 andMOrTL2 repeats as shown in Figure 1C. Conserved amino acids are highlighted with dark blue letters. Electrophoretic mobility shift assays
(C, E)were carried out using 5′ Cy5-labelled double-stranded DNA probes at a final concentration of 50 nM and 200 nM for all proteins indicated. Shifted
bands corresponding to the DNA:protein complexes are indicated with asterisks (*) and free probes with tildes (∼). Each probe (DNA) was incubated
in presence (+) or absence (–) of its cognate protein and run in a 6% polyacrylamide gel. For the competition assays (E) the unlabelled competitor DNA
(A) was added in excess as indicated. The off-target sequence was designed to bear mismatch bases for repeats 6–10 of each construct based on the TALE
code (BEBat1GGTTG for Bat1M1 (3–7) and BEBat1TTGGT for dTALE-Bat1M2 (4–8)). In each case the designation of the protein used is underlined, the probe
italicized and the competitor bold and italicized. (D, F) The interaction between the TALE-MOrTL chimeras and their predicted on- and off target boxes
was quantified using microscale thermophoresis. The bound fraction is shown on the y-axis against the protein concentration. Standard deviation for three
replicates is indicated. Measurements were made with 20% LED and 30% laser power. The dark blue line indicates the KD fit.
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Figure 5. The repressor assay provides evidence for an incompatibility between MOrTL2 and TALE repeats. dTALE-Bat1 (A), MOrTL1 (B,D) and
MOrTL2 (C,E) chimeras were tested against cognate on- and off- target reporters in the repressor assay (Figure 3A). Box and whisker plots show mCherry
fluorescence values normalized to cell density (OD600) and compared to positive (LacO TALE) and negative (GFP) control expression plasmids for each
reporter tested against all relevant TALE-likes and chimeras. N = 16 in every case. Note that because dTALE-Bat1 and dTALE Bat1M1 (3–7) were assayed
in parallel on their common off-target reporter and the LacO dTALE and GFP control values are thus the same in each plot (A, B off-target reporters).
MOrTL2 do not seem to have a strong impact on the melt-
ing points of corresponding chimeras we found a consistent
difference between all Bat1 and TALE constructs. All Bat1–
derived proteins showed melting points about 15◦C higher
than all TALE-derived constructs. This might be indicative
of a greater thermal stability for Bat proteins compared to
TALEs, and consistent with this TALE nucleases have been
shown to function poorly at 37◦C compared to 30◦C (33).
This is, however, not relevant to our present characterisa-
tion of MOrTL repeats. These data suggest that the intro-
duction of MOrTL repeats does not have a destabilising ef-
fect on the Bat1 or TALE proteins and that the incompati-
Table 1. Comparison of protein melting points of Bat1, dTALE-Bat1 and
their MOrTL chimeras
Protein Melting point
Bat1 44.3 ± 0.1◦C
Bat1 M1 (3–7) 44.6 ± 0.1◦C
Bat1 M2 (2–6) 45.6 ± 0.3◦C
dTALE-Bat1 31.7 ± 0.1◦C
dTALE-Bat1 M1 (3–7) 28.1 ± 0.7◦C
dTALE-Bat1 M2 (4–8) 28.4 ± 0.3◦C
bility suggested between MOrTL2 and TALE repeats has a
different cause.
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Functional conservation is likely a consequence of structural
conservation
We were able to show that MOrTL1 and 2 repeats medi-
ate DNA binding with a sequence specificity matching the
TALE code when embedded in a Bat1 repeat array and in
the case of MOrTL1 also a TALE repeat array. DNA bind-
ing properties seem to be broadly conserved among repeats
of TALEs, RipTALs, Bats, MOrTL1 andMOrTL2. By this
we mean sequence specific DNA binding with each repeat
binding a single base and specificity determined by position
13 with specific BSRs having largely the same base prefer-
ence in any TALE-like repeat. This functional conservation
is suggestive of a structural conservation allowing each re-
peat to contact a single nucleotide and for position 13 to
mediate base specific interactions. A broad functional con-
servation, together with sequence similarity are suggestive
of a conserved structure but further evidence is obviously
desirable. There is already evidence in support of a high de-
gree of structural similarity among TALEs and Bats: crys-
tal structures for Bat1 (alternatively termed BuD), with and
without its DNA target, have been solved (19) and are simi-
lar to analogous structures for TALEs PthXo1, AvrBs3 and
dTALE dHax3 (20,34–35), in so far as all proteins form a
right-handed super helix that contracts tightly around the
B-form DNA helix. The structures are not identical and
one of the most noticeable differences is the double-band
of electropositive residues allowing the Bat1 repeat array to
interact with the phosphate backbone of bothDNA strands
(19) compared to the single band of TALEs (20,34–35).
However, the key structural properties responsible for the
1-to-1 base specific binding behaviour of TALE-likes are
similar in TALE and Bat1 structures. The repeats of Bat1
and TALEs are helix-loop-helix structures with BSRs lo-
cated in the loops that point into the major groove of the
target DNA. Assuming these features form structural pre-
requisites for the DNA-binding properties of TALE-likes,
we expect the MOrTL repeats, for which no experimentally
derived structure is available yet, to adopt a similar struc-
ture. To evaluate this hypothesis, we generatedmodels of the
functionally validated chimeras Bat1M1 (3–7) and Bat1M2 (2–6)
using the structure of Bat1 (BuD) bound to DNA as a tem-
plate. Both models show structural properties similar to
those described earlier for TALE-like repeats (Figure 6A
and B; supplementary data files 1–2). While these homol-
ogy models resulted in a plausible protein structure, they
do not provide functional information. To get information
about the stability of the predicted protein–DNA interac-
tion interface over time we conducted molecular dynamics
(MD). Both independent simulations for predicted struc-
tures of MOrTL1 and MOrTL2 repeats embedded in Bat1
revealed highly stable complexes between the proteins and
their target DNA, seen in the values for atomic distances be-
tween protein and DNA partners (Figure 6A and B). Mea-
suring base–BSR distances duringMD simulations showed
that under the simulated conditions such interactions were
stable and comparable for Bat1 and MOrTL derived re-
peats (Supplementary Tables S3 and S4). Overlays of iden-
tical BSR–base interactions taken from repeats of different
origins show that nearly identical interactions were sam-
pled in each case (Figure 6C). Thus the simulated structures
and DNA-binding interactions are consistent with our in
vitro and in vivo DNA-binding data. We also wanted to see
if the same intra-molecular interactions stabilise MOrTL
repeats as have been observed for other TALE-likes. Hy-
drophobic interactions between specific residues have been
predicted to stabilise Bat1 repeat arrays (19). We exam-
ined MOrTL1 repeats from our homology model since the
DNAbinding properties, and thus presumably repeat struc-
tures of Bat1M1 (3–7), more closely resembled Bat1 than did
repeats of MOrTL2. Intra- and inter-repeat interactions
were indeed present during simulation, and in similar po-
sitions on the repeat, but mediated by different residues,
than those found in Bat1 repeats (e.g. Val22 of Bat1 repeats
versus Leu22 of MOrTL1 repeats (19)) (Figure 6D). Simi-
larly, stabilising interactions are present for TALE repeats
at the same or neighbouring positions as those predicted
forMOrTL1 repeats butmediated by different residues (36).
This would suggest that while TALE-like repeats adopt very
similar structures some structural details and particularly
the residues involved in stabilising interactions are likely to
differ between groups.
Taken together, it seems likely that repeats of TALEs,
RipTALs, Bats, MOrTL1 and MOrTL2, adopt similar
structures, facilitating a conserved DNA-binding mecha-
nism. We suggest therefore that the designation TALE-like
should refer to proteins bearing an array of repeats broadly
conserved both functionally and structurally with those of
TALEs.
MOrTL repeats differ from all other TALE-likes in residues
around the BSR
The structural similarities between TALE-like repeats are
surprising considering the low sequence similarity in some
cases. To illustrate the variation among TALE-like repeats
we created amino acid alignments of core repeats from rep-
resentatives of each TALE-like group so far described, in-
cluding but not limited to those used to create the consensus
repeats of Figure 1C (see Supplementary Table S5 for list
of all TALE-likes used). These alignments show first that
TALE repeats are somewhat exceptional for their very low
sequence diversity. In all other TALE-like groupsmore than
one third of repeat positions are highly polymorphic. More
specifically TALEs are highly polymorphic only at positions
4, 12, 13, 32 and 35; Bat and RipTAL repeats, in contrast,
are polymorphic across much of the long helix (positions
15–32) and inter-repeat loop (positions 33–2) regions.
It is clear that some positions seem to be more conserved
than others both within and between groups. We calculated
percentage conservations at each position of each separate
alignment (Supplementary Table S6) and all positions at
least 75% conserved within all five TALE-like groups are
shaded grey (Figure 7, Supplementary Figure S6). Many of
these cluster around positions 5–19 (Figure 7B), which is
logical considering their proximity to the crucial BSR posi-
tion (see Figure 6) in addition to the constraint inherent in
formation of an alpha-helical structure.
These positions are highly conserved within groups but
not necessarily between groups. In fact only three positions
are highly-conserved across all five groups (red-lettering;
Figure 7B). In contrast other positions are highly conserved
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Figure 6. Homology models supported by molecular dynamics (MD) simulations of Bat1-MOrTL chimeras bound to cognate BEs, correspond to known
TALE-like structures. Homology models of Bat1M1 (3–7)(A) and Bat1M2 (2–6)(B) were built using PDB entry 4cja as template structure with template DNA
structuresmutated in silico in order tomatch the optimal bases for both constructs. The resulting protein–DNAcomplexes were subjected to 50 nsmolecular
dynamics simulations. Single snapshots of the models bound to DNA (purple) are shown as well as RMSD read outs from the simulations for DNA (blue
traces) and protein C-alpha backbone (red traces). Bat1 repeats are shown in grey. MOrTL repeats are highlighted in dark blue. Models are orientated with
the N-terminus of each protein in the bottom left corner. (C) Using these models single snapshots of BSR–base interactions were taken from repeats of
Bat1 (grey), MOrTL1 (blue) and MOrLT2 (yellow) with Asp or Gly at the BSR position. (D) Interactions between MOrTL1 repeats in Bat1M1 (3–7) were
also observed to be mediated by certain residues both within (yellow) and between repeats (green).
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Figure 7. TALE-like repeat alignments show an underlying pattern of se-
quence conservation around the BSR position. (A)Repeat alignments and
corresponding sequence logos were derived from representative core re-
peat arrays from each TALE-like group characterized so far (Supplemen-
tary Table S5), using CLC Main Workbench 7. In the sequence logo the
total height in each column correlates to conservation at that position.
Percentage conservations were calculated for each position (Supplemen-
tary Table S6). Positions that are at least 75% conserved in all groups are
shaded grey. Predicted secondary structural features are indicated above
the alignment (arrows indicate alpha-helices). The most common residues
for each TALE-like group at the highly conserved (grey-shaded) positions
are indicated underneath the logos (B), and positions within the repeat are
numbered. Among these the residues unique to MOrTL1 or MOrTL2 are
highlighted with blue lettering, whilst red lettering highlights those posi-
tions fully conserved across TALE-likes.
within groups but different residues are found in different
TALE-like groups (e.g. positions 8 and 15; Figure 7B). This
could be useful as a tool to examine different selective pres-
sures constraining sequence evolution within and between
different TALE-like repeat groups.
There is little polymorphism around the BSR of TALE,
RipTAL and Bat repeats (Figure 7A). This is limiting for
repeat engineering efforts because these residues are espe-
cially likely to exert significant influence over DNA binding
properties. Previous efforts to exploit natural diversity for
TALE-like repeat engineering may have been hindered by
the lack of diversity in this key region. Furthermore any ef-
fort to create sequence-diverse TALE-likes less prone to re-
peat recombination (37,38) based on natural diversity will
be held back by the lack of sequence diversity in this re-
gion, although one approach using codon redundancy to
boost the sequence diversity was able to overcome the re-
peat loss issue in lentiviral delivery vectors (39). Repeats of
MOrTL1 and 2, however, have unique residues in otherwise
highly conserved positions in this region around the BSR
(Figure 7B; dark blue-lettering). At positions, 10, 15, 17 and
19 there is little to no sequence diversity among TALE-likes
except that found inMOrTLs 1 and 2. ThusMOrTLs 1 and
2 make a substantial contribution to the sequence diversity
of TALE-like repeats in residues around the BSR.
DISCUSSION
We have been able to show that repeats from MOrTL1
and 2 (Figure 1) recognise DNA with a sequence speci-
ficity matching the TALE-code (Figures 2–5). Blocks of five
MOrTL1 repeats, embedded in Bat1 or TALE repeat ar-
rays, were competent to discriminate TALE-code-predicted
on-target BEs, from off-target sequences (Figures 2–5).
MOrTL2 repeats share no derived sequence features with
those of MOrTL1 (Figure 1C, D) and also demonstrated
some striking functional differences. MOrTL2 repeats in
a Bat1 context mediated strong DNA binding similar to
the MOrTL1-Bat1 chimera (Figure 3) and demonstrated a
clear base preference (Figure 2D–F). However, there was
a difference in specificity in so far as the discriminating
power of the repeats is concerned. We see specificity as
formed of two components: base-preference and discrim-
inating power. The base-preference of a repeat is a state-
ment of its relative interaction strengths for different bases.
The absolute values for each interaction are not important
only the ratios. However, the contribution of a particular re-
peat to the selection of one binding site over another for the
whole repeat array is its discriminating power. This comes
from the absolute interaction strength for a given repeat
binding a given base, in the context of the whole repeat ar-
ray. If the positive contribution from a best-match interac-
tion or the negative contribution from a mismatch is strong
enough, it can make a decisive contribution to target site
discrimination. This difference between base preference and
discriminating power can be understood for TALE-likes by
referring to previous studies on TALE repeat specificity.
The SELEX method which uses repeated rounds of selec-
tion to identify the preferred target site of an array has
consistently shown that every repeat in a TALE array ex-
erts a preference corresponding to the TALE code (11,33).
Base preference is constant across all positions in the ar-
ray (though there are minor qualifications to this (40)). In
contrast several lines of evidence have shown that the dis-
criminating power of TALE repeats reduces past repeat
10 (15,41). To us the behaviour of Bat1M2 (2–6) is sugges-
tive of MOrTL2 repeats having a base preference consis-
tent with the TALE code but low discriminating power. In
addition to this possible difference in discriminating power
between MOrTL1 and 2 repeats there is also the clear com-
patibility difference with TALE repeats (Figures 4 and 5).
dTALE-MOrTL1 chimeras mediated strong DNA binding
(Figure 4) and reporter repression (Figure 5), clearly dis-
criminating on- from off-targets (Figure 4 D–F). dTALE-
MOrTL2 chimeras mediated weak and barely sequence-
specific DNA binding (Figure 4) and weak reporter repres-
sion compared to the other dTALE constructs (Figure 5).
Since during all these tests on- and off-target BEs were pre-
dicted based on the TALE-code we believe the data demon-
strate that MOrTL1 and MOrTL2 repeats are able to me-
diate DNA binding with a base preference adhering to the
TALE code but that there a functional differences between
MOrTL1 and MOrTL2 repeats.
We can use this information to make a refined descrip-
tion of the TALE-likes, a grouping until now defined only
loosely and inconsistently. We would suggest the designa-
tion TALE-like refer only to any protein bearing a tandem
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array of 33–35 amino acid repeats mediating 1-to-1 DNA
binding with position 13 determining DNA binding speci-
ficity in accordance with the TALE code. Repeat arrays
of such proteins should also structurally resemble those of
TALEs insofar as forming a super helix with each repeat
formed of paired alpha-helices.
Comparison of TALE-like repeat sequencesmay improve
understanding of TALE-like repeat structure and the con-
nection between structure and DNA binding properties.
This improved understanding will in turn benefit TALE re-
peat engineering efforts. Until now assumptions on the roles
of different TALE or TALE-like repeat residues, apart from
the RVD, have been based on structural models (19,34–35).
Hypotheses about residue roles remain largely untested in
a wet lab setting though molecular dynamics simulations
have provided some insights (42). Data from the natural
experiment of evolution can help answer some questions
or provide a starting point for hypothesis testing, comple-
menting other methods. For example, positively charged
residues Lys16 and Gln17 of TALE repeats were suggested
to form an electropositive stripe along the TALE super-
helix and to form hydrogen bonds to the phosphate back-
bone of the DNA (35). In Bat, MOrTL1 and MOrTL2 re-
peats, position 16 is generally occupied by an uncharged
residue, speaking against the importance of Lys16 for re-
peat array function, unless the effect is elsewhere compen-
sated. Gln17 in contrast is conserved across all groups, ex-
cept for MOrTL2 where a Lysine is found at this position.
This would support an important role for the electropositive
strip formed from positive residues at position 17 only. To
take another example, it seems logical that the highly con-
served double Glycine at positions 14–15 in TALEs, Rip-
TALs, Bats and MOrTL2 is necessary for the flexibility of
the repeat loop. MOrTL1 repeats have either Alanine or
Serine at position 15; does this affect flexibility of the BSR
loop and consequently the interaction between BSR and
base? Other positions are surprisingly conserved. Leu29 is
one of only three residues highly conserved between all the
TALE-like groups. Until now the only function attributed
to this residue is a role in hydrophobic interactions that
bring together neighbouring repeats as the TALE structure
contracts upon DNA binding (19), yet other hydrophobic
residues seem not to be tolerated at this position. Since
MOrTL repeats are polymorphic at otherwise highly con-
served positions in all other TALE-likes they may be es-
pecially useful for such comparative approaches to under-
standing the interplay of sequence, structure and function
in the TALE-like repeat.
There are additional insights to be gained by compar-
ing sequence conservation within groups to conservation
between groups. Certain positions are highly conserved in
repeats of every TALE-like group (grey shading Figure 7).
However at some of these positions different residues are
found in several of the different TALE-like groups (Fig-
ure 7B). If one assumes that these sequences should encode
protein domains with analogous functions then this obser-
vation might suggest that some positions are constrained
at the level of array function more than at the level of in-
dividual repeat function. That is to say that for some rea-
son, such as inter-repeat interactions, these positions must
be conserved within any given array. Alternatives may be
equally good as long as they are borne by all repeats in the
array. If this were the case then those residues indicated in
Figure 7B may be particularly likely to play a role in the
compatibility or incompatibility of repeats from different
TALE-like groups.
MOrTL1 and 2 also make useful outgroups for asking
questions about the evolutionary history of other TALE-
likes. As mentioned previously TALE and RipTAL repeats
are conserved atmany positions, while the Bats show greater
sequence divergence. However some residues around the
BSR are conserved among TALE, RipTAL and Bat re-
peats (Figure 7). So far it has remained an open question
as to whether these sequence similarities are an indicator
of common evolutionary origin or are rather the result of
convergent evolution of similar proteins with a constrained
sequence-structure space. The diversity of MOrTL1 repeat
sequences in this region shows that several alternative se-
quences are tolerated within this structure. Therefore, that
the TALEs, RipTALs and Bats are conserved in this region
suggests that they share a common ancestor. To determine
whether MOrTL1 and MOrTL2 share this common ances-
tor requires the identification of a plausible TALE repeat
progenitor sequence to use as an outgroup for creation of a
phylogenetic tree.
What struck us most clearly when comparing TALE-like
repeat sequence diversity (Figure 7) was that TALE repeats
display by far the lowest sequence diversity. This sequence
conservation is even more apparent when examining indi-
vidual TALE repeat arrays as opposed to the pooled se-
quence logo presented inFigure 7A. There is almost no non-
RVD repeat polymorphism between the repeats of TALE
AvrBs3 for example (Supplementary Figure S11). The low
repeat polymorphism among TALEs is thus exceptional
and evidence of particular selection pressures or mecha-
nisms of sequence evolution relevant to TALEs only.
Considering the full sequence diversity of TALE-like
repeats may also assist with the identification of further
TALE-likes. While TALE repeats are highly conserved
across most positions only three residues are conserved
across all groups (Figure 7B, red lettering): Val7, Gly14 and
Leu29. That these positions are so highly conserved sug-
gests functional importance as discussed above, but in ad-
dition these conserved residues allow us to provide a con-
sensus definition of TALE-like repeats as conforming to the
sequence motif X6VX6GX13LX4–6. This motif may be use-
ful as a basis for identifying additional TALE-likes from
database DNA sequences, especially if combined with sec-
ondary structure predictions to identify the necessary two
alpha helices with intervening BSR loop.
By demonstrating that MOrTL repeats mediate DNA
binding behaviour analogous to that of other TALE-like re-
peats (Figures 2–5) we have gained insights into the nature
of the whole TALE-like family and we hope this will enable
further research into the distribution and functions of these
fascinating DNA binding proteins.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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Supplementary Figure 1: Annotated genomic loci bearing MOrTL1 and 2 ORFs.  
 
MOrTL1 (GenBank ECG96326) is a translation of a predicted ORF found in marine 
bacterial genomic contig EM567463.1 (available at GenBank). This contig is an 
assembly of two reads both bearing ORFs encoding similar repeat array proteins: 
JCVI_READ_1093012032286 (a) encoding ECG96325 (b) and 
JCVI_READ_1092963399564 (c) encoding MOrTL1 (d). These sequences form part 
of environmental sample ID 1103283000023 from the Global Oceanic Survey. 
Sample Metadata are available via the CAMERA metagenomics data distribution 
centre: http://camera.crbs.ucsd.edu/projects/details.php?id=CAM_PROJ_GOS. 
Sequences from this dataset were obtained by paired-end Sanger sequencing of a 
plasmid library of sheared microbial DNA.  
 
MOrTL2 (GenBank EBN91409) is a translation of a predicted ORF found in marine 
bacterial genomic contig EN814823.1. This contig is also an assembly of two reads 
each bearing similar repeat protein ORFs: JCVI_READ_1091143078068 (e) 
encoding EBN91408 (f) and JCVI_READ_1091143109172 (f) encoding MOrTL2 
(h). These sequences form part of environmental sample ID 1103283000022 from the 
Global Oceanic Survey.  
 
Synthesised coding sequences for MOrTL1 (i) and MOrTL2 (j) used in this study are 
also provided.  
 
Note that In addition to the sequences presented here a further accession from the 
same metagenomics dataset, GenBank accession EMO47375.1, bears an ORF 
encoding repeats similar to those of MOrLT1. However, there are only three repeats 
in this ORF and it was not taken as a candidate for DNA binding assays in this study.  
 
(a)  
>JCVI_READ_1093012032286 
GTAGGCTGAGGCTTAGATAGTTGGGACAAGTTAGTTGAAAAGGATTGGATAAGAACG
CCATTTTAAAGATTTCAATTTGTAACGGGGCTCATTTGGCGATTACCACGTTACTAG
AAAACTGGGATGCGTTAATAGATTTGGAACTGGAACCCAAAGATATTGTATCTATTG
CGTCTCATGGTGGGGCAACTCAGGCGATTACCACGTTACTAAACAAGTGGGATGACT
TAAGAGATAAGGGACTGGAACCCAAAGATATTGTATCCATTGCGTCTAATAATGGCG
CAACTCAGGCTATTGCTACGTTATTAGCAAAATGGGATTCCTTAATAGCTAAGGGAC
TGCAGCCCAAAGATATTGTATCCATTGCGTCTCATGGTGGGGCAACTCAGGCTATTA
CCACGTTACTAAACAGGTGGGGTGACTTAAGAGCTAAGGAACTGGAACCCAAAGATA
TTGTATCCATTGCGTCTCATGATGGGGCAACTCAGGCTATTACCACGTTACTAGAAA
AATGGGATGAGTTAAGAGCTAAGGGACTGGAACCCAAAGATATTGTATCCATTGCGT
CTCATATTGGCGCAAATCAGACTATTACTACGTTACTAAACAAGTGGGGTGCGTTAA
TAGATTTGGAACTGGAACCCAAAGATATTGTATCCATTGCGTCTCATGGTGGGGCAA
ATAAGGCTATTACCACGTTACTAGAAAAGTGGGCTGCCTTAAGAGCTAAGGAACTGG
AACCCAAAGATATTGTATCCATTGCGTCTCATAATGGAGCAACTCACGCTATTACTA
CGTTACTAAACAAGTGGGCTGCCTTAAGAGCTAAAGAACTGGAACCCAAAGATATTG
TATCCATTGCGTCTCATAATGGAGCAACTCACGCTATTACCATGTTATTAAACAAGT
GGGGTGACTTAAGAGCTAAGAACTGGAACCCAAAGATATTGTGTCCATTGCGTCACA
TGATGGGGCAACTCATGCTATTACTACGTTACTAGAAAATGGGATGAGTTAGAGCTA
ATGGTACTGCACCCAAAGATATTGTATCTATTGCGTCTATATGGCGCAAATCAGCGA
TTTCCACGTTACTAGAAAAGTGGGGTGCGTTATAG 
 
(b)  
>JCVI_READ_1093012032286 translation frame +3  
RLRLR*LGQVS*KGLDKNAILKISICNGAHLAITTLLENWDALIDLE 
LEPKDIVSIASHGGATQAITTLLNKWDDLRDKG 
LEPKDIVSIASNNGATQAIATLLAKWDSLIAKG 
LQPKDIVSIASHGGATQAITTLLNRWGDLRAKE 
LEPKDIVSIASHDGATQAITTLLEKWDELRAKG 
LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
LEPKDIVSIASHGGANKAITTLLEKWAALRAKE 
LEPKDIVSIASHNGATHAITTLLNKWAALRAKE 
LEPKDIVSIASHNGATHAITMLLNKWGDLRAKN 
WNPKILCPLRHMMGQLMLLLRY*KMG*VRANGTAPKDIVSIASIWRKSAISTLLEKW
GAL* 
(highlighted section = ECG96325) 
 
(c)  
>Reverse complement of JCVI_READ_1092963399564  
ATGGCGCAAATCCAGGCGATTTCCACGTTACTAGAAAAGTGGGGTGCGTTAATAGAT
TTGGAACTGGAACCCAAAGATATGTATCCATGCGTCTCATAATGAGCAAATCAGGCG
ATTACACGTTACTAAACAAGTGGGTGACTTAAGAGCTAAGGAACTGGAACCCAAAGA
TATTGTGTCCATTGCGTCTAATACTGGCGCAAATAAGACTATTACCAGGTTACTAGA
AAAGTGGGGTGACTTAAGAGCTAAGGAACTGGAACCCAAAGATATTGTATCCATTGC
GTCACATGATGGGTCAAATCAGACTATTACAAAGTTACTAGAAAAATGGGATGAGTT
AAGAGCTAAGGGACTGGAGCCCAAAGATATTGTATCCATTGCGTCTCATATTGGCGC
AAATCAGACTATTACTACGTTACTAAACAAGTGGGGTGCGTTAATAGATTTGGAACT
GGAACCCAAAGATATTGTATCCATTGCGTCTCATATTGGCGCAACTCAGGCTATTAC
TACGTTACTAAACAAGTGGGCTGCCTTAAGAGCTAAGGGACTGGACCCCAAAGATAT
TGTATCTATTGCGTCACATGATGGGTCAAATCAGACGATTACAAAGTTACTAGAAAA
ATGGGATGAGTTAAGAGCTAAGGAACTGGAATCCAAAGATATTGTATCCATTGCGTC
TAATAATGGCGCAACTCAGACTATTACCAGGTTACTAGAAAAATGGGATGAGTTAAG
AGCTAAGGGACTGGACCCCAAAGATATTGTATCCATTGCGTCTCATGGTGGTGCAAC
TCAGGCTATTACCACGTTACTAAACAGGTGGGGTGACTTAATAGATTTGGAACTGGA
ACCCAAAGATATTGTATCCATTGCGTCTCATAAAGGAGCAAATCAGGTTATTACTAC
GTTACTAGAAAAGTGGGATGACTTAATTAGTCAGGCATATACTAAGTCTAGCATTGT
GAGTATTGCTTCTACTCAGAATGGCGTATTAGGCCTATTGGAGGCGTTAGGTTAATA
ACATTATTTTCAAAGTAAAAAAGGGTTTATAAATACTGGAATATATTACTGATTATT
AAGTAAGGGAGTCTGCAATCCGTTAC 
 
(d)  
>Reverse complement of JCVI_READ_1092963399564 translation Frame +2  
WRKSRRFPRY*KSGVR**IWN 
WNPK ICIHASHNE QIRRLHVTKQVGDLRAKE 
LEPKDIVSIASNTGANKTITRLLEKWGDLRAKE 
LEPKDIVSIASHDGSNQTITKLLEKWDELRAKG 
LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
LEPKDIVSIASHIGATQAITTLLNKWAALRAKG 
LDPKDIVSIASHDGSNQTITKLLEKWDELRAKE 
LESKDIVSIASNNGATQTITRLLEKWDELRAKG 
LDPKDIVSIASHGGATQAITTLLNRWGDLIDLE 
LEPKDIVSIASHKGANQVITTLLEKWDDLISQA 
YTKSSIVSIASTQNGVLGLLEALG**HYFQSKKGFINTGIYY*LLSKGVCNPL 
(highlighted section = MOrTL1/ECG96326) 
 
(e)  
>JCVI_READ_1091143078068 
GTGGCCCCGTCGGCTTGACCACATAACTAACTTTTGTTGAGTTTCAGGGTTCAAGCA
TTAACTAATTAGGATTGCATGGTGTGAGAACATATTATTAATTTATATTTTGCAAGG
AGTTTTGTATTTATGAGTAATCAAACAGAGCAAAAAATTCTAAAGTTTAAGCTAGAG
CTGCGCTATCCAACAGAATCAGCTCAATTAATACGTGCTGGATTTAATCGAGATCAA
GCGGATAGGATTATCTTAAGAGGCTCTTCACAACGTACCGTTGCAAAGTTACTGGAA
ATTCACAAGACGTTGTTAGCTCATCCCTATAGAATAACCTACGACGACCTCACTCGA
ATTGCAGCAAGAAATGGAGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCT
GCCTTAACAGAACTCGGGTTTAGTGCTAAGGATATTGTGCAGATGGTGTCACATGGT
GGAGGCTCTAAAAACTTAGAGGTGGTACAAGCAAACTATGCTGCCTTAACAGGACTC
GGGTTTCGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAAC
TTAGCGGCTATGATAGACAAGTCTACTGCCTTAAAAGACCTTGGGTTTCGTACTGAG
GATATTGTGCAGATGGTGTCACATGATGGAAGCTCTAAAAACTTAGCGGCTATGATA
GACAAGTCTACTGCCTTAAAAGGCCTCGGATTTCGTACTGAGGGTATTGTGCAGATG
GTGTCACATGGGTGGAGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGC
CTTAACAGGACTCGGATTTCGTACTGAGGGTATTGTGCAGATGGTGTCACATGGTGG
AGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCCTTAACAGGACTCGG
GTTTCGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAACTTA
GCGGCTATTATAGACAAGTCTACTGCCTTATAGGCCTTGGGTTTCGTACTGAGGATA
TTGTGCAGATGGTGTCTAACAATGGAGGCTCTAAAACTTAGCGGCTAGATAGACAAG
TCTACTGCCTTAAAAGGCGCCCGATTTCGTACTGAAGAGATTGTTGCCCATGGTGTC
CCATGGGTGGGAGGGCTCTTACAAACTATAAAGGGGGTGGGAGGGCGGAC 
 
(f) 
>JCVI_READ_1091143078068 translation frame +1  
VAPSA*PHN*LLLSFRVQALTN*DCMV*EHIINLY 
FARSFVFMSNQTEQKILKFKLELRYPTESAQLIRAG 
FNRDQADRIILRGSSQRTVAKLLEIHKTLLAHPYR 
ITYDDLTRIAARNGGSKNLVAVQANYAALTELG 
FSAKDIVQMVSHGGGSKNLEVVQANYAALTGLG 
FRTEDIVQMVSHDGGSKNLAAMIDKSTALKDLG 
FRTEDIVQMVSHDGSSKNLAAMIDKSTALKGLG 
FRTEGIVQMVSHGWRL*KLSGGASKLCCLNRTRISY*GYCADGVTWWRL*KLSGGAS
KLCCLNRTRVSY*GYCADGVT*WRL*NLAAIIDKSTAL*ALGFVLRILCRWCLTMEA
LKLSG*IDKSTALKGARFRTEEIVAHGVPWVGGLLQTIKGVGGR 
(highlighted section = EBN19408) 
 
(g)  
>Reverse complement of JCVI_READ_1091143109172  
CTTAGCGGCTATGATAGACAAGTCTACTGCCTTAAAAGACTTCGGGTTTCGTACTGA
GGATATGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTAGCGGCTATGATA
GACAAGTCTACTGCCTTAAAAGGCCTCGGATTTCGTACTGAGGGTATTGTGCAGATG
GTGTCACATGGTGGAGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCC
TTAACAGGACTCGGATTTCGTACTGAGGGTATTGTGCAGATGGTGTCACATGGTGGA
GGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCCTTAACAGGACTCGGG
TTTCGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTA
GCGGCTATTATAGACAAGTCTACTGCCTTAACAGGCCTTGGGTTTCGTACTGAGGAT
ATTGTGCAGATGGTGTCTAACAATGGAGGCTCTAAAAACTTAGCGGCTATTATAGAC
AAGTCTACTGCCTTAAAAGGCCTCGGATTTCGTACTGAGGATATTGTGCAGATGGTG
TCACATGGTGGAGGCTCTAAAAACTTAGAGGTGGTGCAAGCAAACTATGCTGCCTTA
ACAGGACTCGGATTTCGTACTGAGGGTATTGTGCAGATGGTGTCACATGGTGGAGGC
TCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCCTTAACAGGACTCGGGTTT
CGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTAGCG
GCTATGATAGACAAGTATACTGCCTTAAAAGACCTTGGGTTTCGTACTGAGGATATT
GTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTAGCGGCTATTATAGACAAG
TCTACTGCCTTAAAAGGCCTCGGATTTCTTACTGAGGATATTGTGCAGATGGTGTCA
CATGATGGAGGCTCTAAAAACTTAGAGGTGGTGCAAGCAAGCTATGATACCTTAACA
GAACTCAAGTTTAGTGCTGAGCATCTCAGCCCTTC 
 
(h)  
>Reverse complement of JCVI_READ_1091143109172 translation frame +1  
LSGYDRQVYCLKRLRVSY*GYVQMVSHDGGSKNLAAMIDKSTALKGLG 
FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
FRTEDIVQMVSHDGGSKNLAAMIDKYTALKDLG 
FRTEDIVQMVSHDGGSKNLAAIIDKSTALKGLG 
FLTEDIVQMVSHDGGSKNLEVVQASYDTLTELKFSAEHLSP 
(highlighted section = MOrTL2/ EBN19409) 
 
Note, the sequences at the N-terminus of MOrTL2 (RVLCRWCHM) differs from the 
sequence above. This is because MOrTL2 is a translation of the assembled sequence 
not the individual reads. Differences arise in the N-terminal section of MOrTL2 from 
reconciling polymorphic bases between this read and read 1091143078068. Looking 
at translations of the raw reads it seems likely that sequencing did not cover the whole 
insert and further MOrTL repeats separate the two reads.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(i) MOrTL 1/ECG96326 – synthesized CDS (GenScript). BsaI restriction enzyme 
binding sites underlined and overlaps italicized. Start and stop codons bold. 
 
>MOrTL1_CDS_Genscript 
GGTCTCATATGGTTGGCGATCTGCGTGCGAAAGAACTGGAACCGAAAGACATTGTGA
GCATTGCCTCTAACACCGGCGCGAATAAAACGATTACCCGCCTGCTGGAAAAATGGG
GCGATCTGCGTGCCAAGGAGCTGGAACCGAAAGATATTGTCAGCATCGCCTCTCATG
ACGGCAGTAACCAGACCATTACGAAACTGCTGGAAAAATGGGATGAACTGCGCGCAA
AAGGTCTGGAACCGAAAGATATCGTGAGTATCGCATCCCACATTGGCGCTAACCAAA
CGATCACCACGCTGCTGAATAAATGGGGTGCACTGATTGATCTGGAATTAGAGCCGA
AAGATATCGTTTCAATCGCTTCGCATATTGGTGCAACCCAGGCTATCACCACGCTGC
TGAACAAATGGGCGGCCCTGCGTGCAAAAGGCCTGGATCCGAAAGACATTGTCAGCA
TCGCTTCTCACGATGGTTCTAATCAAACGATCACCAAGTTACTGGAAAAATGGGACG
AACTGCGCGCCAAAGAACTGGAAAGCAAAGACATTGTGAGTATCGCGTCCAACAATG
GCGCCACCCAGACGATCACCCGTCTGCTGGAGAAGTGGGACGAACTGCGCGCGAAAG
GTCTGGATCCGAAAGATATCGTGAGCATCGCATCGCATGGCGGTGCAACCCAGGCAA
TTACCACGCTGCTGAACCGTTGGGGCGATCTGATCGACCTGGAATTAGAACCTAAAG
ACATTGTGAGCATCGCATCTCACAAAGGTGCTAATCAGGTTATTACCACGCTGCTGG
AAAAATGGGACGACCTGATCAGTCAAGCGTATACCAAATCCTCAATCGTGTCAATCG
CATCAACGCAAAATGGTGTCCTGGGTCTGCTGGAAGCCCTGGGTTAGGGTGAGAGAC
C 
 
(j) MOrTL 2/EBN91409 – Synthesised CDS (GenScript). BsaI restriction enzyme 
binding sites underlined and overlaps italicized. Start and stop codons bold. 
 
>MOrTL2_CDS_Genscript 
GGTCTCATATGATGCGCGTTCTGTGTCGTTGGTGCCACATGGGCGGCGGCTCTAAAA
ATCTGGTTGCTGTTCAAGCTAACTATGCGGCTCTGACGGGCCTGGGTTTTCGTACCG
AAGGCATTGTCCAGATGGTGAGCCATGGCGGTGGCTCTAAAAACCTGGTCGCGGTGC
AAGCCAATTATGCAGCACTGACCGGTCTGGGCTTCCGTACGGAAGATATTGTTCAGA
TGGTCAGTCACGATGGTGGCTCCAAAAACCTGGTTGCAGTCCAAGCTAATTACGCAG
CTCTGACCGGTCTGGGCTTTCGTACGGAAGATATTGTGCAGATGGTTTCACATGATG
GTGGCTCGAAAAACCTGGCGGCCATTATCGACAAAAGTACCGCACTGACGGGTCTGG
GCTTCCGTACCGAAGATATCGTCCAAATGGTGAGCAACAATGGTGGCTCTAAAAATC
TGGCAGCTATTATCGATAAAAGCACCGCCCTGAAAGGTCTGGGCTTCCGCACCGAAG
ATATTGTCCAAATGGTCAGTCACGGTGGCGGTTCCAAAAATCTGGAAGTGGTGCAGG
CCAACTACGCCGCCCTGACGGGTCTGGGCTTTCGCACCGAAGGTATCGTTCAAATGG
TTTCACATGGCGGTGGCTCGAAAAATCTGGTGGCAGTTCAAGCGAACTATGCCGCCT
TAACGGGTCTGGGCTTTCGTACCGAAGATATTGTCCAGATGGTTAGCCACGATGGTG
GCTCTAAGAATCTGGCGGCCATGATTGATAAATATACCGCGCTGAAAGACCTGGGTT
TCCGCACGGAAGATATCGTGCAGATGGTTAGTCATGACGGTGGCTCCAAAAATCTGG
CCGCCATTATCGATAAATCTACGGCGCTGAAAGGTCTGGGCTTTCTGACCGAAGATA
TTGTTCAAATGGTGAGCCACGATGGCGGTAGCAAAAACCTGGAAGTGGTGCAAGCAT
CATACGACACGCTGACGGAACTGAAATTCTAGGGTGAGAGACC 
 
 
  
Supplementary Figure 2: Sequences of TALE, RipTAL and Bat repeats used to 
create the consensus repeats in Figure 1c and for the calculation of percentage 
identities in Figure 1d. Grey shading indicates conflicting residues.   
 
 
 
  
 
  
Supplementary Figure 3: (a) Protein expression gel for MOrTL1 and MOrTL2 and 
(b) EMSA gel for MOrTL1 against BEMOrTL1. hpi= hours post induction with IPTG. 
 
 
 
 
 
 
 
 
 
 
 
(b) 
(a) 
Supplementary Figure 4: Amino acid sequence of fusion protein EBN91408-
MOrTL2. The two ORFs of genomic accession EN814823.1 (see Figure S1) are 
separated by a frame-shift in the middle of MOrTL1 repeat 1. Removal of a single 
guanine base allows read through of a longer protein designated EBN91408-MOrTL2. 
Although, as noted in Figure S1, the true genomic locus likely contains further 
intervening repeats not covered in the assembly. EBN91408 is underlined.  Repeats 
are numbered and 0 and -1 are uses to designate the sequence degenerate N-terminal 
repeats.  
 
> EBN91408-MOrTL2. 
   MSNQTEQKILKFKLELRYPTESAQLIRAG 
-1 FNRDQADRIILRGSSQRTVAKLLEIHKTLLAHPYR 
0  ITYDDLTRIAARNGGSKNLVAVQANYAALTELG 
1  FSAKDIVQMVSHGGGSKNLEVVQANYAALTGLG 
2  FRTEDIVQMVSHDGGSKNLAAMIDKSTALKDLG 
3  FRTEDIVQMVSHDGSSKNLAAMIDKSTALKGLG 
4  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
5  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
6  FRTEDIVQMVSHDGGSKNLVAVQANYAALTGLG 
7  FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
8  FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
9  FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
10 FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
11 FRTEDIVQMVSHDGGSKNLAAMIDKYTALKDLG 
12 FRTEDIVQMVSHDGGSKNLAAIIDKSTALKGLG 
13 FLTEDIVQMVSHDGGSKNLEVVQASYDTLTELKF 
 
 
 
 
Supplementary Figure 5: Protein expression gel for Bat1M1(3-7), Bat1M2(2-6), dTALE-
Bat1M1(3-7) and dTALE-Bat1M2(4-8). 
 
 
 
Supplementary Figure 6: Quantifications of protein : DNA relative to free-DNA in 
EMSAs shown in Figures 2d and 4d. EMSAs were carried out three times and 
standard deviations are shown. The proportion of shifted probe is expressed as a 
decimal along the y-axis of each plot. The fold excess of competitor DNA is shown 
below each bar.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 7:  MST-Traces for figures 4 and 5.  
 
 
 
 
Supplementary Figure 8:  
 
Maps of E.coli repressor reporter plasmids pMBS6 and pBT102*. TALE-like binding 
elements (BEs) are added to pCherry at the indicated position via PCR. TALE-like 
chimeras were added to pBT102* using BsaI cut-ligation. The pBT102 derivative 
with BsaI digest overlaps TATG (5’) and GGTG (3’) was used for the assembly of 
TALE chimeras. An additional derivative with overlaps CACC (5’) and AAGG (3’) 
but otherwise identical was created for the assembly of Bat1 chimeras. See materials 
and methods section for further details.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Supplementary Figure 9: Sequences of pCherry reporter constructs 
 
pCherry – BE Bat1 
mCherry CDS 
Lac operator 
Binding element Bat1 
 
CGACTGCACGGTGCACCAATGCTTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTAT
GGCTGTGCAGGTCGTAAATCACTGCATAATTCGTGTCGCTCAAGGCGCACTCCCGTT
CTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCTGAAATGA
GCTGTTGACAATTAATCATCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACA
ATTTCTaagagaagcaaagacgttatGAATTCAAAAGATCTATCGATCGAGGATCCA
GGAGGTACAATCAATGGTGAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGA
GTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGAT
CGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGT
GACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTA
CGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTC
CTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGT
GACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCT
GCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTG
GGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAA
GCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTA
CAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGTTGGA
CATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGG
CCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAA 
 
Underlined sequence differs between the various reporters, with capital letters  
indicating sequences corresponding to MOrTL repeats 
 
BE Bat1 M1 (3-7) 
aagagAACGTaagacgttat 
 
BE dTALE-Bat1 M1 (2-6) 
aagagCAACGaagacgttat 
 
BE Bat1 M2 (2-6) 
aagagTCCGTaagacgttat 
 
BE dTALE-Bat1 M2 (4-8) 
aagagCGTTCaagacgttat 
 
BE dTALE-Bat1 M2 (2-6) 
aagagTCCGTaagacgttat 
 
BE Bat1 GGTTG 
aagagGGTTGaagacgttat 
 
BE Bat1 TTGGT 
aagagTTGGTaagacgttat 
Supplementary Figure 10: Sequences of (a) Bat1-MOrTL and (b) TALE-MOrTL 
reporter constructs 
 
(a) 
Bat1 constructs expressed form pDEST-17 are preceded by an N-terminal His-Tag of 
sequence: MSYYHHHHHHLESTSLYKKAGSAAAPFM  
  
 
>Bat1 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
6  FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
7  FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
8  FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
9  FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
 
In PBT102 (extra C-terminal residues from cloning vector): 
… GGTLIIPDLHSRKSKTSDRRLLT 
 
>Bat1M1 (3-7) 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
6  LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
7  LEPKDIVSIASHIGATQAITTLLNKWAALRAKG 
8  LDPKDIVSIASHDGSNQTITKLLEKWDELRAKE 
9  LESKDIVSIASNNGATQTITRLLEKWDELRAKG 
10 LDPKDIVSIASHGGATQAITTLLNRWGDLIDLG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
 
In PBT102 (extra C-terminal residues from cloning vector) 
… GGTLIIPDLHSRKSKTSDRRLLT 
 
>Bat1M2 (2-6) 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
6  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
7  FRTEDIVQMVSHDGGSKNLVAVQANYAALTGLG 
8  FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
9  FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
10 FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
 
in PBT102 (extra C-terminal residues from cloning vector) 
… GGTLIIPDLHSRKSKTSDRRLLT 
 
 
 
 
 
 
 
 
(b)  
dTALE-Bat1 In pDEST-17 (E.coli protein expression and purification construct): 
Underlined sequences represent peptide tags, N-terminal HA and C-terminal 3xflag 
with flexible linker.  
MSYYHHHHHHLESTSLYKKAGSAAAPF 
 
>dTALE-Bat1 In pDEST-17 
MDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVK
YQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
0  LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
6  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
7  LTPQQVVAIASNIGGKQALETVQALLPVLCQAHG 
8  LTPEQVVAIASNNGGKQALETVQALLPVLCQAHG 
9  LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACLGGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVA 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEAS 
 
 
In pBT102 (E.coli expression, repressor assay construct): 
 
These constructs lack the N-terminal HA tag but otherwise are identical from the N-
terminus until after the C-terminal degenerate repeats: the TALE-C-terminal section 
is longer and there is a C-terminal GFP.  
… 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACLGGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMS 
GSVSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATIGKLTLKFICTTGKLPV
PWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTISFKDDGKYKTRAVV
KFEGDTLVNRIELKGTDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFTVRH
NVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQTVLSKDPNEKRDHMVLHEYVNA
AGIT 
 
 
 
 
>dTALE-Bat1M1 (3-7) 
… 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAFASNNGGKQALTKLLEKWDELRAKG 
6  LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
7  LEPKDIVSIASHIGATQAITTLLNKWAALRAKG 
8  LDPKDIVSIASHDGSNQTITKLLEKWDELRAKE 
9  LESKDIVSIASNNGATQTITRLLEKWDELRAKG 
10 LDPKDIVSIASHGGATQAITTLLNRWGDLIDLE 
11 LEPKDIVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
… 
 
>dTALE-Bat1M2 (4-8) 
… 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAIASNNGGKQALVAVQANYAALTGLG 
6  FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
7  FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
8  FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
9  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
10 FRTEDIVQMVSHDGGSKNLAAMIDKYTALKDLG 
11 FRTEDIVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
… 
 
  
>dTALE-Bat1M1 (2-6) 
… 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAFASNNGGKQALTRLLEKWGDLRAKE 
6  LEPKDIVSIASHDGSNQTITKLLEKWDELRAKG 
7  LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
8  LEPKDIVSIASHIGATQAITTLLNKWAALRAKG 
9  LDPKDIVSIASHDGSNQTITKLLEKWDELRAKE 
10 LESKDIVSIASNNGATQTITRLLEKWDELRAKG 
11 LDPKDIVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
… 
 
>dTALE-Bat1M2 (2-6) 
… 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAIASNNGGKQALVAVQANYAALTGLG 
6  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
7  FRTEDIVQMVSHDGGSKNLVAVQANYAALTGLG 
8  FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
9  FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
10 FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
11 FRTEGIVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
 
 
 
 
 
 
 
 
Supplementary Figure 11: Core repeat alignments of a representative RipTAL 
(Brg11) and TALE (AvrBs3). Alignments were constructed with CLC Main 
Workbench and images generated with Boxshade. Conserved residues are shown as 
white letters on a black background.  The BSRs are highlighted in bold-italic font.  
>RipTAL (Brg11) 
 1 LTPQQVVAIASNTGGkRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGkQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGkQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGkQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGkQALEAVKAHLLDLRGVPYA 
 6 LSTEQVVAIASHNGGkQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGkQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGkQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGkQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGnQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGkQALEAVGAQLVALRAAPYA 
12 LNTEQVVAIASSHGGkQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGkQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGkQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGkQALEAVWALLPVLRATPYD 
16 LNTAQIVAIASHDGGkPALEAVWAKLPVLRGAPYA 
>TALE (AvrBs3) 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
 
 
 
 
 
 
 
 
 
Supplementary Table 1: The TALE code 
 
A reference guide for the specificities of commonly occurring BSRs, based on several 
publications: 
1: Yang et al., 2014 
2: de Lange et al.,  2014 
3: Boch et al., 2009 
4: Cong et al., 2012 
Boch et al., 2009; de Lange et al., 2013; Mak, Bradley, & Cernadas, 2012; Meckler et 
al., 2013; Moscou & Bogdanove, 2009; Yang et al., 2014). 
 
BSR Best-match 2nd best Tolerated Mismatch  
Gly T - A, G, C (2, 4) - 
GlySL C, Cme  - T, A, G (3, 4)  - 
Asp C -  A(3,4) G, T 
Ile A - - G, C, T 
Ser A, G, C  T (1)  
Arg G A - C, T 
His G - A, C (2) C, T 
Lys G -  A, C, T 
 
Note: since specificity is only a measure of relative affinity the absolute affinities for 
BSRs to their best-match or mismatch bases can vary greatly. See Meckler et al., 
Nucl. Acids Res., 2013 for more detail on this.  
GlySL = Glycine Short-loop referring to TALE repeats with a truncated BSR-loop 
(missing position 13 relative to other repeats). In such repeats the first residue of the 
glycine di-residue following the BSR position acts as the BSR in these repeats (Mak 
et al., Science, 2012) 
 
 
Supplementary Table 2: A list of oligonucleotides used in this study 
Primer name Sequence Notes 
EMSA probes 
BEMOrTL1 EMSA 
Fwd TAGCACAACGTGCTGAC 
EMSA Probe for non-chimeric 
MOrTL1 protein 
BEMOrTL1 EMSA 
Rev GTCAGCACGTTGTGCTA 
EMSA Probe for non-chimeric 
MOrTL1 protein 
BEMOrTL2 EMSA 
Fwd 
TAGCTTCCGTTCCCTGA
C 
EMSA Probe for non-chimeric 
MOrTL2 protein 
BEMOrTL2 EMSA 
Rev 
GTCAGGGAACGGAAGCT
A 
EMSA Probe for non-chimeric 
MOrTL2 protein 
BEBat1 M1 6-10 
EMSA Fwd 
TAGACTAAGAGAACGTA
AGACGTTATATGC 
EMSA probe for BatM1 6-10 and 
dTALE-Bat1M1 6-10 
 
BEBat1 M1 6-10 
EMSA Rev 
GCATATAACGTCTTACG
TTCTCTTAGTCTA 
EMSA probe for BatM1 6-10 and 
dTALE-Bat1M1 6-10 
 
BEBat1 M2 6-10 
EMSA Fwd 
TAGACTAAGAGTCCGTA
AGACGTTATATGC 
EMSA probe for BatM2 6-10  
 
BEBat1 M2 6-10 
EMSA Rev 
GCATATAACGTCTTACG
GACTCTTAGTCTA 
EMSA probe for BatM2 6-10  
 
BEdTALE-Bat1 
M2 6-10 EMSA 
Fwd 
TAGACTAAGAGCGTTCA
AGACGTTATATGC 
EMSA probe for dTALE- BatM2 6-10  
 
BEdTALE-Bat1 
M2 6-10 EMSA 
Rev 
GCATATAACGTCTTGAA
CGCTCTTAGTCTA 
EMSA probe for dTALE- BatM2 6-10  
 
BEBat1 GGTTG 
EMSA Fwd 
TAGACTAAGAGGGTTGA
AGACGTTATATGC 
OFF-target EMSA probe for all 
except dTALE-Bat1M2 6-10 
BEBat1 GGTTG 
EMSA REv 
GCATATAACGTCTTCAA
CCCTCTTAGTCTA 
OFF-target EMSA probe for all 
except dTALE-Bat1M2 6-10 
BEBat1 TTGGT 
EMSA Fwd 
TAGACTAAGAGTTGGTA
AGACGTTATATGC 
OFF-target EMSA probe dTALE-
Bat1M2 6-10 
BEBat1 TTGGT 
EMSA Rev 
GCATATAACGTCTTAAC
CACTCTTAGTCTA 
OFF-target EMSA probe dTALE-
Bat1M2 6-10 
Primers for PCR mutagenesis 
MOrTL1 Bat1 
Block2 Mimic 
Fwd  
GGTCTCTTGGGCTGGAA
CCGAAAGATATCGTG 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL1 Bat1 
Block2 Mimic Rev 
GGTCTCAAACCCAGGTC
GATCAGATCGCCCC 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL2 Bat1 
Block2 Mimic 
Fwd  
GGTCTCTTGGGTTTCGT
ACCGAAGGCATTGTCCA 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL2 Bat1 
Block2 Mimic Rev 
GGTCTCAAACCCAGACC
CGTCAGGGCGGCGTAG 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL1 dTALE 
5B mimic Fwd 
GAAGACTCTCTGACGAA
ACTGCTGGAAAAATG 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
MOrTL1 dTALE 
5B mimic Rev 
GAAGACTCCGCTACAAT
GTCTTTAGGTTCTAATT
C 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
MOrTL2 dTALE 
5B mimic Fwd 
GAAGACTCTCTGGTTGC
AGTCCAAGCTAATTACG
C 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
MOrTL2dTALE 
5B mimic Rev 
GAAGACTCCGCTACGAT
ATCTTCCGTGCGGAAAC 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
MOrTL1 dTALE 
5B mimic Fwd 2 
ATGAAGACTCTCTGACC
CGCCTGCTGGAAAAATG
GGGCGATC 
To create the 2nd set of MOrTL 
repeats to insert into dTALE-Bat1 
MOrTL1 dTALE 
5B mimic Rev 2 
CAGAAGACTCCGCTACG
ATATCTTTCGGATCCAG
ACCTTTCG 
To create the 2nd set of MOrTL 
repeats to insert into dTALE-Bat1 
MOrTL2 dTALE 
5B mimic Fwd 2 
ATGAAGACTCTCTGGTT
GCTGTTCAAGCTAACTA
TGC 
To create the 2nd set of MOrTL 
repeats to insert into dTALE-Bat1 
MOrTL2 dTALE 
5B mimic Rev 2 
CAGAAGACTCCGCTACG
ATACCTTCGGTGCGAAA
GCC 
To create the 2nd set of MOrTL 
repeats to insert into dTALE-Bat1 
GFP-VS-Fwd ATGGTGTCTAAGGGCGA To create a GFP only pBT102 
AGAACTC expression plasmid 
TATG_BsaI_Rev 
AAGAGACCCCTGCATGC
AAGC 
To create a GFP only pBT102 
expression plasmid 
pMBS6 BEBat1 MX 
6-10 Fwd 
AAGACGTTATGAATTCA
AAAGATCTATCGA 
To get BEBat1 M1 or M2 6-10 into 
pMBS6 
pMBS6 BEBat1 M1 
6-10 Rev 
ACGTTCTCTTAGAAATT
GTTACCGCTC To get BEBat1 M1 6-10 into pMBS6 
pMBS6 BEBat1 M2 
6-10 Rev 
ACGGACTCTTAGAAATT
GTTATCCGCTC To get BEBat1 M2 6-10 into pMBS6 
AvrBs3DeltaCTD
Rev 
GCTCATCCCGAACTGCG
TCA 
To create C-terminal TALE 
truncation derivate to match Politz 
et al. LacO dTALE 
AvrBs3DeltaCTD
Fwd 
AAGGTGAGACCTTTGGG
ATCCGA 
To create C-terminal TALE 
truncation derivate to match Politz 
et al. LacO dTALE 
   
pMBS6 BEdTALE-
Bat1 M2 6-10 Rev 
GAACGCTCTTGAAATTG
TTATCCGCTC 
To get BEdTALE-Bat1 M2 6-10 into 
pMBS6 
BsaI AAGG Rev 
CCT TTG AGA CCG 
GTC GAC CTG C 
To create a goldengate version of 
E.coli expression vector pBT102 
BsaI GGTG Rev 
CAC CTG AGA CCG 
GTC GAC CTG 
To create a goldengate version of 
E.coli expression vector pBT102 
BsaI TATG Fwd  
TAT GTG AGA CCG 
CGG CCC CTC 
To create a goldengate version of 
E.coli expression vector pBT102 
Sequencing primers 
Sco5B MidSeqF 
TATCGATAAAAGCACCG
CCC 
To sequence central section of 
pDEST17 dTALE-Bat1M2 6-10 
Sco5B MidSeqR 
ACCGTGACTGACCATTT
GGA 
To sequence central section of 
pDEST17 dTALE-Bat1M2 6-10 
  
Supplementary Table 3: Averaged base-BSR distances from MD model  
of Bat1 M1 6-10. Average distances over all MD snapshots between BSR Cα-atom 
and the ring nitrogen that connects nucleobase and deoxyribose moieties. MOrTL 
pairs are highlighted in green. 
 
BSR Nucleotide Average distance (nm) SD 
ILE 95 DA 1 0,742 0,044 
ILE 128 DA 2 0,719 0,022 
ASN 161 DG 3 0,666 0,026 
THR 194 DA 4 0,706 0,027 
ASN 227 DG 5 0,669 0,029 
ILE 260 DA 6 0,753 0,040 
ILE 293 DA 7 0,830 0,075 
ASP 326 DC 8 0,853 0,088 
ASN 359 DG 9 0,888 0,050 
GLY 392 DT 10 0,815 0,044 
ILE 425 DA 11 0,742 0,029 
THR 458 DA 12 0,708 0,042 
ARG 491 DT 13 0,854 0,047 
SER 524 DA 14 0,696 0,043 
ASP 557 DC 15 0,709 0,026 
ASN 590 DG 16 0,671 0,025 
GLY 623 DT 17 0,754 0,026 
GLY 656 DT 18 0,782 0,030 
SER 689 DA 19 0,661 0,032 
  
Supplementary Table 4: Averaged base-BSR distances from MD model  
of Bat1 M2 6-10. Average distances over all MD snapshots between BSR Cα-atom and 
the ring nitrogen that connects nucleobase and deoxyribose moieties. MOrTL pairs 
are highlighted in green. 
 
BSR Nucleotide Average distance (nm) SD 
ILE 95 DA 1 0,728 0,028 
ILE 128 DA 2 0,707 0,026 
ASN 161 DG 3 0,674 0,029 
THR 194 DA 4 0,716 0,028 
ASN 227 DG 5 0,642 0,021 
GLY 260 DT 6 0,738 0,030 
ASP 293 DC 7 0,739 0,047 
ASP 326 DC 8 0,763 0,068 
ASN 359 DG 9 0,816 0,100 
GLY 392 DT 10 0,815 0,056 
ILE 425 DA 11 0,767 0,044 
THR 458 DA 12 0,708 0,042 
ARG 491 DT 13 0,869 0,051 
SER 524 DA 14 0,715 0,042 
ASP 557 DC 15 0,698 0,021 
ASN 590 DG 16 0,685 0,033 
GLY 623 DT 17 0,739 0,027 
GLY 656 DT 18 0,773 0,035 
SER 689 DA 19 0,661 0,022 
 
 
Supplementary Table 5: TALE-likes used in the creation of repeat sequence logos 
shown in Figure 7. GenBank designations are given where relevant to avoid 
ambiguity.  
 
TALEs AvrBs3, AvrBs4, AvrXa27, AvrXa7, PthXo1 
(ACD58243), PthB (NP_942641), AvrHah1, 
Hax2, Hax3, Hax4 TalC (AEK86668),AvrPth3, 
PthA (AAC43587) 
RipTALs Brg11, CCA82456,CAQ18687, RipTALI_14, 
YP_003750492 
Bats BAT1_BURRH, Bat2 (E5AW45), 
Bat3(E5AW43) 
MOrTL1 EBN91408, EBN91409, ECG96325, ECG96326 
 
 
 
 
 
 
 
Supplementary Table 6: Percentage conservation in each of the sequence logos seen 
in Figure 7. Grey shading indicates positions with 75% conservation or over in all 
groups, as displayed also in Figure 7. 
 
Position TALEs RipTALs Bats MOrTL1 MOrTL2 
1 100 100 86.5 100 100 
2 99.4 77 65.4 75 83.3 
3 88.8 81.1 50 87.5 91.7 
4 40 59.5 48.1 100 91.7 
5 100 100 82.7 100 83.3 
6 100 95.9 98.1 100 100 
7 100 98.6 82.7 100 100 
8 100 93.2 75 100 100 
9 100 87.8 71.2 100 100 
10 100 100 94.2 100 100 
11 92.9 90.5 73.1 100 100 
12 67.6 59.5 92.3 75 91.7 
13 29.4 43.2 25 25 58.3 
14 100 100 100 100 100 
15 98.8 100 98.1 75 91.7 
16 99.4 93.2 96.2 62.5 100 
17 99.4 87.8 98.1 87.5 100 
18 100 95.9 98.1 62.5 100 
19 100 100 100 100 100 
20 98.8 95.9 50 100 50 
21 99.4 91.9 76.9 50 75 
22 98.2 87.8 96.2 100 50 
23 98.8 40.5 80.8 100 50 
24 90.6 75.7 42.3 62.5 50 
25 100 70.3 53.8 87.5 50 
26 100 91.9 59.6 100 58.3 
27 100 55.4 76.9 50 50 
28 99.4 33.8 53.8 37.5 91.7 
29 100 100 88.5 100 100 
30 96.5 97.3 46.2 62.5 58.3 
31 87.1 70.3 0 0 0 
32 64.1 81.1 0 0 0 
33 17.6 98.6 61.5 62.5 75 
34 100 97.3 80.8 62.5 100 
35 82.4 40.5 92.3 50 91.7 
 
